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Summary 
The main goal of bone repair is to regenerate pre-existing properties and restore tissue 
integrity and function. It has been reported that bone contains numerous growth factors 
which are proposed to be released from the matrix during injury and mediate the repair 
process. These molecules act in synergistic action causing recruitment of progenitor 
stem cells to sites of bone injury, which then proliferate and differentiate into mature 
bone synthesising cells capable to initiate repair processes. It has been demonstrated 
that combinations of growth factors, such as the combinations found in the bone matrix, 
may be more effective in promoting bone healing compared with single growth factor 
therapy. 
  
This project focuses on understanding bone repair processes by stimulating ex vivo 
fractured rat mandible model with either endogenous growth factors released by 
chemical treatment or by exogenous single growth factor therapy and investigating their 
effects on cellular behaviour. This project utilised the ex vivo mandible model as a 
promising alternative to current model and fractures were made within the ex vivo 
mandible slices to mimic bone fracture repair scenario. In summary, ex vivo 
experimental models were used successfully to investigate mechanism of bone repair. 
The results demonstrated that bioactive growth factors, particularly TGF-β1, BMP2 and 
VEGF successfully released from the bone matrix by EDTA, citric acid and calcium 
hydroxide. These growth factors found to affect cellular behaviour, by influencing 
proliferation and differentiation of osteoprogenitor cells. Calcium hydroxide derived 
endogenous growth factors mediated the repair process of mandibular bone greater 
than exogenously applied BMP2. Calcium hydroxide may provide a novel therapeutic 
approaches to utilise the synergistic effect of cocktail growth factors entrapped in bone 
matrix to stimulate optimal bone regeneration and avoid issues regard single growth 
factor therapy.  
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Chapter 1. Introduction 
 
1.1 Basic bone biology 
In order to understand the mechanism of bone repair, it is crucial to understand 
the basic composition of bone and its influence on the process of bone 
regeneration. Bone is a mineralized dense connective tissue involved in different 
functions such as providing framework and support to the body as well as 
protecting internal vital organs (Nanci and Ten Cate 2013). It also plays other 
roles in providing a reservoir of mineral ions and attachment points for muscles 
and tendons (Hadjidakis and Androulakis 2006; Deng et al. 2008).  
 
Bone includes different tissues such as endosteum, periosteum, neural, vascular 
and chondoral tissues. Endosteum is thin connective tissue membrane that lines 
the interior cavities within the bone. It contains haematopoietic stem cells 
(HSCs) that generate blood cells (Arai et al. 2009), osteoblasts, osteoclasts and 
osteoprogenitor cells (Clarke 2008; Lang and Lindhe 2015). Periosteum, the 
outer surface of  bone, consists of an outer fibrous layer rich in fibroblast cells 
and inner osteogenic layer containing progenitor cells that develop into 
osteoblast cells (Kalfas 2001). Blood supply in bone plays an important role in 
bone nourishment, healing and maintaining homeostasis.  
 
 
2 
Histological cross sections of bone tissue can be classified into compact cortical 
bone and spongy trabecular bone (Figure 1.1). Compact bone is a dense bone 
surrounding the trabecular bone. It consists mainly of haversian systems or 
secondary osteons. Spongy bone is a cancellous sponge like bone within the 
medullary cavity. It consists of extensively connected bony trabeculae make 
room for blood vessels and marrow (Figure 1.2) (Nanci and Ten Cate 2013; 
Lang and Lindhe 2015). Osseous tissue consists of a complex composite of 
cells and extracellular matrix (ECM). The cellular components participate in 
maintaining bone structure and function. The extracellular matrix (ECM) is made 
of inorganic hydroxyapatite crystals and organic part composed mainly of Type I 
collagen (Nanci and Ten Cate 2013; Lang and Lindhe 2015).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1- 1: Mandible body. Compact bone is a dense bone surrounding the trabecular bone. 
(adapted from Nanci and Ten Cate 2013). 
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1.1.1 Cellular Components of Bone 
The cellular components of bone participate in maintaining bone structure and 
function. Bone cells include osteoprogenitor cells, osteoblasts, osteocytes and 
osteoclasts. Each of these cells is involved in different functions.  They play an 
important role in formation, breakdown and general regulation of bone 
(Kartsogiannis and Ng 2004; Hughes et al. 2006a). Imbalances in their actions 
directly affect bone growth and remodelling.  
 
Several connective tissue cells are derived from mesenchymal stem cells. 
Mesenchymal stem cells are undifferentiated, self-renewing cells found within 
the marrow space and periosteum (Bielby et al. 2007b). They have the potential 
to differentiate into several cell types such as adipocytes, chondrocytes, 
Figure 1- 2: Structure of bone (adapted from Nanci and Ten Cate 2013). 
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osteoblasts, osteocytes and myoblasts (Kartsogiannis and Ng 2004; Taichman 
2005). The bone marrow space also contains hemopoietic stem cell niche which 
produce erythrocytes, leukocytes and ultimately osteoclasts (Kartsogiannis and 
Ng 2004; Taichman 2005). Osteoprogenitor cells are derived from mesenchymal 
stem cell and able to differentiate into osteoblast cell. During bone regeneration, 
mesenchymal stem cells are recruited to the site of injury. Numerous growth 
factors and signalling molecules, detailed later, stimulate the proliferation and 
differentiation of these mesenchymal cells, until a population of fully mature, 
active osteoblasts are present at the site of injury (Bielby et al. 2007b).   
 
Osteoblast cells arise from multipotent mesenchymal stem cells. They are found 
on the surface of bone or osteoid usually as a single layer. They participate in 
embryonic skeletal development and post-natal bone remodelling (Mackie 2003; 
Clarke 2008). Osteoblast cells undergo a number of proliferation and 
differentiation process before reaching a terminal phenotype (Kartsogiannis and 
Ng 2004; Hughes et al. 2006a). The differentiation process is regulated by a 
complex system of growth factors which determine the final fate of these cells 
(Lieberman et al. 2002b). Most of the organic components of the bone matrix are 
produced by the osteoblasts, including type I collagen, proteoglycans, 
glycoproteins and alkaline phosphatase enzyme. Active osteoblasts have a 
lifespan of around 3 months, after which they either undergo programmed cell 
death (apoptosis), become inactive bone lining cells or become embedded in the 
mineralized matrix and differentiate into osteocytes (Jilka et al. 1998; Manolagas 
2000b).  
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Osteoblasts differentiate into osteocytes when the cell is encased by osteoid 
matrix which subsequently mineralises. Osteocytes are the most abundant cells 
found in bone tissue, comprising around 95% of the total, 10 times more 
prevalent than osteoblasts (Tamara A. Franz-Odendaal 2006) and their lifespan 
are approximately 25 years, exceeds that of the osteoblast (Knothe Tate et al. 
2004). The processes of adjacent cells contact each other via gap junctions, 
maintain the vitality of osteocytes by passing nutrients and metabolites between 
blood vessels and distant osteocytes, regulating ion homeostasis, and 
transmitting electrical signals in bone (Furlan et al. 2007; Jiang et al. 2007). It is 
currently not clear what specific events lead to certain osteoblasts being 
selected for terminal differentiation to osteocytes and effectively becoming 
trapped in newly formed bone, although it is probably influenced by a variety of 
factors, such as cell position and the presence of local signalling factors 
(Manolagas 2000a). Although osteocytes have reduced synthetic activity and 
diminished mitotic division, they are actively involved with remodelling of bone. 
Osteocytes develop a web of dendritic extensions which extend along the bone 
canaliculi, minute channels running through the compact bone tissue, 
connecting osteocytes to other cell types (Manolagas 2000a). It has been 
theorized that osteocytes act as mechanosensors that can respond to 
mechanical strain and bone microdamage, then transmit signals to osteoblasts 
and/or osteoclasts for resorption or bone formation (Rodan 1997; Manolagas 
2000a; Burger et al. 2003). Thus, osteocyte cells responsible for overall control 
of bone maintenance and communication with surrounding tissues (Owen 1967; 
Tamara A. Franz-Odendaal 2006). 
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Osteoclasts are osseous cells that also play important roles during bone 
regeneration. They are large, multinucleated cells with fine, finger like 
cytoplasmic processes derived by the differentiation of monocyte / macrophage 
haemopoietic progenitor cells, found in the bone marrow (Schell et al. 2006). 
Monocyte precursor cells migrate from the bone marrow to the bone surfaces 
where they proliferate, differentiate into mononuclear preosteoclasts, and fuse 
with each other to form multinucleated mature osteoclasts, capable to cause 
resorption of the bone (Chambers 2000; Boyle et al. 2003). Osteoclasts present 
in resorption craters known as Howship lacunae on bone surfaces or in deep 
resorption cavities called cutting cones. They are specialized in resorbing 
mineralized bone matrix by binding tightly to the bone surface via the apical 
membrane and secreting protons and osteolytic enzymes, forming a structure 
known as a resorption pit (Chambers 2000; Boyle et al. 2003). Osteoclasts are 
recruited into the osteoclast lineage pools of monocyte precursors at the bone 
surface (Chambers 2000). Cells that express the full morphologic and functional 
properties of mature osteoclasts are known to be restricted to the surfaces of 
bones. Osteoclasts or their committed precursors do not possess receptors for 
parathyroid hormone. The hormonal signal is regulated by osteoblasts (Li et al. 
2007). However, osteoclasts do have receptors for calcitonin (Nicholson et al. 
1986). Calcitonin inhibits osteoclast activity by impeding the motility, cytoplasmic 
spreading, and bone resorption abilities of osteoclasts (Nicholson et al. 1986; 
Lee et al. 1995) thus it can be used for treatment of different diseases such as: 
osteoporosis, hypercalcaemia and paget's disease. Osteoclasts have a much 
shorter life span than osteoblasts and osteocytes, the maximal survival of 
osteoclasts without fusion of precursors is less than 6 weeks (Marks and Seifert 
1985). Osteoclasts are not usually seen in routine histologic sections of normal 
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bone. An increased number of osteoclasts is characteristic marker of 
pathological conditions associated with increased bone turnover.  
 
1.1.2 Bone signalling pathways 
  
The study of bone signalling pathways has improved our understanding of 
cellular behavior during bone remodelling. Different bone signalling pathways 
are activated during migration, differentiation, and activation of bone cells. 
Remodelling of bone is regulated mainly by the balanced action of osteoblast 
and osteoclast cells. Differentiation of osteoblast and osteoclast is regulated by 
a complex system of growth factors (Lieberman et al. 2002b). The intracellular 
signals conveyed by these growth factors in turn influence the expression of an 
array of transcription factors and proteins (Hughes et al. 2006b).  
 
Figure 1- 3: Simplified schematic diagram showing the main stages of the osteoblast 
differentiation. A host of growth factors act temporally and spatially to drive the stages of 
differentiation. Intracellular growth factor signalling influences expression of transcription 
factors which in turn induce expression of osteoblastic proteins. (Adapted from Hughes et al., 
2006). 
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Numerous growth factors exert their influences on different stages of osteoblast 
differentiation pathway, inducing intracellular signalling processes that in turn 
affect the expression of transcription factors and proteins within the cells 
(Hughes et al. 2006b) (Figure1.3). For example, transcription factor TAZ, 
expressed early in the osteoblast differentiation pathway, associated with the 
differentiation of mesenchymal stem cells into fully committed osteoprogenitor 
cells (Hong et al. 2005; Hughes et al. 2006b). Runx2/Cbfa1, another 
transcription factor that is reported to be responsible for differentiation of 
osteoprogenitor cells into the pre-osteoblast. Komori and his group have 
reported that Runx2 expression is an absolute requirement for bone formation, 
as Runx2 knockout mice failed to develop either osteoblasts or a skeletal system 
(Komori et al. 1997). Osterix is transcription factor which is expressed in terminal 
stage of osteoblasts differentiation (Hughes et al. 2006b). It plays an important 
role in bone mineralization and It is suggested to be positioned downstream to 
Runx2 (Nakashima et al. 2002a). Osterix knockout mice failed to express osterix 
as well as to develop a skeleton (Nakashima et al. 2002a). Osterix, is essential 
for osteoblast differentiation, inducing expression of many osteoblast proteins, 
including osteocalcin and bone sialoprotein (Kim et al. 2004). Runx2 however 
regulates the expression of osteocalcin, bone sialoprotein (BSP) (Kim et al. 
2004), osteopontin and type I collagen (Ducy et al. 1997; Hung et al. 2011). 
Bone morphogenetic protein-2 (BMP2) is capable of inducing expression of 
Runx2 and Osterix, via the upstream regulators Msx-2 and Dlx-5, which are 
involved in upregulating the expression of Osterix and Runx2 respectively (Kim 
et al. 2004; Matsubara et al. 2008).  
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Figure 1- 4: Differentiation pathway of osteoclast from haematopoietic precursor cells. 
Differentiation is derived via OPG, M-CSF and RANKL, and is associated with expression of 
phenotypic markers such as tartrate-resistant acid phosphatase, calcitonin receptor (CTR) 
and the β3 integrin. (Adapted from (Boyle et al. 2003) 
 
 
Local signalling molecules produced by osteoblast cells play a central role in 
controlling the process of osteoclastogenesis and bone remodelling (Figure1.4). 
Differentiation of haematopoietic precursor cells into mature osteoclasts is 
dependent on the presence of macrophage colony-stimulating factor (M-CSF) 
and receptor for activation of nuclear factor kappa B ligand (RANKL). M-CSF 
and RANKL work synergistically to induce osteoclast differentiation, with M-CSF 
driving proliferation of osteoclast progenitors, and RANKL inducing 
differentiation of this expanded population (Quinn et al. 1998). During osteoclast 
differentiation pathway, M-CSF and RANKL induce expression of phenotypic 
markers that characterise the osteoclast lineage. These include tartrate-resistant 
acid phosphatase (Bayatian et al. 2007), cathepsin K, calcitonin receptor (CTR), 
and the β3 integrin (Boyle et al. 2003). TRAP is an enzyme that has been used 
extensively as a marker for terminally differentiated osteoclasts (Angel et al. 
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2000). The exact role of TRAP in osteoclasts is not fully understood, however 
TRAP knock-out mice show decreased resorptive activity of osteoclasts 
(Hayman et al. 1996). RANKL is a soluble transmembrane protein, found on the 
surface of expressing osteogenic cells. Osteoprotegerin (OPG) is a soluble 
decoy receptor for RANKL that inhibits osteoclast differentiation in vitro and 
bone resorption in vivo by preventing binding of RANKL to Rank (Simonet et al. 
1997; Udagawa et al. 2000; Schoppet et al. 2002). While OPG knockout mice 
demonstrated osteopenia, OPG-overexpressed transgenic mouse exhibit major 
increase in bone mass (Simonet et al. 1997) indicating the critical role of OPG 
pathway in mediating osteoclastogenesis and bone remodelling. OPG is 
secreted by osteoblasts in response to various osteogenic signals, for example 
growth factors sequestered in the matrix during its formation, thus preventing 
bone resorption as required by the physiological situation (Udagawa et al. 2000; 
Schoppet et al. 2002). The activation and inhibition of osteoclast differentiation is 
therefore regulated by the receptor Rank, via its interactions with either RankL or 
OPG produced by osteoblasts. 
 
These identified transcription factors and bone signalling proteins act as key 
regulatory factors maintaining normal physiological bone remodelling. Any 
alteration or disruption of these signalling pathways may potentially suppress or 
delay bone formation and repair process. Therefore the expression of these 
proteins can be considered biomarkers to assess behaviour of the cells during 
bone regeneration. 
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1.1.3 Extracellular matrix components 
Extracellular matrix of bone is made of organic and inorganic components which 
provide bone hardness and resistance to the bone (Nanci and Ten Cate 2013). 
The organic component is composed of collagen fibers with predominately type I 
collagen and ground substances which are an aggregate of proteoglycan and 
non-collagenous glycoprotein (Nanci and Ten Cate 2013). Inorganic part is 
composed mainly of hydroxyapatite crystals formed from calcium and 
phosphorus. It includes also smaller amounts of bicarbonate, citrate, 
magnesium, potassium, sodium and amorphous calcium. Most of these ECM 
proteins regulate processes of bone formation and resorption by driving 
osteoblast and osteoclast differentiation. Although each protein has specific 
roles, they work in synergistic action in order to mediate bone repair process. 
Expression of these phenotypic proteins during cellular differentiation pathways, 
make them useful biomarkers for monitoring repair process as well as ideal 
indicators of cellular behaviour around site of bone injury (Table 1).    
Table 1.1: Some of the phenotypic markers seen at different stages of osteoblast 
differentiation pathway. Compiled from (Katagiri and Takahashi 2002; Hughes et al. 
2006a). 
Differentiation 
Stage 
Mesenchymal 
Stem Cells 
Osteoprogenitor 
Cells 
Pre-
osteoblasts 
Osteoblasts 
Markers 
Expressed 
-(AlP –ve)  
-Collagen type 
I,III,V  
-AlP +/–ve 
-Collagen type 
I,III,V  
- Alkaline 
Phosphatase 
- Collagen type I 
-Bone Sialoprotein 
-Parathyroid 
hormone related 
protein receptor 
 
 
-Alkaline 
Phosphatase 
-Bone Sialoprotein 
-Parathyroid 
hormone related 
protein receptor 
- Collagen type I 
-Osteopontin 
-Osteocalcin 
-Osteonectin 
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1.1.3.1  Major proteins expressed throughout osteoblast differentiation 
pathway 
Type I collagen is the primary secretary product of osteoblasts and is the most 
abundant collagen in the organic part of bone (90%) and the main constituent of 
the osteoid matrix. Collagen type I molecule is a triple helix composed of three 
helical polypeptide chains. These collagen helices coil together forming fibrils, 
which may then further bundle together to form collagen fibres (Allori et al. 
2008). This arrangement is critical for bone mineralization as the structural 
network of type I collagen fibres provides gaps between collagen subunit serve 
as nucleation sites for hydroxyapatite crystal deposition (Buckwalter et al. 1995; 
Baht et al. 2008). Since collagen type I is secreted throughout the osteoblast 
lineage (Seyedin and Rosen 1990; Buckwalter et al. 1995; Kalfas 2001), 
expression of type I collagen can be a useful indicator of osteoblast activity 
during bone regeneration. 
 
Another important protein that is expressed throughout osteoblast differentiation 
are alkaline phosphatases. They are enzymes that also expressed throughout 
the body in four isoforms; three are considered as tissue-specific enzymes 
particularly concentrated in liver, intestine and placenta (Schär et al. 1997). 
However the fourth isoenzyme is tissue non-specific alkaline phosphatase 
(TNAP) that is widely expressed in the body but is particularly concentrated in 
liver, kidney, and bone (Schär et al. 1997). Bone-specific alkaline phosphatase 
enzyme is associated with bone mineralisation (Robison 1923), by removing 
pyrophosphates which inhibit hydroxyapatite formation (Whyte 1994), and 
releasing inorganic phosphate into the matrix (Houston et al. 2004). Alkaline 
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phosphatase is known to be expressed on the surface of both osteoblasts and 
osteoblast progenitor cells during bone repair, thus it is commonly used as an 
indicator of osteoblast differentiation and activity (Katagiri and Takahashi 2002; 
Sharp and Magnusson 2008). Although serum levels of the enzyme have been 
shown to be high during fracture repair (Taniguchi et al. 2003), it is best to put in 
consideration that the ubiquity of alkaline phosphatase is not specific indicator of 
bone formation. However its expression alongside other markers of osteoblast 
activity would serve as a definite indicator of bone formation at the fracture site. 
 
Bone sialoprotein (BSP) is a non-collagenous matrix protein that is expressed by 
pre-osteoblasts and mature osteoblasts and present at high levels within 
mineralised bone tissues (Ganss et al. 1999; Gordon et al. 2007b). The exact 
function of BSP remains unknown as it ables to bind to different matrix 
components such as collagen, matrix metalloproteinases, hydroxyapatite, and 
integrins (Oldberg et al. 1988; Fisher et al. 2001; Baht et al. 2008). BSP 
knockout mice are smaller than normal counterparts with deficient mineralisation 
in their skeletons and show impaired bone repair (Malaval et al. 2008; Malaval et 
al. 2009). This suggests that BSP plays major role in bone mineralisation. In 
regards to bone repair, BSP has been reported to be expressed during the 
mineralisation stage (Chen et al. 1994; Baht et al. 2008), and also contribute in 
later stages of osteoblast differentiation (Gordon et al. 2007a), therefore its 
expression is important indicative of bone mineralization during regeneration 
process. 
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1.1.3.2  Major proteins expressed by differentiating osteoblasts   
Osteocalcin (OCN) is the most abundant non-collagenous protein found in bone 
matrix (Lian and Gundberg 1988). It is thought to be the most bone specific 
protein as it is synthesized solely by mature osteoblast cells (Weinreb et al. 
1990; Ducy et al. 1996; Hughes et al. 2006a; Lee et al. 2007). Osteocalcin binds 
tightly to hydroxyapatite, facilitating protein accumulation within the matrix (Lian 
and Friedman 1978; Kudo et al. 1998); thus suggest that osteocalcin involves in 
bone mineralization and calcium ion homeostasis. Although osteocalcin is 
mainly incorporated into the bone matrix, it can also be released into the blood 
circulation where it can function as an indicator of bone turnover in osteoporosis 
(Price and Nishimoto 1980; Polak-Jonkisz and Zwolinska 1998; Lateef et al. 
2010). Clinically, osteocalcin can function as a biomarker on the effectiveness of 
a given drug on bone formation through doing assays for circulating osteocalcin 
in the serum (Singer and Eyre 2008; Lateef et al. 2010). Recent studies raise the 
possibility that osteocalcin acts as a hormone that influences energy metabolism 
by regulating the release of insulin from beta cells in the pancreas (Lee et al. 
2007). Osteocalcin knockout mice show no initial skeletal defects and present 
normal levels of all other bone matrix non-collagenous proteins, but over time 
reveal increased bone formation rate and a higher overall BMD, indicating a 
currently undefined regulatory role in skeletal development (Ducy et al. 1996). 
Although the exact function of osteocalcin is unknown, it is exclusively 
expressed in bone tissue by osteoblasts and is therefore a good marker of bone 
formation by osteoblast cell. 
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Osteopontin (OPN) is another non-collagenous extracellular matrix protein, 
which is synthesized by a variety of cells including fibroblasts (Ashizawa et al. 
1996), osteoblasts, osteocytes, odontoblasts, hypertrophic chondrocytes, 
dendritic cells and macrophages (Murry et al. 1994). Osteopontin is reported to 
modulate different cell action in a variety of manners. It has chemotactic 
properties, which promote recruitment of inflammatory cells such as neutrophil 
(Apte et al. 2005; Banerjee et al. 2006; Koh et al. 2007), mast cell (Nagasaka et 
al. 2008) and macrophage (Burdo et al. 2007; McKee et al. 2011) to 
inflammatory sites. It also acts as an adhesion protein which associated with cell 
attachment and wound healing (Merry et al. 1993; Yamate et al. 1997; McKee et 
al. 2011). In addition, OPN can function as an anti-apoptotic factor in which it 
inhibits the activation-induced cell death of macrophages and T cells as well as 
fibroblasts and endothelial cells exposed to harmful stimuli (Denhardt et al. 
2001; Standal et al. 2004). In case of bone regeneration, expression of 
osteopontin indicates that osteoblast progenitor cells have migrated to the 
fracture site, differentiated into osteoblasts and attached themselves to the 
surrounding tissues in order to initiate osteoid matrix synthesis.     
 
Osteonectin (ON) is a calcium binding glycoprotein that is expressed by 
osteoblasts in bone undergoing remodelling or repair (Alford and Hankenson 
2006; Brekken and Sage 2001; Lane and Sage 1994). It shows affinity to ECM 
components such as collagen and hydroxyapatite, thus assessing bone matrix 
organisation, and may be implicated in regulating cell proliferation and cell-
matrix interactions (Brekken and Sage 2000; Young et al. 1992). Osteonectin is 
assumed to be associated with mineralised tissue formation through regulating 
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the deposition and assembly of other osteoid matrix proteins (Lane and Sage 
1994; Brekken and Sage 2001). Interestingly, osteonectin knock-out mice show 
significant deficient in osteoclasts and osteoblasts numbers, leading to impaired 
bone formation and display a low-turnover osteoporosis-like phenotype (Delany 
et al. 2000; Delany et al. 2003).  Due to its expression by osteoblasts and 
association with bone healing, thus its presence in the fracture site would be 
indicative of existence of osteoblast cells and bone regeneration. 
 
Expression of most of these bone markers has been demonstrated within the ex 
vivo mandible model, within cells residing within the PDL and bone marrow 
spaces (Smith et al. 2010). These results correlated with previous in vivo studies 
that demonstrate presence of osteoblasts and their progenitors within both the 
PDL and bone marrow spaces (Isaka et al. 2001; Krebsbach et al. 1999; Lekic et 
al. 1996). Most of these ECM proteins work in a complex and synergistic way in 
order to mediate the processes of osteoid deposition and mineralization during 
bone repair. Although the exact roles of many of the non-collagenous proteins 
produced by osteoblasts have not been understood, the phase in the osteoblast 
differentiation pathway at which they are expressed is generally known. This 
makes them vital indicators in assessing stage of repair processes as well as 
cellular behaviour around fractured site. 
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1.2 Physiology and Process of Bone Healing 
Regeneration of bone can depend on different factors such as patient’s age, 
fracture location, degree of dislocation and extent of the injury. The process of 
fracture repair involves a complex cascade of events and is mainly divided into 
three major phases; reactive phase, reparative phase and remodeling phase. An 
understanding of these phases is essential to identify cellular behaviour and 
molecular signals involved during process of bone regeneration.  
 
1.2.1 Reactive Phase 
Reactive phase is the inflammatory phase which occurs immediately after initial 
bone disruption due to fracture and lasts 3–4 days. Bone fractures cause cutting 
of the blood vessels followed by extravasation of blood. Traumatic disruption of 
the blood flow causes ischemic necrosis characterised microscopically by the 
presence of empty lacunae and the presence of blood cells within the tissues 
adjacent to site of bone injury (Griffon 2008). After injury, a fibrin-rich clot known 
as hematoma forms at the fracture site, initiating spontaneous fracture healing. 
Most of the fracture repair process took place around rather than middle of the 
interfragmentary hematoma (Tecklin 2008). Although bone repair can be 
obstructed by the presence of persisting unchanged large blood clots at the 
fracture site(Whittick 1990; Morgan and Leighton 1995), hematoma works as a 
scaffold for cells, and a spacer guiding the size and shape of the callus (Slatter 
1995).  
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During repair process, presence of hematoma assesses release of different 
growth factors, thereby stimulating angiogenesis and osteogenesis (Griffon 
2008). Transplantation of fracture hematoma has been found to induce 
endochondral bone formation in ectopic sites, which would be consistent with 
the presence of osteoinductive growth factors within the hematoma (Mizuno et 
al. 1990; Street et al. 2000). Blood clot is rich with thrombocytes which release 
coagulation factors for angiogenesis and platelet-derived growth factor (PDGF) 
and transforming growth factor-β1 (TGF-β1) to stimulate osteogenesis 
(Lieberman et al. 2002b). Mast cells play a role in formation of new vessels via 
releasing of vasoactive substances (Heppenstall 1980). The angiogenic 
properties of fracture hematoma appear to be stimulated by vascular endothelial 
growth factor (VEGF) (Street et al. 2000) and prostaglandins E1 and E2 which 
may also mediate early bone resorption by osteoclasts and proliferation of 
osteoprogenitor cells (Millis 1999). Revascularization of the hypoxic fracture site 
occurs within hours after the fracture by the transient extraosseous blood 
vessels emerge from the surrounding soft tissues. Mononuclear phagocytes 
transported by these new vessels aid in the removal of necrotic bone and 
construction of the callus. 
 
Macrophages also play a major role in fracture repair by releasing several 
growth factors, such as fibroblast growth factor (FGF) which initiate fibroplasia 
both in soft tissue as well as interfragmentary (Leibovich and Ross 1975; 
Lieberman et al. 2002b). By the end of the first week, blood flow resumes and 
the blood clot degenerates unless infection, excessive motion, or extensive 
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necrosis of the surrounding soft tissues persists at the fracture site. Clinically, 
the end of the inflammatory stage associates with decrease of pain and swelling. 
 
1.2.2 Reparative Phase  
Within a few days, mononuclear cells and fibroblast cells begin the 
transformation of a hematoma into granulation tissue, a loose aggregate of cells 
interspersed with small blood vessels. This phase is characterised with a slight 
gain in mechanical strength, since granulation tissue can withstand a tensile 
force up to 0.1 Nm/mm2 (Perren and Boitzy 1978). Granulation tissue is rich with 
collagen fibres types I, II, and III. Collagen are initially deposited, but as the 
maturation process continues, type I collagen predominates (Lane et al. 1979; 
Remedios 1999). The granulation tissue eventually contains number of 
mesenchymal stem cells, numerous newly formed blood vessels to provide 
oxygen and nutrients and macrophages to clean the wound and release 
cytokines and growth factors (Lang and Lindhe 2015). Mesenchymal stem cells 
within the cambium layer of the periosteum, the endosteum, the bone marrow, 
and adjacent soft tissues begin to proliferate during the reactive phase and 
deposit matrix components in an extracellular location. Several growth factors 
such as bone morphogenic proteins (BMPs), insulin-like growth factor (IGF), 
platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) play a 
major role in chemotaxis, proliferation and differentiation of these stem cells into  
osteoblasts (Griffon 2008; Lang and Lindhe 2015).  
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It is unclear the exact time and order of the formation and maturation of tissues 
within the fracture gap. Days after fracture, osteoprogenitor cells migrate and 
aggregate prior to their differentiation into osteoblast cells which lay down a 
matrix of collagen fibres known as osteoid. The osteoblast cells are entrapped 
inside the matrix and differentiate into osteocyte cells. The osteoid is mineralized 
by mineral deposition mainly calcium and phosphate (Clarke 2008). The exact 
mechanism of this process is unclear; however it has been demonstrated that 
osteoblast cells release a small, membrane-bound matrix vesicles that support 
nucleation by concentrating calcium and phosphate and enzymatically destroy 
mineralization inhibitors such as pyrophosphate or proteoglycans (Anderson 
2003). It is also assumed that mitochondria in the fracture gap accumulate 
calcium-containing granules that are released in the hypoxic media created by 
anaerobic metabolism. Intramitochondrial clusters of calcium phosphate are 
released in the extracellular matrix and become the source for growth of apatite 
microcrystallites (Boonrungsiman et al. 2012). 
 
At the end of this phase, the fracture gap is bridged by primary bone tissue 
known as woven immature bone (Sumner-Smith 1982; Whittick 1990) which is  
transformed into mature lamellar bone. The bony substitution of immature woven 
bone is represented by trabeculae rod-like features which are later replaced with 
plate-like trabeculae and fibred lamellar bone and marrow space  (Berglundh et 
al. 2003). At this point, bone union is gained however, structure and strength of 
the fracture site is different from that of the original bone. 
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1.2.3 Remodelling Phase 
The ultimate goal of the healing process is to restore tissue integrity, structure 
and function. Depending on factors such as age or general condition, the 
remodelling phase may last for 6–9 years in humans (Wendeberg 1961; 
Remedios 1999). The remodelling process is influenced by the balanced action 
between osteoclastic resorption and osteoblastic deposition. At this phase the 
trabecular bone is substituted with compact bone. Osteoclasts resorb trabecular 
bone forming a shallow resorption pit known as a "Howship's lacuna”. Then 
compact bone deposited by osteoblasts within the resorption pit. 
 
 At the end of the remodelling phase, the fracture callus is remodelled and 
transformed into a new structure which closely resembles the original bone 
shape and strength. A key factor for spontaneous fracture bone healing is 
availability of adequate blood supply together with the gradual increase in 
stability at the fracture site. Any changes in the vascularity and mechanical 
support of the fracture site can compromise the healing process causing 
malunion or non-union which lead to fibrous/cartilage tissue formation. On the 
other hand an immobilize fracture with sufficient blood supply allow formation of 
mineralized callus and subsequent good healing (Griffon 2008). 
 
1.3 Growth Factors Involved in Bone Repair 
Since growth factors play a ajor role in mediating bone regeneration, evaluation 
of their precise roles in the healing process is extremely beneficial. These 
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growth factors act in synergistic way to recruit progenitor cells to sites of bone 
injury, and stimulate them to proliferate and differentiate into mature bone cells 
capable of initiating repair processes. Numerous studies have demonstrated 
their role, expression and application in mediating bone healing (Hughes et al. 
2006b; Baker et al. 2009; Ehnert et al. 2010). A study by Jacobsen et al (2008); 
demonstrated that growth factors regulate bone formation during fracture healing 
and distraction osteogenesis by stimulating molecular mechanisms and 
controlling osteoblasts proliferation and differentiation (Jacobsen et al. 2008). 
Among the abundant growth factors available, a number have been identified to 
be relatively significant in bone healing and repair, such as the following: 
 
TGF-β1 is a secreted protein that belongs to the transforming growth factor beta 
superfamily. Although TGF-β1 is found in many tissues of the body, it is more 
prevalent in bone and platelets (Lieberman et al. 2002b; Janssens et al. 2005). 
TGF-β1 has been studied extensively in the field of bone repair (Poniatowski et 
al. 2015), and has been reported to promote fracture healing in several studies 
by different roles. TGF-β1 is secreted by osteoblasts and osteoclasts and 
deposited within the bone matrix in a latent inactive dimeric complex termed 
latency-associated peptide (LAP).  During bone turnover, acidification of the 
resorption lacuna created by osteoclasts is able to activate TGF-β1 (Pfeilschifter 
et al. 1990; Bonewald et al. 1997), which should then stimulate the formation of 
bone. During bone injury, TGF-β1 induces chemotactic recruitment of 
mesenchymal stem cells and osteoprogenitors from the bone marrow, 
periodontal ligament and periosteum, and increases their proliferation (Barnes et 
al. 1999; Smith et al. 2010). It has been demonstrated that TGF-β1 RNA is 
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intensively expressed during the whole healing process (Cho et al. 2002; 
Wildemann et al. 2004). TGF-β1 also promotes the early stages of differentiation 
within these cells, increasing levels of type I collagen synthesis and inducing 
expression of Runx2, a key transcription factor associated with osteoblast 
differentiation (Bostrom and Asnis 1998; Janssens et al. 2005). During later 
stages of osteoblast differentiation, TGF-β1 has been observed to inhibit the 
expression of both Runx2 and osteocalcin, thus acting to inhibit the later stages 
of osteoblast maturation (Janssens et al. 2005). Therefore, the expression of 
TGF-β1 around fracture site is a strong indicator of early osteoblast 
differentiation activity. TGF-β1 has been shown to regulate bone resorption 
through inhibition of activation, proliferation, and differentiation of osteoclast cells 
and moreover induces suppression of the recruitment of new osteoclasts (Chenu 
et al. 1988; Pfeilschifter et al. 1988; Ehnert et al. 2010). 
 
It has been reported from in vitro model that TGF-β1 increases both the 
proliferation rate of osteoblast cells and the synthesis of type I collagen, 
indicating its importance in bone matrix production (Centrella et al. 1986; 
Centrella et al. 1992). TGF-β1 knockout mice have shown decreased 
proliferation and differentiation of osteoprogenitor population with disturbed 
collagen maturation and impaired matrix deposition and mineralisation (Atti et al. 
2002). Therefore, the role of TGF-β1 during bone regeneration is mainly to 
maintain recruitment and proliferation of local mesenchymal stem cells and 
osteoprogenitors, and stimulate some early differentiation stages. Essentially 
this has the effect of producing a large pool of matrix producing cells ready to be 
moved on into the later stages of osteoblast differentiation by other growth 
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factors such as the bone morphogenetic proteins (Centrella et al. 1992; 
Janssens et al. 2005; Hughes et al. 2006a). 
  
Bone morphogenetic proteins (BMPs) are also members of transforming growth 
factor β (TGF-β) superfamily. They were identified by Urist and colleagues 
(1971) where decalcified bone matrix explants in muscle stimulated ectopic bone 
formation. It has been reported that osteoblast cells synthesize BMPs and 
sequester them in the bone matrix, which can be released at time of bone 
resorption, thus maintaining bone mass homeostasis (Mackie 2003). BMP2 and 
BMP7 are members of the BMP family and have shown to play a major role in 
bone regeneration, due to their ability to differentiate mesenchymal stem cells 
and osteoprogenitors into mature fully functional osteoblast cells. BMP2 has 
been shown to overexpressed at fracture healing site, where it exerts an 
osteogenic role via direct stimulation of osteoblasts (Bouletreau et al. 2002). 
Several studies have shown that BMP2 is a potent osteogenic factor that 
controls the osteogenic transcription factors, Dlx5, Runx2 and OSX (Nakashima 
et al. 2002b; Hughes et al. 2006b). BMP7 has been shown to induce cartilage 
and bone formation as well as increases tissue vascularization and 
adipogenesis (Lu et al. 2010).  BMP7 has also been shown to stimulate alveolar 
bone regeneration in 5mm mandibular osseous defects through stimulation of 
osteogenesis, regenerative cementum, and new attachment formation 
(Giannobile et al. 1998) and in maxillary sinus floor augmentation procedures 
before placing implant (Bergh et al. 2000).  The presence of BMPs around 
fracture site may indicate the status of the cell differentiation. While BMP2 acts 
as early and late osteogenic markers and its expression indicates the presence 
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of mesenchymal stem cells or early osteoprogenitors around the site, the 
expression of BMP7 may indicates the presence of committed osteoblasts 
(Cheng et al. 2003).  
 
Both BMP and TGF-β influence osteoblast differentiation by signalling through a 
serine-threonine kinase receptors at the cell surface to initiate complex 
intracellular signalling cascades resulting in a wide range of effects on the 
transcriptional and translation activity of the cell (Yamaguchi et al. 2000; Chen et 
al. 2012). Intracellular signalling occurs with downstream signalling via 
phosphorylation of cytoplasmatic R-Smads 1, 5, and 8 in case of BMP and 
Smads 2 and 3 in case of TGF-β (Chen et al. 2012), which translocate to the 
nucleus via Smad 4 and regulate transcription of target genes such as Runx2 
(Phimphilai et al. 2006). It is apparent that BMP and TGF-β are highly involved in 
skeletal formation and osteoblast differentiation. During bone healing, it is likely 
that these two growth factors work in a complex and synergistic relationship; in 
which TGF-β1 stimulates recruitment and proliferation of mesenchymal stem 
cells and osteoprogenitors, while BMP serves to differentiate these cells into 
mature osteoblast cells capable of producing new bone. 
 
Vascular endothelial growth factor (VEGF) is a signalling protein that stimulates 
vasculogenesis and angiogenesis (Yang et al. 2012). During healing process, 
fibrous and granulation tissue are rapidly vascularised through the actions of 
VEGF, angiogenic growth factors, in order to provide the repair site with the 
required blood supply (Einhorn 1998; Johnson and Wilgus 2014). Good blood 
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supply is important for successful osteogenesis, since the vasculature is 
responsible for providing oxygen, nutrients, soluble factors and cells to the bone 
tissue (Kanczler and Oreffo 2008; Yang et al. 2012; Johnson and Wilgus 2014). 
Although the primary target of VEGF is endothelial cells, VEGF has also been 
shown to directly associated with modulating recruitment, survival, and 
differentiation of osteoblasts (Mayr-Wohlfart et al. 2002; Street et al. 2002). 
Several studies have been demonstrated that there is an interaction between 
angiogenic and osteogenic factors during bone formation and bone healing. For 
example, VEGF is able to recruit more mesenchymal stem cells when combined 
with osteoinductive growth factors such as BMP4 (Peng et al. 2002). Although 
expression of VEGF at fracture site indicates presence of good blood supply, 
expression of VEGF together with other osteoinductive growth factors is good 
indicators of both angiogenesis and osseogenesis. 
 
1.4 Impaired Bone Healing 
The main goal of bone regeneration is to restore tissue integrity and function, 
which can be achieved by the integrated complex action of cells, proteins, and 
growth factors detailed above. In normal bone injuries, a certain amount of time 
is required before bone fracture can be expected to heal. This normal time may 
vary according to different factors include age, bone involved, level of the 
fracture, and associated soft tissue injury. However, there are many factors 
associated with impaired bone healing in which the normal process of bone 
healing is interrupted resulting in malunion, delayed union or non-union. A 
malunion is a fractured bone that has healed but in an unacceptable position. 
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Nonunion refers to fractures that have healed by forming fibrous or cartilaginous 
tissue rather than new bone after several months. The differentiation between 
delayed union and nonunion is sometimes difficult and often based on 
radiographic criteria and time. 
 
Numerous factors may interfere with bone healing. These include pathological 
factors such as diabetes (LODER 1988; Gandhi et al. 2005), osteomylities, 
osteonecrosis (Reid 2009) and osteoporosis (Namkung-Matthai et al. 2001; 
Tang et al. 2008). As well as lifestyle factors including smoking (César-Neto et 
al. 2003; Balatsouka et al. 2005), alcohol and poor nutritional status. Certain 
mechanical factors also contribute to loss of bone strength and make healing 
more difficult. These include inadequate reduction and inadequate 
immobilization which cause excessive motion and loss of bone stability at the 
fracture site. Other physiological factors can also contribute to poor healing 
include older age, menopause and reduced blood flow to the fracture site. 
Certain medications, such as corticosteroid drugs and non-steroidal anti-
inflammatory drugs (NSAIDs) may also interfere healing of bone (Harder and An 
2003). 
 
Most malunions and nonunions require open reduction and internal fixation 
surgery to realign and stabilize the fracture fragments into their normal 
anatomical position. Infection requires surgical debridement followed by 
intensive antibiotic treatment. Thus, there is much interest in refining and 
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developing different treatment strategies to use in conditions where healing is 
impaired or occurs at a significantly reduced rate.  
 
1.5 Conventional clinical approaches to enhance bone 
regeneration 
Fractures are classified into complete and incomplete fractures; open and closed 
fractures. Most fractures, if left completely alone, would probably heal by normal 
physiological healing but complete open fracture with large displacement 
between fracture fragments will need external intervention to promote functional 
fracture healing. In case of severe trauma, bone resection after ablative surgery 
or congenital bone deformities, the bone healing is usually difficult or impossible. 
Current clinical therapies for bone injury are mostly used to aid normal bone 
healing processes by using distraction osteogenesis and/ or bone graft to 
restore the bone defects even if there are some limitations in using it.  
 
Different types of distraction devices are currently used for bone regeneration, 
including external monorail distraction devices (Raschke et al. 1993), and 
intramedullary lengthening devices (Cole et al. 2001). They are commonly used 
to treat bone loss or limb-length discrepancies and deformities. During 
distraction osteogenesis, bone regeneration is induced between the gradually 
distracted osseous surfaces. Although these methods are widely used in clinical 
practice to stimulate or augment bone, they are technically demanding and have 
several disadvantages, including associated complications, requirement for 
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lengthy treatment for both the distraction (1 mm per day) and the consolidation 
period (usually twice the distraction phase), as well as impacts on the patient’s 
psychology (Green et al. 1992; Aronson and Rock 1997; Dimitriou et al. 2011). 
 
Different types of bone grafts are currently used for bone injury autograft, 
allograft and xenograft. Autogenous bone graft is bone obtained directly from the 
patient. It has numerous advantages including its ability to be osteoconductive 
and osteoinductive. Although it is safe, available and shows no risk of immune 
rejection, it necessitates additional surgery to the patient increasing the risk of 
morbidity at the donor site as well as increasing the cost of the surgical 
operation (Salkeld et al. 2001). Allogenic bone graft is constructed from another 
individual after treating it with different sterilizing techniques. It is an alternative 
material which provide large amount of bone graft and overcome some problems 
in autogenous graft. It has a limited supply, limited capacity to incorporate with 
host bone (Heiple et al. 1963) and reduced osteoinductivity (Lutolf et al. 2003), 
When compared to autograft. Xenograft is made from animal bone, most 
commonly bovine bone, after removing the organic materials from the tissue and 
leaving the hydroxyaptite. It has an osteoconductive properties acting as a 
scaffold stimulating bone formation at the recipient site. Furthermore, the 
xenogenic grafting materials show some degree of osteoinductive potential by 
stimulate transformation of the patient's mesenchymal cells into osteoblast cells. 
Xenograft has the ability to be resorped and replaced by the patient's bone.  
Synthetic materials which called "alloplastic grafts" such as metal, ceramic, 
composite and polymers also can be used in treating bone defect. They are 
available in large amounts thus they can be used to reconstruct segmental bone 
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defect. The problems associated with bone grafts materials continue to drive the 
refining and development of novel clinical therapies for bone regeneration. 
 
1.6 Bone Tissue Regeneration 
Recently within the last 20 years, the idea of regenerating human tissue is 
rapidly growing.  Tissue regeneration in field of orthopedic and maxillofacial 
surgery gives a great promise in treating bone defects and overcomes the 
limitations associated with the conventional treatment approaches. Three ideal 
properties required for successful tissue regeneration; osteoinduction (bone 
morphogenetic proteins (BMPs) and other growth factors), osteogenesis 
(osteoprogenitor cells) and osteoconduction (scaffold). 
 
1.6.1 Cells  
It has long been recognized that stem cells are potent and have the ability to 
differentiate into different cell lineages. These characteristics raise the interest of 
scientists to consider stem cells in bone regeneration. There are two broad types 
of stem cells commonly used in tissue regeneration studies; embryonic stem 
cells and adult stem cells. Embryonic stem cells have the ability differentiate into 
all adult cell lineages (pluripotent), however their applications are limited due to 
different ethical issues.  Adult stem cells can differentiate into single cell line 
(unipotent) and it can be isolated from different sources such as bone marrow, 
brain or adipose tissue.  
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Adult bone marrow stem cells (BMSC) are capable to differentiate into multiple 
mesenchymal tissues in vivo including bone (Friedenstein et al. 1987; Pittenger 
et al. 1999). They are commonly used in bone regeneration. They have several 
characteristic features such as; ease of isolation, ability to adhere and grow on 
tissue culture plastics. They have also high proliferation rate, can reach up to 50 
population doublings in culture, and their osteogenic potential are not affected by 
freezing conditions. Clinically, surgeons are used to deliver osteogenic cells 
aspirated from iliac crest bone marrow directly to the regeneration site, which 
also contains growth factors (Dimitriou et al. 2011). Although this technique 
provide satisfactory results in improving bone repair with minimal invasive 
procedure (Pountos et al. 2010b), it depend on patient's health statue, aspiration 
sites and techniques used (Huibregtse et al. 2000). It has been reported that 
bone-marrow aspiration concentrate (BMAC) is considered an effective product 
to enhance bone regeneration (Hernigou et al. 2005; Jager et al. 2011), however 
it is associated with significant issue with regards to the adequate number of 
MSCs/ osteoprogenitors required to provide optimal repair responses (Hernigou 
et al. 2005). Another technique used to facilitate bone regeneration by cell 
harvesting, in vitro expansion followed by cells implantation to the defect area 
(Bianchi et al. 2003; D'Ippolito et al. 2004). Such technique is already applied for 
cartilage regeneration (Wakitani et al. 2011), however, it adds substantial time, 
cost and risks of contamination (McGonagle et al. 2007). 
 
Adipose tissue is another attractive and accessible source of osteogenic cells. 
They are characterised by their abundant availability as well as their ability to 
expand and proliferate (Niemeyer et al. 2010). It has been reported that adipose 
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stem cells (ASC) can undergo differentiation into various lineages, including 
osteogenic, chondrogenic and endothelial (Gimble et al. 2007). Mesenchymal 
stem cells extracted from adipose tissue are considered to be alternative to MSC 
from bone marrow. It is hypothesised that ASC have an equivalent osteogenic 
potential as BMSC. Studies by Niemeyer et al, 2010 have shown that the 
osteogenic potential of ASC is seem to be inferior to BMSC. However addition of 
platelet-rich plasma (PRP) can partially compensate the inferior osteogenic 
potential of ASC which represents a promising therapeutic approach (Niemeyer 
et al. 2010). Therefore more work is needed to compare the differentiation 
potential of ASC and BMSC. As well as investigate the osteogenic potential of 
using PRP together with adipose stem cells during bone repair. 
 
Issues of limited cell quantity and finding alternative sources of MSCs are being 
extensively investigated. Recently, periodontal ligament has been reported to 
possess stem cell properties similar to MSCs (Kaku et al. 2012). These 
periodontal ligament stem cells (PDLSCs) are multipotent cells that are able to 
differentiate into periodontal ligaments, alveolar bone, cementum (Ji et al. 2013), 
peripheral nerve and blood vessel (Seo et al. 2004; Huang et al. 2010; Park et 
al. 2011). They have been harvested from the periodontal ligament of human 
impacted third molars (Seo et al. 2004), permanent teeth and deciduous teeth 
(Silverio et al. 2010; Ji et al. 2013), supernumerary teeth (Song et al. 2012) and 
inflamed granulation tissue (Hung et al. 2012; Ronay et al. 2014). PDLSCs 
located in the perivascular wall of periodontal ligaments share similarities with 
pericytes in morphology, differentiation potential, and the ability to form capillary-
like structures in vitro (Iwasaki et al. 2013). PDLSCs demonstrated better colony-
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forming efficiency than BMMSCs and could differentiate into adipocytes and 
osteoblasts (Silverio et al. 2010; Song et al. 2012; Ji et al. 2013). Several studies 
have been investigated the effect of growth factors on stem cell properties of 
PDLSCs. While BMP4 has been shown to enhance the proliferation and 
maintain the stemness of PDLSCs during a long-term culture (Liu et al. 2013), 
TGF-β1 upregulates type I collagen and accelerates proliferation and fibroblastic 
differentiation of PDLSCs (Fujii et al. 2010; Kono et al. 2013). BMP2, BMP7 and 
VEGF have also shown to promote repair of bony defect in animal models via 
enhancing osteogenic differentiation of PDLSCs (Lee et al. 2012; Hakki et al. 
2014). All of these studies suggest that periodontal ligament provides a good 
source of stem cells that can be used to enhance fracture repair. Ex vivo 
fractured mandible model will give better approach to study the characterisation 
and cellular behavior of periodontal ligament stem cells within the fracture 
environment that ultimately improve outcomes of impaired fractured healing. 
 
1.6.2 Growth Factor Therapy 
Bone regeneration is driven by different growth factors. During regeneration 
process, it is necessary to give the cells some cues or signals. Several 
growth factors have been implicated in guiding cells during fracture healing. 
Most of these growth factors have been used clinically or under investigation 
to enhance bone regeneration. Studies on animal models have demonstrated 
that exogenous application of TGF-β1 can increase callus formation and 
strength, and bone formation, either on its own or in conjunction with IGF-1 
(Srouji et al. 2004; Lee et al. 2006). 
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BMPs have been extensively investigated, as they are potent osteoinductive 
factors. Different animal models have been utilised to investigate the effects 
of BMPs on bone formation. Recombinant BMPs have the ability to repair 
bone defects when combined with a carrier of collagen, demineralised bone 
matrix, biodegradable polymers, or hydroxyapatite (Kang et al. 2004). 
Several experimental and clinical trials have supported the safety and 
efficacy of the use of BMP2 and BMP7 as osteoinductive bone-graft 
substitutes for bone regeneration. Particular attention has focused on using a 
biomimetic scaffold or carrier to deliver BMP2 and BMP7 into the site of injury 
(Gautschi et al. 2007). In clinical studies, BMP2 and BMP7 have also been 
successfully used to treat  case of non-union in long bones  (Friedlaender et 
al. 2001; Govender et al. 2002a) and in the induction of spinal fusion (Boden 
et al. 2000; Vaccaro et al. 2003). Studies using an ex vivo tooth slice culture 
system (Sloan et al. 1998) have demonstrated that exogenouse applications of 
TGF-β1 by using either alginate hydrogels or agarose beads, show mitogenic 
effects on subodontoblast cells, and is capable of inducing differentiation of 
odontoblast-like cells within the dentine-pulp complex (Sloan and Smith 1999; 
Dobie et al. 2002). Recent studies have also been shown that exogenouse 
applications of TGF-β1 by using agarose beads, demonstrated increase in 
cellular migration and proliferation; as well as expression of bone matrix protein 
within ex vivo fractured mandible model (Smith et al. 2011). Although BMPs 
have been licensed for clinical use in bone-tissue engineering, several issues 
need to be further examined. These include identification of the optimum 
dosage required to elicit a therapeutic response (Reddi 1998; Dimitriou et al. 
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2011) and understanding the synergistic action of using 'cocktail' of growth 
factors that have shown significant promising results in preclinical and early 
clinical investigation (Nauth et al. 2010; Dimitriou et al. 2011). 
 
ECM bone is known to act as reservoir of endogenous growth factors bound 
within it (Hauschka et al. 1986; Taipale and Keski-Oja 1997). Release of these 
factors following bone injury allows presentation of these factors to target cells, 
and subsequent cellular signalling to initiate reparative processes at these sites, 
leading to optimal regeneration of the bone (Schonherr and Hausser 2000; 
Ramirez and Rifkin 2003; Hughes et al. 2006b). There are several chemical 
treatments that have been demonstrated to solubilise growth factors from within 
the mineralised matrix of dentine, including ethylenediaminetetraacetic acid 
(EDTA), calcium hydroxide (Zhao et al. 2000; Graham et al. 2006) as well as 
citric acid (De-Deus et al. 2008b). Recent studies have been shown that such 
chemical treatment modalities may also release growth factors from within the 
matrix of in vitro bone slab model (Smith et al. 2011). These acids solubilise 
growth factors by matrix demineralisation, local matrix dissolution or chelating 
calcium ions present within the mineralised matrix (De-Deus et al. 2008b).It is 
unclear whether this simply releases bound growth factors, or if a more complex 
mechanism is responsible for the release of the matrix-bound growth factors.  
 
Currently, numbers of clinical therapies are benefit from utilising endogenous 
matrix-bound growth factors rather than addition of exogenous growth factors. 
Topical application of Dycal®, calcium hydroxide-based material such as mineral 
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trioxide aggregate (Bayatian et al. 2007), is commonly used in clinical dentistry 
to facilitate formation of reparative dentine after dentine-pulp complex injury, by 
driving release of growth factors from dentine matrix (Tziafas et al. 2000; 
Hörsted-Bindslev et al. 2003; Graham et al. 2006). Emdogain, a purified enamel 
matrix protein product, is also used in clinical periodontology to increase growth 
factor release and inducing cementogenesis and osteogenesis (Nakamura et al. 
2001; He et al. 2004). Expansion of such dental-based materials or development 
of novel treatments that can facilitate growth factor release, for use in bone 
regeneration may overcome some of the problems associated with current 
growth factor therapies using exogenously added bioactive molecules. 
Development of the ex vivo mandible organ culture system may provide an ideal 
model system with which to test such therapeutics.   
 
1.6.3 Scaffolds 
Scaffolds are fundamental for successful bone tissue regeneration. It provides 
an appropriate place for the cells to migrate, proliferate and differentiate. The 
ideal scaffold should have specific characteristics; including osteoconductivity, 
osteoinductivity and osteogenic properties. Moreover, the scaffolds materials 
should be biocompatible, biodegradable, nontoxic, nonantigenic and 
nonteratogenic. The scaffold should be highly porous which allows 
vascularization and nutrient delivery. In addition, the mechanical properties of 
scaffold must keep the structural integrity during first stage of bone formation. 
The materials that usually used to produce the scaffolds are either natural or 
synthetic. Natural derived scaffolds are come from natural tissue such as 
collagen, fibrin, hyaluronic acids and deminarlized bone matrix. It is usually act 
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as extracellular matrix and has high biodegradable affinity. Synthetic materials 
are either absorbable or permanent. The synthetic absorbable materials include; 
poly glycolic acid (PGA), polylactic acid (PLA) and Polyvinyl alcohol (PVA). 
Metals and alloys are examples of permanent scaffolds. Synthetic bone 
substitutes are widely used in clinical practice as osteoconductive materials; 
however they lack osteoinductive or osteogenic properties. They promote the 
migration, proliferation and differentiation of bone cells for bone regeneration. 
They are usually used as adjuncts or alternatives to autologous bone grafts, 
especially for regeneration of large bone defects, where the requirements for 
grafting material are substantial. Scaffolds can be used in combination with 
autologous bone graft, growth factors or cells (Giannoudis et al. 2005). Different 
studies are ongoing to improve scaffold's properties, to enhance cellular 
adhesion, growth and differentiation, as well as to allow vascular ingrowth and 
bone-tissue formation (Dimitriou et al. 2011). Three dimensional scaffolds/cells 
can be added to the ex vivo fractured mandible slices to study bone 
regeneration. The assessment of the 3D scaffolds in the ex vivo fractured model 
can give clear outcome about the synergistic effects of the growth factor on 
proliferation and differentiation of the resident and seeded cells.  
 
1.7 Modelling of Bone Regeneration 
During bone regeneration, suitable model and clinical systems are required to 
understand the effects of new therapies on bone structure. In vitro studies use 
only a single or two cell system models to investigate the behaviour of cells to 
varying treatments such as addition of exogenous growth factors (Itonaga et al. 
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2004; Abdelmagid et al. 2007). In vitro models have been used to co-culture two 
different cell types such as osteoblasts with chondrocytes to investigate the 
biological integration of cartilage grafts with subchondral bone (Jiang et al. 
2005). In vitro models have also been used to co-culture of osteoblasts and 
haematopoietic stem cells to investigate physical interactions between the cell 
types (Jung et al. 2005). Although in vitro models can provide information about 
cellular behaviour in response to varying factors, the information they can yield 
is limited as they are unable to recapitulate the spatial arrangement of cells in 
vivo. 
 
To explore and investigate mechanism of bone regeneration, large numbers of 
in vivo models are used such as rabbits, rodents, primates, and genetic knock-
out mice. In vivo models of bone repair have been used in critical sized defect 
models developed in the femur (Fini et al. 2005); as well as in the calvaria and 
mandible (SCHMITZ and Hollinger 1986). Although they have yielded 
considerable information on bone repair, in vivo models also have some 
limitations and problems. Such as the cost of running the experiments and the 
technical difficulties of obtaining clear data from cell to cell interaction between 
different cell types that may have effect on the cells behaviour. Furthermore, 
ethical implications can be raised from the large number of animals that must be 
used with such experiments. All of that suggests the need of finding a novel 
precise experimental model.  
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To minimise the issues associated with the in vivo models and in vitro cell 
culture systems, Sloan and his colleague developed a novel ex vivo tooth slice 
models to investigate dentine repair (Sloan et al. 1998). Using such ex vivo 
models have significant advantages of reducing the number of animals required 
for in vivo experimentation. It can be used to study a wide variety of 
developmental, physiological and pathological conditions. By using this model 
clearer data may be obtained from the cells and tissues cultured as would be 
found in the in vivo situation, but the systemic influences, which often hinder in 
vivo work, are removed. As well as eliminate the need for costly and 
unnecessarily numerous in vivo studies.  
 
Ex vivo culture of incisor rat slices has been used greatly to improve the 
understanding of a wide range of dental tissue repair processes, such as 
angiogenesis inside the pulp tissue (Magloire et al. 1996; Smith et al. 1998; 
Sloan and Smith 1999). This culture system has also been used to assess the 
biocompatibility and cytotoxicity of commonly used dental materials (Turner 
2002; Waddington et al. 2004a; Graichen et al. 2005a).  Dhopatkar et al. (2005) 
developed a mandibular slice ex vivo organ culture model system to investigate 
the effect of externally applied forces on the dentin-pulp complex (Dhopatkar et 
al. 2005b). Ex vivo culture system has also been used to investigate the effects 
of orthodontic forces on root resorption (Wan Hassan et al. 2012). Ex vivo organ 
culture allowed us to develop a system which supports the differentiation, 
proliferation and activity of different cells such as fibroblasts, osteoblasts, 
osteoclasts and immune system cells within cultured slices of mouse mandible 
(Taylor 2008). Through the ex vivo mandibular slices culture it is possible to 
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have a natural tissue environment which can be used to assess biological 
responses of the tissue as well as monitor the cellular responses much closer 
than in vivo models. 
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1.8 Aims 
Several studies have demonstrated that growth factors play an important role 
during bone repair process. Using combinations of different growth factors, such 
as the combinations found in the bone matrix, may be more effective in 
promoting bone healing compared with single growth factor therapy such as 
bone morphogenic protein-2, which has found clinical application, but requires 
high doses to be effective. This thesis seeks to: 
 Investigate processes of bone repair within the ex vivo fractured mandible 
culture model for extended cultures time. 
 Investigate the responsiveness of the ex vivo fractured mandible culture 
model to exogenously applied BMP2, in particular investigating the effect of 
BMP2 on proliferation and differentiation of osteoblasts and their progenitor 
cells present within the model.  
 Use the ex vivo fractured mandible culture model to stimulate the release of 
endogenous growth factors from fractured surfaces of rodent mandibular 
bone and investigate the ability of endogenously released growth factors to 
mediate the regeneration of mandibular bone during culture. 
 Investigate the effect of calcium hydroxide on cellular behaviour of bone 
marrow stem cells (BMSCs).  
 Assess functionality of a low dose of BMP2-2, BMP7-7 and BMP2-7 
expressed by HEK cell lines using human bone marrow stromal cell and ex 
vivo fractured mandible model.   
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Chapter 2.  
STIMULATION OF THE EX VIVO FRACTURED MANDIBLE 
MODEL WITH EXOGENOUS GROWTH FACTOR 
 
2.1 Introduction 
To study bone regeneration, a suitable model is essential to understand and 
simplify the complex interactions that occur during healing and repair processes. 
Results from in vitro cell culture have some limitation because cells are usually 
cultured outside their normal environment and away from their surrounding 
tissues. There are also some concerns associated with the current in vivo animal 
models which include the cost of running the experiments, the systemic 
influence and the technical difficulties of obtaining clear data from cell to cell 
interaction between different cell types that may have effect on the cells 
behaviour. Furthermore, ethical implications can be raised from the large 
number of animals that must be used to examine the many variables associated 
with such experiments. All of this suggests the need of finding alternative 
models.  
 
To minimise the issues associated with the in vivo models and in vitro cell 
culture systems, Sloan and colleagues (1998) developed a novel ex vivo tooth 
slice model to investigate dentine repair (Sloan et al. 1998; Bielby et al. 2007a). 
Using such ex vivo models ensured significant advantages of reducing the cost 
as well as the number of animals required compared to in vivo experimentation. 
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It can be used to study a wide variety of developmental, physiological and 
pathological conditions. By using this model clearer data may be obtained from 
the cells and tissues cultured as would be found in the in vivo situation, but the 
systemic influences, which often hinder in vivo work, are removed. The model 
involves slicing of rat incisor (Sloan et al. 1998) or mandible (Bielby et al. 2007a; 
Smith et al. 2010; Colombo et al. 2015) into 2mm transverse slices followed by 
culturing each slice separately in a way that each slice considered as a one 
experiment.  
 
Ex vivo culture models have been used for different studies such as to improve 
the understanding of cartilage defects (Graichen et al. 2005b) and angiogenesis 
inside the pulp tissue (Smith et al., 1998, Sloan and Smith, 1999, Magloire et al., 
1996). These models have also been used to test biocompatibility and 
cytotoxicity of drug activity (Turner et al. 2002; Waddington et al. 2004b) and to 
assess effect of externally applied forces on the dentin-pulp complex (Dhopatkar 
et al. 2005a).  Ex vivo culture system have also been used to investigate the 
effects of orthodontic forces on root resorption (Wan Hassan et al. 2012) as well 
as assess tissue response to bacterial growth (Roberts et al. 2013). The model 
was responsive also to TGF-β1, applied via agarose beads to tooth slice culture 
system (Sloan et al. 1998) and to mandible slice culture system (Smith et al. 
2010), and results demonstrated that exogenously applied TGF-β1 is capable of 
stimulating cellular migration, proliferation and expression of bone matrix 
proteins. Recently the model was used successfully for culture and 
characterization of transplanted dental pulp progenitor cells (Colombo et al. 
2015). 
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BMP2, as discussed in the introduction to this thesis, is a growth factor that 
plays an important role during bone regeneration procedures as it is capable of 
differentiating mesenchymal stem cells and osteoprogenitor cells into mature, 
fully functional osteoblast cells, capable of producing new bone (Wozney 1992; 
Lieberman et al. 2002b; Cheng et al. 2003). BMP2 has been approved by food 
and drug administration (FDA) to be used clinically in the treatment of non-union 
in long bones (Govender et al. 2002) and in the induction of spinal fusion (Boden 
et al. 2000). This thesis chapter aims to investigate the validity of the fractured 
rat mandible slice model when culture for more than 21 days also to investigate 
the effect of adding BMP2, as a single growth factor therapy, to the fracture site 
of the mandible model in an environment mimic fracture repair. 
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2.2 Materials and Methods 
2.2.1 Preparation of fractured mandible slices  
Twenty eight day old male Wistar rats, housed in the animal house facility of 
Cardiff University, were freshly sacrificed in accordance with Schedule 1 of the 
UK Animal (Scientific Procedures) Act 1986. Mandibles were dissected and soft 
tissue was removed by using a sterile disposable scalpel blade and sterile 
forceps then placed into sterile washing medium. Mandibles were held by two 
Mosquito forceps; and the condyle, ramus, and molars were removed with a 
segmented diamond-edged rotary bone saw (TAAB, Berkshire, UK) (Figure 2.1). 
Mandibles were sectioned into slices of approximately 2mm thickness and 
placed immediately into washing medium of Dulbecco’s Modified Eagle’s 
Medium (DMEM) (Sigma Chemical Co Ltd, UK) prepared containing 1% 
concentration of antibiotics solution (10,000 units of penicillin, 10mg/ml of 
streptomycin, and 25µg/ml amphotericin B) (Invitrogen, UK) and 200mM L-
glutamine (Invitrogen, UK).The rotary disc was sterilized by washing with 70% 
ethanol prior to use and cooled with washing medium during slicing. Mandible 
slices were fractured by placing pressure onto the central portion of the lingual 
plate using a sterile scalpel blade. Fractures were prepared in a similar location 
in each mandible slice. Fractured mandible slices were cultured using Trowel 
type cultures (Begue-Kirn et al. 1992; Sloan et al. 1998; Smith et al. 2010).  
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Figure 2- 1: Schematic representation of dissected mandible preparation. The condyle, ramus, 
molar and incisor teeth were cut using a rotary bone saw and discarded. Two-millimetre-thick 
transverse slices of mandibles were prepared by cutting through the tissue as indicated by the vertical 
lines. 
 
 
 
2.2.1.1 Trowel type cultures  
Mandible slices were embedded into individual wells of a plastic 96-well plate 
(Greiner Bio-One, UK), which was filled previously with 100µl sterile molten 
embedding media prepared by mixing 1% low melting point agar (agarose type 
VII; Sigma Gillingham) 1:1 with culture medium. Culture medium prepared by 
adding 10% heat inactivated foetal calf serum (Invitrogen, UK), 0.15mg/ml of 
ascorbic acid (Invitrogen, UK), 200mM L-glutamine (Invitrogen) and 1% 
concentration of antibiotics solution (10,000 units of penicillin, 10mg/ml of 
streptomycin, and 25µg/ml amphotericin B) (Invitrogen, UK) into DMEM 
(Invitrogen). Mandible slices were left at room temperature for approximately five 
minutes until embedding media became semi-solid.  
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During agar setting, a sterile plastic ring support and Millipore filter (mixed esters 
of cellulose acetate and nitrate) were placed in each well of plastic 12-well plate 
(Greiner Bio-One, UK). Embedded mandible slices were transferred from the 
multi well dish and placed on a Millipore filter which was floated on the surface of 
2 ml of culture medium in Trowel type cultures (Trowell and Westgarth 1959) 
(Figure 2.2). Mandible slices in Trowel type cultures were incubated at 37oC, in a 
humidified atmosphere of 5% CO2 in air and cultured for 35 days.  Culture 
medium was changed every other day. 
 
 
 
 
 
 
2.2.2 Addition of BMP coated agarose beads to fractured mandible 
slices 
Human recombinant BMP2 (Invitrogen, UK) was solubilised in 20mM acetic acid 
to a concentration of 0.1mg/ml, and then further diluted to a working 
concentration in 0.1% BSA in TBS and stored in -20oC. 150µm sized Affi Gel 
Blue agarose beads (BioRad Laboratories, UK) were centrifuged to separate 
agarose beads from PBS then incubated with 50µl 100ng/ml BMP2 in 0.1% BSA 
in TBS for 1 hour at 37oC.  
Individual well of 12 
well plate 
Mandible slice 
Culture medium 
Millipore filter 
Plastic ring support 
Agar medium 
Figure 2- 2: Trowel type culture. Embedded mandible slices were placed on millipore filter 
floated on culture medium and supported by plastic ring.  
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Mandible slices were prepared as described above. Prior to embedding in semi-
solid agar medium, the fracture site was packed with 3 agarose beads (Figure 
2.3) using sterile forceps and perio probe, with the aid of a dissecting 
microscope (Bausch and Lomb, UK). As a control, fracture sites were left empty 
without beads or packed with agarose beads that had been previously incubated 
in PBS. The mandible slices were cultured in Trowel type cultures for 7, 14 and 
21 days. 
 
 
 
 
 
2.2.2.1 Haematoxylin and Eosin (H&E) 
Following culture, mandible slices were fixed in 10% (w/v) neutral buffered 
formalin at room temperature for 48 hrs. Slices were then demineralised in 10% 
(w/v) formic acid at room temperature for 72 hrs. Mandible slices were placed in 
a plastic basket and covered with lid. Mandible slices were processed for 
histological examination by dehydrating through a series of 70, 90, and 100% 
graded alcohols, cleared through xylene, and taken to molten paraffin wax 
(Raymond Lamb, UK) on an automatic tissue processer (Shandon Pathcentre). 
Slices were embedded in paraffin wax in a metal mould prior to sectioning. 
Sections of 7µm thickness were cut on a sledge microtome (Leica SM 2400) at 
different levels throughout the tissue and mounted onto polysine glass slides 
Figure 2- 3: Agarose beads soaked in BMP2 were placed in fractured area (arrow), 
before embedding in semisolid agar medium. 
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(Thermo Scientific, UK). In order to improve adhesion of sections to the slides, 
sections were dried in an oven at 60oC for 30 minutes. Sections were stained 
with haematoxylin and eosin using an automatic tissue stainer (Shandon 
LiniStain, UK) in which sections were taken through a series of solutions 
containing xylene, series of descending graded alcohols, water, haematoxylin, 
acid alcohol, Scott’s tap water and eosin. After a final wash in tap water, 
sections were finally dehydrated with alcohol and cleared with xylene. Slides 
were mounted under a glass cover slip with DPX mounting medium (Raymond 
Lamb, UK). Stained sections were examined on an Olympus AX70 light 
microscope. Photographs were taken using a Nikon DXM digital camera and 
ACT-1 imaging software. Cells within the periodontal ligament (PDL) of H&E 
stained sections were automatically counted digitally using Image ProPlus 
software (Media Cybernetics Inc, USA). 100µm2 areas within five areas around 
and proximal to the fracture site were counted per section as well as 
unfractured, contralateral, away and opposite to the fracture site (Figure 2.4).  
 
 
 
 
 
 
Un-fractured site 
(control) 
 
Fractured 
 site 
 
 
Figure 2- 4: Areas of interest showing number of cells were counted proximal to the fracture 
site and at un-fracture site which was away and opposite to the fracture site, used as an 
internal control. 
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2.2.2.2 Immunohistochemistry 
 
Immunohistochemical staining was carried out using a Vectastain ABC 
peroxidase kit (Vector Laboratories Ltd). The kit included normal horse serum, a 
universal biotinylated secondary antibody and the ‘ABC’ reagent. The 
horseradish peroxidase was visualised by the development of a peroxidase 
substrate that produces a colour. Paraffin embedded mandible slices were cut 
and mounted on polysine glass slides as described above (section 2.2.2.1). 
Slides were dried at 60°C overnight. Sections were deparaffinised with two 
washes of xylene for 5 minutes then cleared with 100% of industrial methylated 
spirits (IMS) twice for 5 minutes and then rinsed twice with tap water for 5 
minutes. Sections were incubated in 0.1% triton X 100 for 10 min and washed 
twice in tris-buffered saline (TBS) buffer for 5 min. Sections were then incubated 
in 3% hydrogen peroxide solution for 10 min and washed twice in (TBS) buffer 
for 5 min. Sections were outlined with a paraffin wax marker followed by addition 
of blocking serum (50µl serum in 2ml TBS) for 20 min. Excess serum was wiped 
from the slides and sections incubated for 1 hour with appropriate primary 
antibody. 
 
An indicator of cellular proliferation, proliferating cell nuclear antigen (PCNA) 
primary antibody, rabbit anti-rat (Santa Cruz Biotech, Santa Cruz, CA,USA), was 
diluted 1:20 in 1% BSA/TBS. Osteopontin (OPN) primary antibody, bone marker, 
goat anti-rat OPN (Santa Cruz Biotech, Santa Cruz, CA,USA), was diluted 1:250 
in 1% BSA/TBS. Another bone marker, osteocalcin (OCN) primary antibody, 
goat anti-rat OCN (Santa Cruz Biotech, Santa Cruz, CA, USA), was diluted 1:50 
in 1% BSA/TBS. As a negative control, the primary antibody was excluded and 
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replaced with TBS. Following primary antibody incubation sections were washed 
twice for 5 min in TBS buffer. Sections were then incubated for 30 min with the 
universal biotinylated secondary antibody and washed twice for 5 min in (TBS) 
buffer. Sections were incubated for 30 min with the VECTASTAIN ‘ABC’ reagent. 
Following two further TBS buffer washes for 5 min, sections were incubated with 
DAB peroxidase substrate solution (Vector Laboratories) for 4 min. Sections 
were rinsed in tap water for 5 min, and counterstained with 0.1% light green for 
30 seconds. Finally, sections were dehydrated in IMS for 5 min, cleared in 
xylene for 5 min, and glass coverslips were applied using DPX mounting 
medium (Raymond Lamb, UK). Sections were evaluated microscopically on an 
Olympus AX70 light microscope. Photographs were taken using a Nikon DXM 
digital camera and ACT-1 imaging software. A total of 5 mandible slices were 
used per treatment, for each marker.  
 
2.2.3 Statistical analysis 
Statistical analysis was carried out using GraphPad InStat 3 software (GraphPad 
software, Inc, USA). Standard errors of the mean were calculated, and mean 
values were analysed using one-way ANOVA and Tukey’s post hoc test to 
analyse differences between treatment types and controls. P values below 0.05 
at 95% confidence intervals were held to be statistically significant. 
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2.3 Results 
 
2.3.1 Culture of mandible slices for upto 35 days 
 
Histological evaluation of mandible slices that had been cultured for 35 days 
demonstrated maintenance of tissue structure throughout the section (Figure 
2.5). Cells still appeared viable with round, darkly stained nuclei. Cell and tissue 
architecture were well preserved adjacent to the fracture site, demonstrating 
maintenance of cell and tissue structure without sustaining excessive damage to 
cells and tissues within adjacent areas. 
 
Statistical analysis of average PDL cell numbers (Figure 2.6) proximal to the 
fracture sites demonstrated that there were a significant differences between 
uncultured (day 0) fractured mandible slices (48 (±1.5) cells/100µm2) and 
cultured fractured mandible slices (p<0.001). No significant differences were 
identified between fractured mandible slices cultured for 7days (28 (±1.3) 
cells/100µm2) and 14 days (26 (±1.2) cells/100µm2) (P>0.05). Digital image 
analysis of cell counts proximal to the fracture sites calculated an average of (14 
(±1.2) cells/100µm2) in 21 days, (12 (±1.2) cells/100µm2) in 27 days, and (10 
(±1.2) cells/100µm2) in 35 days cultures. Statistical analysis demonstrated that 
there were a significant decrease in average PDL cell numbers after 7 days 
(p<0.001). No significant differences were identified between average PDL cell 
numbers of fracture and unfracture sites at each day (P>0.05).
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Contralateral site 
Figure 2- 5: Histological examination of fractured mandible slices cultured for 35 days. [A-
F] fractured site, [G, H] contralateral side. PDL: periodontal ligament; D: dentine; B: bone; 
F: fracture site. 
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Figure 2- 6: Comparison between fractured mandible slices cultured for 35 days.  Average 
PDL cell numbers per 100 um2 area were counted proximal to the fracture sites and at 
unfractured contralateral site. n=5.  Error bars indicate standard error of the mean. 
***P<0.001.  
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2.3.2 Addition of BMP2 coated agarose beads to fractured 
mandible slices 
2.3.2.1 Histology of BMP2 stimulated mandible slices for 7 days  
Histological evaluation of fractured mandible slices that had been stimulated for 7 
days with BMP2 beads demonstrated maintenance of tissue architecture throughout 
the section when compared with mandible slices packed with PBS beads and 
without beads (Figure 2.7). Fractured mandible slices demonstrated aggregation of 
cells within the PDL in close proximity to the site of fracture and beads placement in 
the three groups. This aggregation of cells was not observed within regions of PDL 
opposite the fractured site (Figure 2.7). Minimal loss of tissue architecture appeared 
within the PDL around area of BMP2 bead placement. 
 
Statistical analysis of average PDL cell counts (Figure 2.8) demonstrated no 
significant differences between treated and untreated mandible slices at site of 
fracture (P>0.05). Digital image analysis of cell counts at the fracture site calculated 
an average of (28 (±1.1) cells/100µm2) in slices with no beads, (24 (±1.2) 
cells/100µm2) in slices with PBS beads and (29 (±1.3) cells/100µm2) in slices with 
BMP2 beads. Although average PDL cell counts demonstrated high cell number in 
BMP2 stimulated slices, this increase was not significant (P>0.05). There was also 
no significant difference in average cell numbers within regions of mandible slices 
opposite the site of stimulation between the three groups (P>0.05). Although not 
significant, there was a slight increase in average cell numbers within regions of 
mandible slices opposite the site of stimulation when compared with fracture site 
(P>0.05). 
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Figure 2- 7: Histological examination of mandible slices cultured with; a) no beads, b) 
PBS beads, c) BMP2 beads for 7 days. (A-C) fractured site, (D-F) contralateral 
unfractured side.  PDL: periodontal ligament; D: dentine; B: bone; F: fracture site. 
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Figure 2- 8: Comparison of average cell numbers per 100 um2 area within the PDL 
of fractured mandible slices cultured with no beads, PBS beads or BMP2 beads for 
7 days. FS: fracture site; Away: contralateral, unfracture site.  (n=8), Error bars 
indicate standard error of the mean. 
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2.3.2.2 Histology of BMP2 stimulated mandible slices for 14 days 
 
Histological evaluation of mandible slices that had been stimulated for 14 days 
demonstrated maintenance of tissue architecture throughout the section (Figure 
2.9). Fractured mandible slices demonstrated an aggregation of cells within the 
PDL in close proximity to the site of fracture and bead placement in the three 
groups. This aggregation of cells was not observed within regions of PDL 
opposite the fractured site. Minimal loss of tissue architecture appeared within 
the PDL around area of bead placement. 
 
Statistical analysis of PDL cell counts (Figure 2.10) demonstrated a slight 
increase in PDL cell numbers at the site of fracture within non stimulated 
mandible slices (20 (±1.1) cells/100µm2) when compared with the mandible 
slices stimulated with PBS-beads (16 (±1.1) cells/100µm2) and BMP2-beads (19 
(±0.8) cells/100µm2) (P>0.05). In area opposite the site of stimulation, digital 
image analysis of cell counts calculated an average of (19.7 (±1.0) cells/100µm2) 
in no beads slices, (19.2 (±1.4) cells/100µm2) in PBS slices, and (18.2 (±1.0) 
cells/100µm2) in BMP2 slices. There was no significant difference in average cell 
numbers within regions of mandible slices opposite the site of stimulation 
between the three groups (P>0.05).  
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Figure 2- 9: Histological examination of mandible slices cultured with a) no beads, b) PBS 
beads, c) BMP2 beads for 14 days. (A-C) fractured site, (D-F) contralateral, unfracture 
site.  PDL: periodontal ligament; D: dentine; B: bone; F: fracture site; arrows indicate 
aggregation of cells. 
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Figure 2- 10: Comparison of average cell numbers per 100 um2 area within the PDL 
of fractured mandible slices cultured with no beads, PBS beads or BMP2 beads for 
14 days. FS: fracture site; Away: contralateral, unfracture site.  (n=8), Error bars 
indicate standard error of the mean. 
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2.3.2.3 Histology of BMP2 stimulated mandible slices for 21 days 
 
Fractured mandible slices stimulated for 21 days demonstrated minimal loss of 
cells throughout the section (Figure 2.11). There was no aggregation of cells 
within the PDL at the site of fracture. Digital image analysis of cell counts (Figure 
2.12) at fracture site calculated an average of (16 (±0.6) cells/100µm2) in no 
beads slices, (17 (±0.9) cells/100µm2) in PBS slices, and (15 (±0.7) 
cells/100µm2) in BMP2 slices. However digital image analysis of cell counts 
opposite to the fracture site calculated an average of (19 (±1.2) cells/100µm2) in 
no beads slices, (20 (±1.6) cells/100µm2) in PBS slices, and (21 (±1.0) 
cells/100µm2) in BMP2 slices. Statistical analysis, demonstrated no significant 
difference in average cell numbers within regions of fractured mandible slices 
(P>0.05). There were also no significant differences in average cell numbers 
between fractured and unfractured sites as well as in areas opposite the site of 
stimulation between the three groups (P>0.05). 
 
 
Statistical analysis of PDL cell counts (Figure 2.13) of BMP2 stimulated fractured 
slices demonstrated significant gradual decrease of cell numbers over the 21 
days. Results demonstrated that PDL cell counts at BMP2 stimulated fractured 
sites were significantly higher after 7 days of culture (30 cells/100µm2) when 
compared with BMP2 stimulated fractured sites after 14 (20 cells/100µm2) and 
21 days (15cells/100µm2). 
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Figure 2- 11: Histological examination of mandible slices cultured with a) no beads, b) PBS 
beads, c) BMP2 beads for 21 days. (A-C) fractured site, (D-F) contralateral, unfracture site.  
PDL: periodontal ligament; D: dentine; B: bone; F: fracture site. 
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Figure 2- 12: Comparison of average cell numbers per 100 um2 area within the PDL 
of fractured mandible slices cultured with no beads, PBS beads or BMP2 beads for 
21 days. FS: fracture site; Away: contralateral, unfracture site.  (n=8), Error bars 
indicate standard error of the mean. 
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Figure 2- 13: Comparison of average cell numbers per 100 um2 area within the PDL of fractured 
mandible slices cultured with BMP2 beads for 7, 14 and 21 days. 
***P<0.01, Error bars indicate standard error of the mean. 
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2.3.3 Immunohistochemical characterisation 
2.3.3.1 PCNA immunolocalisation 
 
Immunohistochemical staining was used to assess expression of PCNA at 
fracture site (Figure 2.14). Cells exhibiting positive expression for the 
proliferation marker PCNA could be observed within the PDL of mandible slices 
cultured without beads and mandible slices cultured with PBS beads and BMP2 
beads at day 7, 14 and 21. Insignificant amount of positive expression could be 
detected within the cells of the pulp. Negative controls where primary antibodies 
were omitted demonstrated only the methyl green counterstain with no non-
specific staining.  
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Figure 2- 14: PCNA immunohistochemistry of fractured mandible slices cultured with  a) 
no beads, b) PBS beads, c) BMP2 beads for 7, 14 and 21 days. Arrows indicate PCNA 
immunopositive cells at fracture site. PDL: periodontal ligament; B: bone; D: dentin. (d) 
control sections where primary antibody was excluded and replaced with TBS. 
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2.3.3.2 Osteopontin and Osteocalcin immunohistochemistry 
 
Cells exhibiting positive expression for the bone marker, osteopontin (OPN) 
(Figure 2.15) and Osteocalcin (OCN) (Figure 2.16) could be observed at fracture 
site within the PDL of mandible slices cultured without beads and mandible 
slices cultured with PBS beads and BMP2 beads at day 7. Mandible slices 
cultured with BMP2 beads demonstrated positive expression of OPN and OCN 
at day 14 and 21 while control mandible slices that cultured without beads or 
with PBS beads demonstrated no expression to OPN and OCN at day 14 and 
21.  Negative controls where primary antibodies were omitted demonstrated only 
the methyl green counterstain with no non-specific staining (Figure 2.15 and 
2.16).   
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Figure 2- 15: Osteopontin immunohistochemistry of fractured mandible slices cultured 
with  a) no beads, b) PBS beads, c) BMP2 beads for 7,14 and 21 days. Arrows indicate 
OPN immunopositive cells at fracture site. PDL: periodontal ligament; B: bone; D: 
dentin. (d) control sections where primary antibody was excluded and replaced with 
TBS. 
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Figure 2- 16: Osteocalcin immunohistochemistry of fractured mandible slices cultured with  a) no 
beads, b) PBS beads, c) BMP2 beads for 7,14 and 21 days. Arrows indicate OCN immunopositive 
cells at fracture site. PDL: periodontal ligament; B: bone; D: dentin. (d) Control sections where 
primary antibody was excluded and replaced with TBS. 
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Discussion 
A major problem towards understanding optimal repair processes is the lack of a 
suitable model system for studying aspects of bone regeneration. An attractive 
alternative to in vitro and in vivo models may be ex vivo organ culture models 
(Smith et al. 2010; Wan Hassan et al. 2012; Al-Daghreer et al. 2013; Colombo et 
al. 2015). Data obtained from the ex vivo mandible model in this chapter have 
demonstrated a novel study where mandible slices can be fractured and cultured 
for up to 35 days without sustaining excessive damage to the cells and tissues 
adjacent to the site of fracture. Fractured rat mandible slices were also 
successfully stimulated with topical application of BMP2 via agarose beads and 
the model demonstrated an osteoinductive response to the applied growth 
factors.  
 
Fractured rat mandible slices were cultured for up to 35 days with general 
maintenance of tissue architecture and cellular morphology during this time. 
However, digital image analysis of cell count of these mandible slices revealed 
gradual decrease in cell numbers across the culture period. Results 
demonstrated that the culture model is considered successful for 14 days, 
suggesting that the model is ideal to study early repair processes, as well as 
study cells ability to synthesize and secrete matrix during bone regeneration. 
The decrease in cell numbers which was seen throughout the tissue in both 
fractured and non fractured site, is probably due to cell death within the PDL 
across the extended time of culture, a problem often encountered during the 
culture of cells and tissues for extended time (Arden and Betenbaugh 2004). 
The gradual decease in cell number across the culture period could be 
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programmed cell death due to aging of cells over time. Cell viability was tested 
on ex vivo mandible model and results demonstrated that a high level of cellular 
viability maintained throughout the tissue (Smith et al. 2010). It has been 
demonstrated that cell survival can be significantly improved by reducing 
hyperosmolality, while maintaining physiological pH and oxygen homeostasis 
(Potter and DeMarse 2001).  Cell death due to tissue hypoxia may also be a 
contributing factor to the decrease in cell numbers, which can affect cellular 
behaviour by reducing cellular proliferation and viability (Park et al. 2002; Utting 
et al. 2006). It has been reported that hypoxia can affect osteoblast viability 
(Utting et al. 2006), and osteogenic differentiation by decreasing the expression 
of the essential transcription factor Runx2 (Park et al. 2002).  
 
Despite the significant loss of PDL cell number after 14 days of culture, previous 
studies have demonstrated presence of highly viable pulpal cells even after 21 
days in the ex vivo culture (unpublished work, Cardiff university). This could 
suggest that PDL cells may be affected with the ex vivo culture environment 
more than other part of the mandible. Cell viability was well maintained after 14 
days of culture, therefore the reduction in cell numbers after 14 days of culture 
might be improved by altering the culture medium, its contents and culture 
conditions for experiments require long culture period.  A study by Potter and 
DeMarse (2001), demonstrated a way to overcome survival issue of the cells by 
using sealed culture dishes and a transparent hydrophobic membrane that is 
selectively permeable to oxygen (O2) and carbon dioxide (CO2), and relatively 
impermeable to water vapour (Potter and DeMarse 2001). Periodontal ligament 
maintains homeostasis to periodontium via mechanical tensile loading caused 
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by occlusion and mastication (Davidovitch et al. 1988; Lekic and McCulloch 
1996). Loss of periodontal ligament function or absence of occlusal stimuli can 
lead to disuse atrophy of the periodontal ligament (Kanzaki et al. 2006). Cyclical 
tensile force on periodontal ligament cells was shown to increase cell number 
and induce TGF-β1 stimulation and upregulation of OPG (Kanzaki et al. 2006). 
Thus stress and strain force are essential to the maintenance of the PDL 
architecture (Fukui et al. 2003; Chiba and Mitani 2004). 
 
BMP2 is a growth factor that plays an important role in stimulating cellular effects 
during bone formation. It has been demonstrated that BMP2 exerts an 
osteogenic role via direct stimulation of osteoblasts at the fracture site 
(Bouletreau et al. 2002). Treatment of mandible slices with BMP2 demonstrated 
aggregation of cells in fractured sites. This aggregation is likely indicates 
proliferation of the cells or migration of cells towards site of injury which is 
probably a cellular response in physiological healing (Lekic and McCulloch 1996; 
Griffon 2008). Slices cultured in presence of BMP2 beads demonstrated 
comparable periodontal cell numbers to control mandible culture at fracture 
sites. This observation suggests that the addition of BMP2 to the fractured 
mandible could not have role in cell proliferation at site of application. This was 
confirmed later by the PCNA immunohistochemistry staining which 
demonstrated expression of PCNA at control and BMP2 stimulated slices. BMP2 
has been shown to stimulate proliferation of osteoprogenitors (Yamaguchi et al. 
1991a; Liu et al. 2009). It is possible that the used concentration, the short half-
life of BMP2 or the amount of BMP2 released from the beads were not enough 
to induce cellular effect. However, different studies have been used beads 
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effectively to deliver a small concentration and a short half-life growth factors 
such as TGF-β1 (Ganan et al. 1996; Sloan and Smith 1999; Smith et al. 2010), 
FGF-2 (Mori et al. 2007), BMP4 and TGF-β2 (Ganan et al. 1996). Although 
digital image analysis of cell count and PCNA immunohistochemistry 
demonstrated no specific proliferation effect at BMP2 stimulated slices, 
immunohistochemistry for the bone markers, OSP and OCN, demonstrated that 
the main function of BMP2 is to drive the differentiation during repair processes  
(Lieberman et al. 2002a; Hughes et al. 2006b). 
 
BMP2 was delivered to the fractured sites via agarose beads. The beads allow 
diffusion of the growth factors from within the bead into the surrounding tissue. 
Such diffusion of growth factors from agarose beads has also been shown in 
previous studies, both in a tooth slice culture model (Sloan and Smith 1999), and 
in mandible slice model (Smith et al. 2010). It has been demonstrated that the 
agarose beads offer a certain degree of protection to the growth factors, keeping 
the growth factors within the bead itself until they diffuse out into the tissue 
(Sloan and Smith 1999; Smith et al.2009). Results demonstrated that PDL cell 
counts at BMP2 stimulated fractured sites were significantly higher after 7 days 
(Figure 2- 17) when compared with BMP2 stimulated fractured sites after 14 and 
21 days of culture. These results may suggest that the BMP2 released from 
agarose beads elicit a greater response in the first 7 days of culture. This could 
be due to the short half-life BMP2 (Noh et al. 2006; Johnson et al. 2009). Growth 
factors may lose its bioactivity owing to their susceptibility to biodegradation 
through different pathways, such as denaturation, oxidation or proteolysis 
(Manning et al. 1989; Krishnamurthy and Manning 2002). Previous studies have 
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demonstrated that the life span of BMP2 is ranging from 4-6 hours (Gruendler et 
al. 2001), which could be the cause of gradual decrease in number of cell over 
the 21 days. Furthermore, it is possible that the greater effect found at the first 7 
days is associated with the biphasic release pattern with an initial burst, followed 
by a slower release (Yang et al. 2002; Ma et al. 2015). It has been shown that 
beads provide rapid diffusion of growth factor after culture (Mori et al. 2007). 
 
Digital image analysis of cell counts demonstrated that there were no significant 
differences between fractured mandible slices stimulated with BMP2 beads and 
the control slices. Insertion of beads within the fracture site enabled slight 
protrusion of the beads into the PDL tissue. It is likely that size of the bead and 
the space occupied with beads may cause interference during histological 
examination of the fracture site. It has been demonstrated that due to existent 
and the size of FGF2- bead, view of the cells was blocked under the microscope 
(Mori et al. 2007). The authors demonstrated that using polyhedra, which was 
very small in size, to deliver growth factor provided precise and prolonged 
growth factor stimulation more than the bead (Mori et al. 2007). Different 
methods have been studied to deliver growth factor clinically and experimentally 
all aim to enhance and accelerate functional bone formation. Ideal carrier, as 
reviewed by Vo et al, should be biocompatible, site specific, have local 
regulation/retention ability and biodegradable for complete tissue regeneration 
(Vo et al. 2012). Affi-gel beads are not biodegradable and occupy adequate size 
inside the tissue but it was used in this study to deliver and investigate the effect 
of exogenous application of BMP2 on organotypic fractured mandible model.   
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Immunohistochemical staining was carried out to characterise the cells residing 
in areas adjacent to the site of fracture and to assess cellular behaviour after 
exogenous application of BMP2 beads. Cellular behaviour assessed by 
investigating the expression of proliferation markers (PCNA) and the bone 
markers (osteocalcin and osteopontin). Results from immunohistochemical 
staining demonstrated that cells exhibiting positive expression for the 
proliferation marker PCNA could be observed within the PDL of mandible slices 
cultured without beads and mandible slices cultured with PBS beads and BMP2 
beads at day 7, 14 and 21. This suggests that the expression of PCNA by 
resident cells were not directly related to presence of BMP2. It is possible that 
this may be a physiological repair in response to the fracture alone (Li et al. 
2002). A fracture can stimulate release of local regulatory factors such as growth 
factors which can stimulate cellular proliferation and hence express PCNA after 
fracture (Iwaki et al. 1997; Einhorn 1998). Unstimulated fractured mandible 
model was also shown to express PCNA due to availability of a highly 
proliferative fibroblasts, osteoprogenitors, and mesenchymal stem cells at 
periodontal ligament and bone (Smith et al. 2010). The ex vivo mandible model 
lacks of blood supply, and lacks the continuous oxygen supply to the site of 
injury and therefore it is likely that this hypoxia induced PCNA expression via 
release of VEGF and TGF-b1 stimulated by hypoxia (Steinbrech et al. 1999; 
Warren et al. 2001; Lynam et al. 2015).   Digital image analysis of cell number at 
fracture site demonstrated no significant differences in cell number between 
treated and untreated mandible slices which confirmed also by 
immunohistochemical staining of PCNA where it detected at treated and control 
mandible slices.  
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Osteocalcin and osteopontin were positively expressed within the cells PDL in 
stimulated and unstimulated fractured mandible slices at day 7 suggesting that 
this expression was not related to BMP2 stimulation. It had been demonstrated 
that PCNA, alkaline phosphatase and OPN were expressed within fractured 
mandible slices without stimulation (Smith et al. 2010). It is likely that the cells 
expressing OPN and OCN at day 7 are osteoprogenitors, or fully differentiated 
osteoblast cells remained in the mandible from the start of culture. Furthermore, 
expression of OPN and OCN observed at day 7 is early to be consider as an 
active differentiation occurred in response to the fracturing of the mandible 
alone, as OPN and OCN are not an early osteogenic marker (Ivanovski et al. 
2001). In contrast, mandible slices cultured with BMP2 beads demonstrated 
positive expression of OPN and OCN at day 14 and 21 but not in control 
mandible slices cultured with PBS beads or without beads. It is possible that the 
fracturing of mandible slices has initiated a reparative response which during 
extended culture has resulted in increased expression of OPN and OCN, not 
observed in earlier time points. OPN is up-regulated at sites of inflammation and 
tissue remodelling (O'Brien et al. 1994; Liaw et al. 1998), and serves as a 
chemotactic molecule to recruit inflammatory cells to the site of injury, mediating 
migration, adhesion, and survival of many cell types (Lund et al. 2009; Kahles et 
al. 2014). Moreover, both osteocalcin and osteopontin have been shown to have 
the ability to form complexes together via calcium bridges (Ritter et al. 1992). If 
the bone lacks either osteopontin, osteocalcin or both, then the bone will have 
propensity to fracture due to altered micro-damage morphology and 
reduced crack propagation toughness (Poundarik et al. 2012; Nikel et al. 
2013). Both osteocalcin and osteopontin play critical role in bone mineralization 
which takes place at later stage of the bone repair process and is enhanced by 
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osteogenic growth factors such as BMP2 (Luong et al. 2012; Sun et al. 2015). 
This could explain expression of osteocalcin and osteopontin at day 7 in control 
and test groups as an early stage of bone repair process while expressing of 
osteocalcin and osteopontin at day 14 and 21 in fractured mandible slices 
stimulated with BMP2 beads. 
 
Although there was significant decrease in cell number after 14 days of culture, 
the ex vivo model proved to be a valid model which enables the culture of more 
than one cell and tissue types at the same time overcoming the complex 
interactions that occur in in vivo models as well as reducing costs and ethical 
issues associated with in vivo models. In this study BMP2 was applied 
exogenously to the fractured mandible model, and its effect on bone repair was 
investigated. Exogenous application of BMP2 induced bone repair by stimulating 
bone differentiation and mineralization. There are no doubts about the 
importance of growth factors during bone repair process, especially BMP2 which 
is approved for clinical therapies. However, there are some concerns associated 
with growth factor therapy such as the dose, time of application and the agonist 
and antagonist action between exogenous and endogenous growth factors. 
Thus investigation the effect of endogenous growth factors bounded within the 
bone matrix may be essential to improve clinical outcome of bone surgeries. 
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Chapter 3.  
STIMULATION OF EX VIVO FRACTURED MANDIBLE MODEL 
WITH CHEMICALLY RELEASED ENDOGENOUS GROWTH 
FACTORS 
3.1 Introduction 
Bone regeneration is driven by different growth factors, most of which have been 
extensively investigated in demonstrating enhanced bone regeneration. Several 
experimental and clinical trials have investigated the safety and efficacy of the 
use of exogenous growth factors as potential supplements for enhancing bone 
regeneration (Friedlaender et al. 2001; Carragee et al. 2011). Although some 
growth factors have been licensed for clinical use in bone regeneration, several 
issues need to be further examined to bring the most safe and effective 
medications into clinical practice. These include identification of the optimum 
dosage required to elicit a therapeutic response (Dimitriou et al. 2011) and 
understanding the synergistic action of using 'cocktail' of growth factors that 
have shown significant promising results in preclinical and early clinical 
investigation (Nauth et al. 2010; Dimitriou et al. 2011).  
 
Growth factors are natural functional proteins that are released or activated 
during development and embryogenesis (Hardy and Spanos 2002). They are 
also essential during wound healing or tissue regeneration (Raja et al. 2009). 
Numerous studies have focused to use different growth factors to accelerate and 
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mediate the healing process into one that will produce tissue regeneration 
(Hughes et al. 2006b; Ai-Aql et al. 2008; Dinh et al. 2015). It has been reported 
that a combination of different growth factors may enhance tissue regeneration 
more efficiently and effectively than single growth factors (Huang et al. 2005; 
Kempen et al. 2009; Suarez-Gonzalez et al. 2014; Dinh et al. 2015). Animal 
models have been utilised to investigate the effects of the addition of PDGF and 
IGF on periodontal regeneration in vivo. The results demonstrated that the 
addition of PDGF and IGF into debrided lesions of experimentally induced 
periodontitis stimulated regeneration of 50% of lost periodontal attachment 
(Rutherford et al. 1992) and significantly increased new bone and cementum 
formation histologically and clinically (Lynch et al. 1991). It has also been 
demonstrated that exogenous application of TGF-β to bone fractures can 
increase callus formation and strength, and bone formation, either on its own or 
in conjunction with IGF-1 (Srouji et al. 2004; Lee et al. 2006). It has also been 
reported that combination of BMP2 and TGF-β3 co-delivered to critical sized 
femoral defects in rats via poly(L-lactide-co-D,L-lactide) scaffolds demonstrated 
an increase in bone formation compared to nontreatment defects (Oest et al. 
2007). Recent studies have shown that the combination of angiogenic and 
osteogenic factors may stimulate bone regeneration. Dual release growth factor 
(VEGF & BMP2) fabricated scaffolds have been shown to enhance the bone 
regenerative capability in a critical sized femoral defect by releasing VEGF 
followed by BMP2 from alginate scaffold (Kanczler et al. 2010). 
 
Although several studies demonstrated an improvement in the bone 
regeneration process by a single or combined drug therapy, in vivo bone 
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regeneration is the result of a complex interplay between the various 
endogenous growth factors. Currently, numbers of clinical therapies are benefit 
from utilising endogenous matrix-bound growth factors rather than addition of 
exogenous growth factors. Ethylenediaminetetraacetic acid (EDTA) and citric 
acid solutions are commonly used in clinical dentistry as detergents to remove 
the smear layer and expose dentine surfaces (Pitoni et al. 2011) as well as 
decalcifying agents for calcified narrow roots. It has been reported that these 
acids are also able to demineralise the human dentine matrix releasing 
sequestered growth factors such as TGF-β1 from the treated surfaces (Zhao et 
al. 2000; Tomson et al. 2007). Calcium hydroxide, Dycal®, is also commonly 
used in clinical dentistry as a pulp capping agent to facilitate the formation of 
reparative dentine after dentine-pulp complex injury (Horsted-Bindslev et al. 
2003; Smith et al. 2008), by driving release of growth factors (Tziafas et al. 
2000). Mineral trioxide aggregate (MTA) is also used in clinical dentistry to 
induce regeneration of dentin, cementum and bone by formation of mineralised 
tissue in the presence of moisture. Like EDTA and calcium hydroxide, MTA has 
found to release growth factors, such as TGF-β1 from dentine matrix (Tomson et 
al. 2007).   
 
Similar to dentin, the extracellular matrix of bone contains a reservoir of different 
growth factors. These growth factors are synthesized and secreted by cells 
resident in the bone and become bound to the ECM (Hossner 2005). For 
example, it has been reported that decorin and biglycan play an important role in 
regulating the sequestration of matrix-bound growth factors, such as TGF-β1 
(Bianco et al. 1990). Both decorin and biglycan can bind to TGF-β1 with high 
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affinity, protecting TGF-β1 from degradation and modulating their sequestration 
and release from the matrix (Baker et al. 2009).  Bound growth factors remain 
protected in their bio-active state until the matrix is resorbed and degraded 
during injury (Baker et al. 2009). Following bone degradation, these growth 
factors are released from their association and may then diffuse to the adjacent 
cells and participate in the reparative processes leading to optimal regeneration 
of the bone (Hughes et al. 2006b). The previously mentioned chemicals have 
been demonstrated to solubilise growth factors from within the mineralised 
matrix of an in vitro bone slab model (Smith et al. 2011). These chemicals 
solubilise growth factors by matrix demineralisation, local matrix dissolution or 
chelating calcium ions present within the mineralised matrix (De-Deus et al. 
2008a). It is unclear whether this simply releases bound growth factors, or if a 
more complex mechanism is responsible for the release of the matrix-bound 
growth factors. This chapter aims to investigate the cellular responses of 
stimulated ex vivo fractured mandible model with chemically released 
endogenous growth factors. Understanding the effect of these chemicals 
modalities will facilitate development of novel treatments for bone regeneration 
which may overcome some of the problems associated with current clinical 
therapies using exogenously added growth factors.  
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3.2 Materials and Methods 
3.2.1 Chemical stimulation of fractured mandible slices 
Mandibles slices were prepared and fractured as described in (section 2.2.1). 
Prior to culture, 10µl of appropriate chemical treatments were applied to the 
fractured site using microcaps pipettes (Fishersci,UK) (Figure 3.1, A). Slices 
were treated for 5, or 15 min with either 17% EDTA (pH 7.2), 0.02 M calcium 
hydroxide (pH 11.7), 10% citric acid (pH 3) or PBS (pH 7.4) as a negative 
control, followed by washing in PBS twice for 2 min. During treatment times, 
mandible slices were partially submerged in media, so that the slice remained 
hydrated. Chemically treated fractured mandible slices were either fixed 
immediately in 10% (w/v) formalin or cultured for 7 days using Trowel type 
cultures as described in (section 2.2.1.1). Prior to histological examination, both 
cultured and uncultured mandible slices were fixed and demineralised for 
haematoxylin and eosin (H&E) tissue staining as described in (section 2.2.2.1). 
Cellular characteristics within the fracture site in response to released growth 
factors were assessed also by immunohistochemistry. Immunohistochemical 
staining was carried out using a Vectastain ABC peroxidase kit (Vector 
Laboratories Ltd) on cultured mandible slices treated with 17% EDTA (pH 7.2) 
and 10% citric acid (pH 3) for 15 min and 0.02 M calcium hydroxide (pH 11.7) 
and PBS for 5 min as described in (section 2.2.2.2).  Proliferating cell nuclear 
antigen (PCNA) primary antibody, mouse anti-rat (Santa Cruz Biotech, Santa 
Cruz, CA,USA) diluted 1:20 in 1% BSA/TBS, bone sialoprotein (BSP) primary 
antibody, bone marker,  rabbit anti-rat BSP (Santa Cruz Biotech, Santa Cruz, 
CA,USA), diluted 1:50 in 1% BSA/TBS and osteopontin (OPN) primary antibody, 
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bone marker,  goat anti-rat OPN (Santa Cruz Biotech, Santa Cruz, CA,USA), 
diluted 1:250 in 1% BSA/TBS were used as an indicator of cellular proliferation 
and bone mineralisation respectively. Sections were evaluated microscopically 
on an Olympus AX70 light microscope. Photographs were taken using a Nikon 
DXM digital camera and ACT-1 imaging software. A total of 5 mandible slices 
were used per treatment, for each marker. Number of positive cells for each of 
the markers was automatically counted within the periodontal ligament using 
Image ProPlus software (Media Cybernetics Inc, USA). 100µm2 areas within five 
areas proximal to the fracture site were counted per section.  
 
3.2.2 Analysis of released growth factors from culture medium 
supernatants 
Supernatants were collected from treated fractured mandible slice cultured for 7 
days. Appropriate dialysis tubes were used to diffuse dissolved solutes across a 
selectively permeable membrane. The dialysis container was kept overnight at 
4oC and water was changed 3 times/day for 3 days. Following dialysis, samples 
were lyophilized by keeping them overnight at -20oC then freeze-dried in freeze 
dryer (Labconco, USA) overnight. Concentrated media were stored at -20oC 
prior to use in ELISA. After lyophilisation, samples were diluted with 800 μL 
PBS. Protein concentration was measured in each sample using a BCA kit 
(Thermo scientific,Uk).  TGF-β1 and VEGF levels were quantified according to 
the manufacturer's specifications using an ELISA kit from R&D Systems (R&D 
Systems, Inc., USA). BMP2 levels were also quantified using an ELISA kit from 
(Antibodies-Online, USA). All assays were carried out in triplicate from 3 
individual samples. 
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3.2.3 Immunogold labelling of released growth factors 
Immunogold labelling was carried out to label exposed TGF-β1, BMP2 and 
VEGF from fractured mandible slices. Mandible slices were prepared as 
described in (section 2.2.1). Slices were then completely fractured by placing 
pressure onto the central portion of the lingual and buccal plate using a sterile 
scalpel blade (Figure 3.1, B) under dissecting microscope (Bausch and Lomb, 
UK). Fractured mandible slices were then treated individually by dipping in 50µl 
of either 17% EDTA (pH 7.2), 10% citric acid (pH 3) for 15 min or 0.02 M calcium 
hydroxide (pH 11.7), PBS for 5 min. After each treatment time, slices were gently 
washed in PBS twice for 2 min to remove the chemical treatment. After chemical 
treatment, slices were immunostained for surface exposed TGF-β1, BMP2 and 
VEGF using an Immunogold silver staining protocol and examined by scanning 
electron microscope imaging (Bayatian et al. 2007). 
 
 
 
  
 
 
 
C
h
e
m
ic
a
ls
 
Figure 3- 1: Chemical treatment of fractured mandible slice. (A) Fractured mandible slice treated 
locally by 10µl of 17% EDTA (pH 7.2), 0.02 M calcium hydroxide (pH 11.7), 10% citric acid (pH 3) 
and PBS (pH 7.4) as a negative control for 5, or 15 min. (B) Fractured mandible slice treated 
entirely by dipping in 50µl of the same previous chemical treatments for scanning electron 
microscope imaging.  
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Chemically treated mandible slices were blocked for 1 h with 5% goat serum, 
10% bovine serum albumin (BSA) in Tris-buffered saline (TBS), followed by 
buffer wash (1% goat serum, 1% BSA, 0.1% Tween 20 in TBS) for 15 min. 
Slices were incubated for 2 h with the appropriate primary antibody (Table 3.1) 
(Santa Cruz Biotech) diluted 1:100 in 1% BSA in TBS followed by twice buffer 
wash for 5min. As a negative control, the primary antibody was replaced with 
TBS. Slices were incubated with gold-labelled secondary antibody (BBI 
diagnostics, Cardiff, UK, particle diameter 30nm, protein 3.6μg/ml; diluted 1:100 
in 1% BSA, TBS) for 1 h. Mandible slices were washed with two washes in buffer 
wash and two washes in distilled water followed by incubation with silver 
enhancing agent (BBI diagnostics) for 15 min. All mandible slices were then 
washed in distilled water twice for 15 min and air dried for 24 hrs. Slices were 
examined by EBT1 scanning electron microscope (SEMTech Ltd, Derbyshire, 
UK) at a magnification of X550. Using Image ProPlus software, the numbers of 
immunogold particles were counted within 20µm2 areas of bone, within five fields 
of view per slice. A total of 5 mandible slices were used for each time point for 
each treatment.   
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Table 3.1: Primary and secondary antibodies used in Immunogold labelling. 
 
3.2.4 Statistical analysis 
Statistical analysis was carried out using the GraphPad InStat 3 software 
(GraphPad software, Inc, USA). Standard errors of the mean were calculated, 
and mean values were analysed using one-way ANOVA and Tukey’s post hoc 
test, to analyse differences between treatment types and controls. P values 
below 0.05 at 95% confidence intervals were held to be statistically significant. 
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3.3 RESULTS 
3.3.1  Histology of fractured mandible slices 
3.3.1.1 Histology of uncultured chemically treated fractured mandible 
slices 
Histological evaluation of mandible slices that had not been cultured 
demonstrated maintenance of tissue architecture throughout the section. The 
morphological appearance of the mandible slices treated for 5 min (Figure 3.2) 
were observed to be similar to the mandible slices treated for 15 min (Figure 
3.3). The pink eosin staining with the darkly stained round nuclei indicate 
presence of viable cells within bone, dentine, periodontal ligament and pulp.  
 
Digital image analysis of cell counts (Figure 3.4) of fractured mandible slices 
treated for 5 min calculated an average of 68 cells/100µm2 for Ca(OH)2, 52 
cells/100µm2 for EDTA and citric acid and 42 cells/100µm2 for PBS. However 
fractured mandible slices treated for 15 min calculated an average of 45 
cells/100µm2 for Ca(OH)2, 60 cells/100µm2 for EDTA, 69 cells/100µm2 for citric 
acid and 46 cells/100µm2 for PBS. Statistical analysis of average PDL cell 
counts demonstrated no significant differences between mandible slices treated 
for 5 or 15 min. Although average PDL cell counts demonstrated high cell 
numbers in fractured mandible slices treated with Ca(OH)2 for 5 min and with 
EDTA and citric acid for 15 min, this increase was not significant (P>0.05). There 
was also non-significant difference in average cell numbers within regions of 
mandible slices opposite the fracture site between all groups, average of 61-72 
cells/100µm2 (P>0.05). There was a non-significant increase in average cell 
 
88 
numbers within regions of mandible slices opposite the site of stimulation when 
compared with fracture sites average of 42-69 cells/100µm2 (P>0.05). 
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Figure 3- 2: Histological examination of uncultured fractured mandible slices treated with 
Ca(OH)2 , EDTA, citric acid and PBS  for 5 minutes. [A-D] fractured site, [E-H] 
contralateral site. PDL, periodontal ligament; D, dentine; B, bone; F, fracture site. 
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Figure 3- 3: Histological examination of uncultured fractured mandible slices treated 
with Ca(OH)2 , EDTA, citric acid and PBS  for 15 minutes. [A-D] fractured site, [E-H] 
contralateral site. PDL, periodontal ligament; D, dentine; B, bone; F, fracture site. 
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Figure 3- 4 Comparison of average cell numbers per 100 um2 area within the PDL of 
uncultured fractured mandible slices treated with  Ca(OH)2 , EDTA, CITRIC ACID or PBS for 
either 5 or 15 minutes. (n=4), Error bars indicate standard error of the mean. 
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3.3.1.2 Histology of cultured chemically treated fractured mandible slices  
 
Histological evaluation of mandible slices that had been cultured for 7 days 
demonstrated maintenance of tissue architecture throughout the section (Figure 3.5) 
and (Figure 3.6). The pink eosin staining with the darkly stained, round nuclei 
indicate presence of viable cells within bone, dentine, periodontal ligament and pulp. 
The morphological appearance of the mandible slices treated for 15 min (Figure 3.6) 
were observed to be similar histologically to the mandible slices treated for 5 min 
(Figure 3.5). 
 
Digital image analysis of cell counts (Figure 3.7) of fractured mandible slices treated 
for 5 min calculated an average of 42 cells/100µm2 for Ca(OH)2, 20 cells/100µm2 for 
EDTA and 19 cells/100µm2 for citric acid. However fractured mandible slices treated 
for 15 min calculated an average of 26 cells/100µm2 for Ca(OH)2, 28 cells/100µm2 
for EDTA, 29 cells/100µm2 for citric acid and 18 cells/100µm2 for control PBS 
treated mandible slices. Statistical analysis of average PDL cell counts 
demonstrated significant differences between mandible slices treated for 5 or 15 min 
(Figure 3.7). Average PDL cell counts demonstrated significant increase in cell 
number at fractured mandible slices treated with Ca(OH)2 for 5 min and EDTA and 
citric acid for 15 min (P<0.05). There was significant increase in average cell 
numbers at fracture sites of mandible slices treated with Ca(OH)2 for 5 min when 
compared with mandible slices treated with PBS, EDTA and citric acid 
(P>0.001).There was also no significant difference in average cell numbers within 
regions opposite the fracture site in all groups (P>0.05).  
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Figure 3- 5: Histological examination of fractured mandible slices treated with Ca(OH)2 , 
EDTA, citric acid and PBS for 5 minutes and cultured for 7 days. [A-D] fractured site, [E-H] 
contralateral site. PDL, periodontal ligament; D, dentine; B, bone; F, fracture site. 
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Figure 3- 6: Histological examination of fractured mandible slices treated with Ca(OH)2 , EDTA, 
citric acid and PBS for 15 minutes and cultured for 7 days. [A-D] fractured site, [E-H] contralateral 
site. PDL, periodontal ligament; D, dentine; B, bone; F, fracture site. 
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Figure 3-7: Comparison of average cell numbers per 100 um2 area within the PDL of 
fractured mandible slices treated for 5 or 15 minutes with Ca(OH)2 , EDTA, CITRIC 
ACID or PBS  and cultured for 7 days. ***P<0.001. *   P<0.05. n=8, Error bars indicate 
standard error of the mean. 
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3.3.2 Immunohistochemical characterisation 
 
Cells exhibiting positive expression for the proliferation marker PCNA (Figure 
3.8) and for the bone marker, bone sialoprotein (Figure 3.9) and osteopontin 
(Figure 3.10) were observed within the PDL of mandible slices treated with 
calcium hydroxide, EDTA or citric acid, when compared with control PBS treated 
slices. Negligible positive expression was detected within the cells of the pulp. 
Negative controls where primary antibodies were omitted demonstrated only the 
methyl green counterstain with no non-specific staining.  
 
Digital image analysis of immunopositive positive cell counts (Figure 3.11) 
calculated an average of (6-9 cells/100µm2) for mandible slices treated with 
Ca(OH)2 and average of (2-3 cells/100µm2) for mandible slices treated with 
EDTA, citric acid or PBS. Statistical analysis of average positive cells 
demonstrated significant increase in the number of PCNA, BSP and OPN 
immunopositive cells within the fracture site of the mandible slices treated with 
calcium hydroxide, when compared with fractured mandible slices treated with 
EDTA, citric acid or PBS (p<0.001).  
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Figure 3-8: Fractured mandible slices treated with Ca(OH)2 , EDTA, citric acid and PBS  
and stained with IHC for expression of PCNA [A-D]. Control sections where primary 
antibody was excluded and replaced with TBS [E-H]. PDL, periodontal ligament; D, 
dentine; B, bone; F, fracture site. 
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Figure 3- 9: Fractured mandible slices treated with Ca(OH)2 , EDTA, citric acid and PBS  and 
stained with IHC for expression of BSP [A-D]. Control sections where primary antibody was 
excluded and replaced with TBS [E-H]. PDL, periodontal ligament; D, dentine; B, bone; F, 
fracture site. 
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Figure 3- 10: Fractured mandible slices treated with  Ca(OH)2 , EDTA, citric acid and PBS  
and stained with IHC for expression of OPN [A-D]. Control sections where primary antibody 
was excluded and replaced with TBS [E-H]. PDL, periodontal ligament; D, dentine; B, bone; 
F, fracture site. 
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Figure 3- 11: Comparison of average positive cells number within 100 um2/PDL of fractured 
mandible slices treated with Ca(OH)2 , EDTA, citric acid or PBS at the fracture site and 
stained immunohistochemically for PCNA, BSP or OPN at fracture site.  
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3.3.3 Quantification of released growth factors from mandible 
slices following chemical treatment  
All chemically treated mandible slices demonstrated significant increases in 
TGF-β1, BMP2 and VEGF concentrations when compared with mandible slices 
treated with PBS (Figure 3.12). In the samples analysed, there were no 
significant differences between the treatment groups. An average concentration 
of 5000pg/mg of TGF-β1, 1000pg/mg of BMP2 and 15000pg/mg of VEGF were 
released from mandible slices treated with calcium hydroxide, citric acid and 
EDTA. Statistical analysis also demonstrated that the amount of VEGF 
concentration released from fractured mandible slices was significantly greater 
than the amount of BMP2 and TGF-β1 (p< 0.001). 
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Figure 3-12: Mean concentration of TGF-β1, BMP2 and VEGF released in pg/mg 
from mandible slices treated with PBS, Ca(OH)2, EDTA or citric acid and cultured 
for 7 days. 
 (n=6), All assays were carried out in triplicate. ***P<0.001. Error bars indicate 
standard error of the mean. 
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3.3.4 Immunogold labelling of surface exposed growth factors in 
scanning electron microscope 
 
SEM examination revealed that all chemically treated mandible slices 
demonstrated a significant increases in immunogold labelling of surface exposed 
TGF-β1 (Figure 3.13), BMP2 (Figure 3.14) and VEGF (Figure 3.15) when 
compared with mandible slices treated with PBS. Fractured mandible slices 
treated with calcium hydroxide exposed an average number of 9 TGF-β1, 15 
BMP2 and 46 VEGF labelled immunogold particles per 20µm2 area of bone 
surface. Fractured mandible slices treated with either citric acid or EDTA 
exposed an average number of 2 TGF-β1 and BMP2 and 12.5 VEGF labelled 
immunogold particles per 20µm2 area of bone surface. Statistical analysis 
(Figure 3.16) demonstrated that the number of immunogold particles labelling to 
VEGF exposed from all chemically treated fractured mandible slices were 
significantly greater than the amount of immunogold particles labelling to BMP2 
and TGF-β1 (p< 0.001). No significant amount of immunogold labelling to TGF-
β1, BMP2 and VEGF were observed on fractured mandible slices treated with 
PBS as well as negative control slices. 
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Figure 3-13: Immunogold labelling of released TGF-β1 (arrows) from fractured mandible slices 
treated with  (A) Ca(OH)2 , (B) EDTA, (C) Citric acid and (D) PBS. (E) control where primary antibody 
was excluded and replaced with TBS. 
Ca(OH)2 EDTA 
PBS  Citric acid  
D 
E 
A B 
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Figure 3-14: Immunogold labelling of released BMP2 (arrows) from fractured mandible slices 
treated with  (A) Ca(OH)2 , (B) EDTA, (C) Citric acid and (D) PBS. (E) control where primary 
antibody was excluded and replaced with TBS. 
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Citric acid  PBS  
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B A 
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Figure 3-15: Immunogold labelling of released VEGF (arrows) from fractured mandible slices 
treated with  (A) Ca(OH)2 , (B) EDTA, (C) Citric acid and (D) PBS. (E) control where primary 
antibody was excluded and replaced with TBS. 
Ca(OH)2 EDTA 
PBS  Citric acid  
E 
B 
C 
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Figure 3-16: Comparison of mean number of (TGF-β1, BMP2, VEGF) immunogold particles 
per 20um2 area of fractured mandible slices treated with Ca(OH)2 , EDTA, citric acid and 
PBS. ***P<0.001. n=5.  Error bars indicate standard error of the mean. 
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3.4 Discussion 
 
Bone matrix contains a reservoir of different growth factors which can be 
released following bone injury. It has been demonstrated that a combination of 
different growth factors may improve tissue regeneration more efficiently and 
effectively than single growth factors (Huang et al. 2005; Kempen et al. 2009; 
Suarez-Gonzalez et al. 2014; Dinh et al. 2015). Results of this chapter represent 
a novel study where ex vivo mandible slices can be fractured and stimulated 
with calcium hydroxide, EDTA and citric acid to drive matrix bound growth 
factors without sustaining excessive damage to the cells and tissues adjacent to 
the site of fracture and chemical treatment. Ex vivo fractured mandible slices 
treated with calcium hydroxide, EDTA and citric acid successfully demonstrated 
a significant increase of the key growth factors during bone repair, VEGF, TGF-
β1 and BMP2, in both immuno-gold particle expressed on fractured treated 
surfaces and within conditioned media. These growth factors demonstrated 
ability to induce cellular proliferation, migration and differentiation during fracture 
repair.  
 
By using ex vivo mandible model, this chapter investigated the effect of 
chemically released endogenous growth factors on facilitating bone 
regeneration. Results from histological examination demonstrated that there 
were no significant differences in cell number between mandible slices treated 
for 5 or 15 min at D0. These suggest that there is no immediate cellular 
response or delay in the cells ability to respond to the slicing, fracturing as well 
as chemical stimulation of the mandible slices. Treated fractured mandible slices 
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were cultured for up to 7 days, with maintenance of tissue architecture and 
cellular morphology during this time.  
 
EDTA and citric acid treated slices displayed a similar cell count, with the 
majority of the increase in cell number occurring only after a treatment time of 15 
min. There were a small cell number counted after 5 min treatment, which may 
indicate an initial gradual increase of the chemicals effects. The number of cells 
counted after 5 min treatment were similar to those observed from PBS treated 
slices, and may therefore be original resident  cells, rather than a cellular 
response to the applied chemicals. Calcium hydroxide however demonstrated 
increase in cell number after a treatment time of 5 min, with significant decrease 
in the cell counts after 15 min. Calcium hydroxide has cytotoxic properties due to 
its high alkaline pH and causes formation of necrotic layer thus it could cause 
apoptosis of the cells and denatured of the protein with the extended treatment 
time (Al-Awadhi et al. 2004). 
 
Slices treated with chemicals demonstrated higher cell number over the control 
slices. This observation suggests that the increases in cell counts are due to the 
effects of the applied chemicals, rather than just physical response to the 
fracture alone. These suggest that the mandible model can respond to 
exogenous cofactors such as acids and calcium hydroxide to facilitate and 
accelerate the healing process during bone regeneration. The aim of treating the 
fractured surfaces with acids and calcium hydroxide was to demonstrate that the 
release of endogenous growth factors in response to chemical treatments could 
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influence cellular behaviour in an ex vivo mandible model system. Release of 
endogenous growth factors using chemical treatment has been shown in 
different studies. For example, EDTA and calcium hydroxide have been shown 
capable to stimulate growth factors release, particularly TGF-β1, from dentine 
(Zhao et al. 2000; Graham et al. 2006) and from the matrix of the femur bone 
slab (Smith et al. 2011). 
 
EDTA and citric acid are known to demineralise both bone (Smith et al. 2011) 
and dentine matrix (De-Deus et al. 2008a). They accomplish this by dissolution 
of mineralised matrix or by acting as chelating agents capable of binding and 
sequestering calcium ions within the mineralised matrix, thus reducing their 
activity (De-Deus et al. 2008a). The similar solubilisation patterns observed with 
EDTA and citric acid treatment suggests that both chemicals release growth 
factors by a similar mechanism. However, previous studies have demonstrated 
that EDTA is a strong acid (Inoue et al. 1995) and potent chelating agent 
(Barnett and Uchtman 1979). It is possible that citric acid, at a 10% 
concentration and a pH 3 may be more efficient or equal to 17% EDTA at a 
physiological pH of 7.2. Calcium hydroxide, an alkaline agent with pH range 9.2-
11.7 is commonly used in clinical dentistry as pulp capping, apexification and 
apexogenesis. The growth factor release observed with calcium hydroxide was 
in contrast to the pattern of release observed with EDTA and citric acid 
treatment. Calcium hydroxide dissociates into calcium ions (Ca2+) and hydroxyl 
ions (OH-). Scientists suggest that the mechanism of growth factor solubilisation 
by calcium hydroxide is mainly pH dependent and its efficiency may result from 
lower solubility. It may be hypothesised that calcium hydroxide has a greater 
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efficacy for altering protein charge and thus growth factor release by its alkaline 
pH and the two hydroxyl groups. 
 
ELISA and immunogold labelling results demonstrated that chemical treatments 
used in this study were capable of releasing TGF-β1, BMP2 and VEGF. The 
amounts of TGF-β1 and BMP2 released from mandible slices were less than 
VEGF. Previous studies have shown that TGF-β1 and BMP2 appeared to play a 
critical role in early stages of fracture healing, whereas VEGF have a greater 
effect at later stages of fracture healing (Dimitriou et al. 2005). Culture 
supernatants were collected after 7 days of culture, thus it could be that the high 
peak of TGF-β1 and BMP2 release was missed. It has also been reported that 
VEGF inhibits expression of BMP2 in rat MSCs (Schonmeyr et al. 2010). The 
mandible is a highly vascularized tissue thus the matrix could have high 
concentration of VEGF than TGF-β1 and BMP2. TGF-β1 and BMP2 are found in 
the matrix modulated by decorin and biglycan which affect release of these 
growth factors (Miguez et al. 2011). VEGF however presented in the matrix as a 
soluble or matrix-bound form which could be released more quicker and easier 
than TGF-β1 and BMP2 by the chemical treatment (Chen et al. 2010). Studies 
have shown that VEGF is highly expressed in angioblasts, osteoprogenitor and 
osteoblast cells during the first 7 days of healing but decreases after eleven 
days (Uchida et al. 2003) thus day 7 could be the peak of angiogenesis but not 
osteogenesis.  
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Fractured mandible slices treated with calcium hydroxide, EDTA and citric acid 
exhibited a significant increase in VEGF, TGF-β1 and BMP2, in both immuno-
gold particle expressions on fractured treated surfaces and within conditioned 
media. The observed increases in number of PDL cells close to the site of 
fracture following chemical stimulation, may indicate stimulation of some early 
reparative processes within the tissue in response to the applied chemical. 
These growth factors could cause stimulation of migration, proliferation as well 
as maintaining survival of cells within the PDL (Zhao et al. 2000; Graham et al. 
2006). Since mandible slices were treated locally by the chemicals and were 
subsequently washed off from the chemicals, it is likely that the findings from this 
study are a result of the released growth factors influencing cell behaviour within 
the tissue, rather than a direct effect of the chemical treatment itself. 
 
Acids and calcium hydroxide have differential effects on behaviour of cells within 
the mandible model due to their different mechanism of action. 
Immunohistochemistry data demonstrated that in mandible slices treated with 
calcium hydroxide there was an increased number of PCNA immunopositive 
cells adjacent to the site of fracture, suggesting that proliferation was being 
influenced by the endogenous growth factors. SEM images of immunogold-
labelled bone surfaces revealed that calcium hydroxide was capable of releasing 
TGF-β1, BMP2 and VEGF from within the matrix of the bone. TGF-β1 shown in 
previous studies to be involved in stimulating migration of bone forming cells and 
macrophages (Tsiridis et al. 2007; Dimitriou et al. 2011) and stimulating 
proliferation of mesenchymal stem cells and osteoprogenitors (Bostrom and 
Asnis 1998; Barnes et al. 1999). Expression of the bone marker, bone 
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sialoprotein and osteopontin, were also significantly increased at the fracture site 
in response to calcium hydroxide treatment. Both bone sialoprotein and 
osteopontin are mineralized tissue-specific protein expressed in differentiated 
osteoblasts that appear to function in the initial mineralization of bone (Hughes 
et al. 2006b; Wang et al. 2011). Calcium hydroxide has been reported to 
increase the levels of BSP and Runx2 mRNA in human osteoblast-like cells 
(Wang et al. 2011). This increase in the number of immunopositive cells to bone 
sialoprotein and osteopontin could be due to increase in protein expression by 
cells differentiated as a result of growth factors released by treating mandible 
slices with calcium hydroxide. The evidence from the SEM images, which shows 
release of BMP2 from mandible slices in response to calcium hydroxide 
treatment, may suggest that the increase in immunopositivity for bone 
sialoprotein and osteopontin could be due to BMP2 inducing differentiation of 
committed cells to the osteoblast lineage (Hughes et al. 2006b). 
 
There was a difference in the expression of PCNA and osteogenic bone markers 
between chemically treated mandible slices, with a higher number for PCNA 
immunopositive cells. This suggests that more than one cell participates in the 
proliferation at the fracture site. It could be proliferation of cells residing within 
the PDL or proliferation of migrated inflammatory cells to subside inflammation 
and phagocytic uptake of the fracture residue. Recent unpublished data however 
demonstrated that macrophage and neutrophil significantly decreased after 
7days of culture (Waddington et al.). Thus it is most likely that the increase in the 
cells could be due to migration and proliferation of periodontal ligament cells as 
well as endothelial cells by TGF-β1 and VEGF (Smith et al. 2010; Zhang et al. 
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2013) and differentiation by BMP2 and VEGF (Lee et al. 2012; Oortgiesen et al. 
2014). 
 
Ex vivo fractured mandible slices were demonstrated an ability to drive matrix 
bound growth factors by calcium hydroxide more than EDTA and citric acids. 
Fractured mandible slices treated with calcium hydroxide exhibited a significant 
increase in VEGF, TGF-β1 and BMP2. These growth factors have the ability to 
induce cellular proliferation, migration and differentiation during fracture repair. 
In large bone fracture, it is difficult to achieve bone union without use of external 
grafts.  Ex vivo fractured mandible slices were further tested to investigate effect 
of endogenous growth factors derived by calcium hydroxide on cells carried by 
scaffold. Poly vinyl alcohol (PVA) scaffolds and green fluorescent protein (GFP) 
cells were used to investigate the effect of growth factors released by calcium 
hydroxide on the scaffold and non-resident cells. Confocal microscope was 
demonstrated that PVA scaffolds and GFP cells were not detected at fracture 
sites after 7 days of culture. The method was not finalised because the scaffold 
was dissolved and the histological processing lead to fade and loss of the green 
fluorescent of the GFP cells. Another venue of investigation would be reusing ex 
vivo fractured mandible model to study the effect of endogenous growth factors 
derived by calcium hydroxide on cells carried on a scaffold. This would allow a 
greater understanding of the ability of the model to carry exogenous cells and 
scaffold and the ability of endogenous growth factors derived by calcium 
hydroxide to enhance bone healing for promising clinical treatment of large bone 
defect.                                                                                                                                               
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Chapter 4.  
Effects of Calcium Hydroxide on Bone Marrow Stem Cells 
4.1 Introduction 
 
Calcium hydroxide has been used extensively in clinical dentistry as a direct 
pulp capping agent to induce dentine regeneration. During the reparative 
process, calcium hydroxide shows the potential to regenerate damaged dentine 
by formation of dentine bridges at sites of calcium hydroxide application through 
sequential steps of proliferation, migration, and differentiation of progenitor cells. 
The previous chapter demonstrated that the use of calcium hydroxide on 
mineralised tissue such as mandibular bone may be effective in inducing hard 
tissue formation by releasing growth factors from bone matrix and hence 
facilitating bone repair. 
 
Calcium hydroxide is considered as a gold standard dental material because of 
its mineralization capacity as well as its effective anti-microbial and anti-
inflammatory action. Most of the physical and biological properties of calcium 
hydroxide are based on dissociation of calcium hydroxide into calcium and 
hydroxyl ions (Apte et al. 2005). Free calcium ions are reported to be essential 
for cellular migration, differentiation, and mineralization (Schröder 1985). An 
increase of local calcium concentration has been shown to activate cells such as 
stem cells (Adams et al. 2006) and osteoblasts (Yamaguchi et al. 1998). 
Calcium ions have been also demonstrated to play a critical role in regulation of 
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cellular proliferation, differentiation and mineralization (Torneck et al. 1983; 
Kulesz‐Martin et al. 1984; Zayzafoon 2006). Extracellular calcium has also been 
reported to up-regulate the gene expression of BMP2 and osteopontin in human 
pulp cells which induce mineralization in dental pulp tissue (Rashid et al. 2003). 
  
Several studies have demonstrated that the mineralisation ability  of calcium 
hydroxide is due to its alkaline pH, leading to release of free hydroxyl ions after 
dissociation of calcium hydroxide (Glass and Zander 1949; Schröder and 
Granath 1971; Stanley and Lundy 1972). Influence of the alkaline pH was 
investigated on human dental pulp cells and the study confirmed that alkaline pH 
caused increased alkaline phosphatase and BMP2 expression and calcified 
nodule formation which enhanced cellular mineralization (Okabe et al. 2006). 
Calcium hydroxide can provide an optimal healing environment by the rise of 
alkaline pH from the free hydroxyl ions. Antimicrobial properties of calcium 
hydroxide are also based on its ability to release hydroxyl ions and to raise pH to 
about 12.5 at which very few bacteria can survive (Byström et al. 1985; Jhamb 
and Chaurasia 2014). Endogenous inflammatory mediators such as interleukin-
1α and tumour necrosis factor-α play an important role in regulation of 
inflammation and associated tissue destruction (Cochran 2008; Gabay et al. 
2010). High alkaline pH has been reported to cause denaturation of such 
proinflammatory cytokines (Khan et al. 2008) and neutralize the acidic 
inflammatory pH produced by inflammatory reaction, which is harmful to the 
healing process (Heithersay 1975).  
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Hard tissue such as bone and dentine, contain numerous growth factors 
entrapped inside the matrix. The previous chapter demonstrated that growth 
factors such as TGFß1, BMP2 and VEGF can be released from the matrix after 
chemical treatment with EDTA, citric acid and calcium hydroxide. In vitro studies 
demonstrated that calcium hydroxide demonstrated ability to solubilize 
sequestered bioactive molecules like TGFß1 from dentine matrix (Smith and 
Smith 1998; Graham et al. 2006) and bone matrix (Smith et al. 2011). Several 
studies demonstrated that calcium hydroxide has stimulatory effect on TGFß1 
from different ways. TGFß1 is secreted mostly in latent form, which restricted its 
biological activity (Barcellos-Hoff 1996)  however it can be activated in alkaline 
culture medium (Lyons et al. 1988). Calcium hydroxide provides an alkaline 
environment through its hydroxyl ions, which in theory promote the bioactivity of 
TGFβ through releasing it from the latent complex. It has been reported in in 
vitro study that dentine matrix components such as TGFß1 can be dissolved 
from the matrix by mineral trioxide aggregate and calcium hydroxide (Tomson et 
al. 2007).  
 
It has been reported that oral administration of calcium hydroxide caused 
significant increase in serum inorganic phosphorus concentration and femoral-
diaphyseal calcium content and alkaline phosphatase activity of rats with 
skeletal unloading (Yamaguchi et al. 1991b). The authors concluded that oral 
administration of calcium hydroxide can prevent partly skeletal unloading-
induced disorder of bone metabolism (Yamaguchi et al. 1991b). Mineralization 
induced by calcium hydroxide was shown to be regulated also by bone 
sialoprotein in rat calvarial osteogenic cell cultures (Da Silva et al. 2008) and 
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human osteoblast-like Saos2 cells (Wang et al. 2011). It has also been reported 
that calcium hydroxide enhanced bone regeneration by influencing the 
differentiation of osteoblasts cells by increasing expression of collagen I and 
osteocalcin (Han et al. 2013) and enhancing osteoblast ALP secreting activity 
(Liang et al. 2000; Kaskos 2013). Oily calcium hydroxide suspension has been 
shown to direct bone regeneration of bone tissue cultures through inhibiting 
bone resorption via inhibition of the proteolytic enzymes such as collagenases 
(Stratul and Sculean 2004). It has also been demonstrated that calcium 
hydroxide promotes attachment, proliferation and mineralization of human 
alveolar osteoblasts (Eick et al. 2014). 
 
Calcium hydroxide has demonstrated an ability to release bioactive molecules, 
either through direct stimulation of cells or by solubilisation of dentine 
extracellular matrix (Sangwan et al. 2013). Results from the previous chapter 
have demonstrated that growth factors can be released from the bone following 
chemical treatment with calcium hydroxide but further studies are required to 
investigate cellular responses to the applied calcium hydroxide. This chapter 
thus aims to investigate the effect of calcium hydroxide on cellular behaviour of 
bone marrow stem cells. Is calcium hydroxide able to improve viability, 
proliferation, and mineralization of BMSCs?  
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4.2 Materials and Methods 
4.2.1 Preparation of calcium hydroxide test solution 
Calcium hydroxide test solution was prepared by dissolving 0.01875 g of calcium 
hydroxide in 12.5 mL of distilled water at 23 °C. This solution was stirred for 30 
min and centrifuged at 1800 rpm for 5 min. The solution filtered and titrated 
against the medium to make sure that the pH of the final media (pH 7 or 11) 
would not be significantly altered (Torneck et al. 1983). A total of 2 mL of the 
Ca(OH)2 solution was added to osteogenic and culture medium making 0.4mM 
Ca(OH)2 concentration. Culture medium consisted of αMEM serum (Invitrogen 
Life Technologies, UK), 20% heat inactivated foetal calf serum serum (Invitrogen 
Life Technologies, UK), 1% L-ascorbate 2-phosphate (Sigma, UK) and 1% 
concentration of antibiotics solution (10,000 units of penicillin, 10mg/ml of 
streptomycin, and 25µg/ml amphotericin B) (Invitrogen, UK). Osteogenic 
medium consisted of αMEM serum (Invitrogen Life Technologies, UK), 10% heat 
inactivated foetal calf serum serum (Invitrogen Life Technologies, UK), 10 µM 
dexamethasone (Sigma, UK), 10 mM β-glycerophosphate (Sigma, UK), 1% L-
ascorbate 2-phosphate (Sigma, UK) and 1% concentration of antibiotics solution 
(10,000 units of penicillin, 10mg/ml of streptomycin, and 25µg/ml amphotericin 
B) (Invitrogen, UK). A positive control was prepared where BMP2 (0.12ng/ml) 
(Gibco Life Technologies, UK), was supplemented to the osteogenic or culture 
medium.  
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4.2.2 Bone marrow stem cell culture 
 
Rat bone marrow stem cells (BMSCs), kind gifts from J Harrington (Harrington et 
al. 2014), were seeded at 4000 cells/cm2 and cultured with culture medium. 
Cells were incubated at 37oC in a 5% CO2 atmosphere. Medium was changed 
every two days and mycoplasma testing was routinely conducted every time 
cells were passaged. When cells reached approximately 80% confluence, they 
were passaged with accutase (Sigma), counted with a haemacytometer using 
Trypan Blue solution and reseeded at 4000 cells/cm2. Cells were continually 
propagated and underwent multiple passaged until sufficient cells were gained. 
Numbers of cells were recorded in proportion to original number of cells to 
calculate population doubling level over the passaged period. Cells were seeded 
in 6-well plates and culture slides in triplicate at 1 × 104 cells/cm2 and cultured 
with culture medium for 24 hours before adding the treatment medium. Cells in 
6-well plates were used for RT-PCR and cells in culture slides were used for 
staining analysis.  Cells were cultured with eight different medium (Table 4.1). 
Cells were incubated at 37oC in a 5% CO2 atmosphere for 1, 3, 7 and 14 days 
during which images were taken.  
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4.2.3 Characterisation of Cell Marker Expression 
4.2.3.1 Extracting mRNA from cell cultures 
RNA Extraction was performed using the Qiagen RNeasy Kit (Qiagen, 
Manchester, UK) following the manufacturer’s protocol. Cells were initially 
cultured in 6-well plates until 80% confluence. Cells were washed with PBS then 
lysed by adding 600 μL of Buffer RLT lysis buffer (Qiagen, UK) supplemented 
with 10 μL/mL of β-mercaptoethanol (Sigma-Aldrich, UK). Cells were disrupted 
using a syringe plunger. The lysate was transferred to a QiaShredder column 
(Qiagen, UK) and centrifuged at 13,300g for 2min. Cell lysates were treated with 
1:1 volumes of 70% molecular-grade ethanol (Sigma-Aldrich, UK) and mixed 
well by pipette action. The mixtures were then transferred into an RNeasy Mini 
spin column (Qiagen, UK) and centrifuged at 10,000 g for 15 seconds. The flow-
through was discarded and the column was washed with 350 μL of Buffer RW1 
(Qiagen, UK) and centrifuged again at 10,000g for 15secs and the flow-though 
was discarded. The column was treated with a mixture of 10 μL of DNase I stock 
and 70 μL Buffer RDD (both Qiagen, UK) and incubated at room temperature for 
Table 4. 1: Different medium used for the culture of BMSCs. Cells were challenged 
with BMP2, Ca(OH)2 at ( pH 7 or 11) supplemented culture or osteogenic media. 
Culture medium 
 
Culture medium 
+Ca(OH)2  at pH 7 
Culture medium 
+Ca(OH)2   at pH 11 
Culture medium 
+BMP2 
Osteogenic medium 
 
Osteogenic medium 
+Ca(OH)2   at pH 7 
Osteogenic medium 
+Ca(OH)2   at pH 11 
Osteogenic medium 
+BMP2 
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15 min. The column was then washed with 350 μL of Buffer RW1 (Qiagen, UK) 
and centrifuged again at 10,000g for 15 seconds and the flow-though was 
discarded. A further 2× 500 μL of Buffer RPE was added and centrifuged for 15 
seconds then 2 min and the flow-through discarded after each spin. The column 
insert was then transferred into an RNase-free 1.5mL eppendorf (Fisher 
Scientific, Loughborough, UK) and 40 μL RNA-free water (Promega, 
Southampton, UK) was added for eluting the RNA by centrifuging at 10,000 ×g 
for 1 min. The eluate was pipetted back into the column and centrifuged again to 
maximise yield. RNA amount in each sample was quantified using NanoVue (GE 
Healthcare, Amersham, UK). Samples were kept on ice during quantification 
procedure. The NanoVue was standardised with double reading of 2 μL of RNA-
free water as a blank before using 2 μL of RNA sample for quantification at 
260/280nm absorbance. Total RNA collected in the eppendorf was stored at -
80ºC. 
 
4.2.3.2 Reserve Transcription (RT) PCR 
RT-PCR was performed using the Moloney murine leukaemia virus (M-MLV) 
reagents from Promega to generate cDNA from RNA. 500ng of total RNA was 
treated with 1 μL of Random Primers (Promega) with the addition of DNase free 
water to adjust final volume to 15 uL. This mixture was then incubated in a G-
storm™ GS1 thermal cycler (Genetic Research Instrumentation Ltd, Braintree, 
UK) at 70 ºC for 5 min to unravel RNA. Samples were immediately cooled and 
stored on ice. A reaction master mix was made from 5 μL of 5xM-MLV reaction 
buffer, 0.6 μL of RNasin, 1.25 μL of 10mM dNTPs, 1 μL of M-MLV and 2.15 μL 
DNase free water to adjust final volume to 10 μL. A 10 μL of Master-mix was 
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added to 15 μLof RNA/random primer mix and incubated at 37 ºC for 1 hour. 
The newly generated cDNA was stored at -20 ºC until further used for PCR 
reaction. A reverse-transcription negative control (RT-ve) was prepared without 
sample RNA. 
 
4.2.3.3 End-Point Polymerase Chain Reaction (PCR) 
PCR was set up by adding 1 μL of cDNA generated by reverse transcription to 5 
μL 5x Green GoTaq™ Flexi Buffer (Promega), 1 μL 25mM magnesium chloride, 
0.5 μL 10mM PCR Nucleotide Mix, 0.25 μL GoTaq™ DNA Polymerase, 1.25 μL 
10μM Forward Primer and 1.25 μL 10μM Reverse Primer (Table 4.2). All 
reaction volumes were adjusted to a total volume of 25µl with nuclease free 
water. Reactions were run on a G-storm™ GS1 thermal cycler (Genetic 
Research Instrumentation Ltd) with an initial denaturing step of 95ºC for 5 min, 
followed by thirty five cycles of a 1 min 95ºC denaturing step, a 1 min 55ºC 
annealing step (as it stated in table) and a 1 min 72ºC extension step. A final 
extension step at 72ºC for 10 min was run, ending the reaction. Primers 
sequences were obtained from related studies and using National Centre for 
Biotechnology Information (NCBI), Primer-BLAST search. β-actin was used as a 
control reference gene. RT-negatives and PCR-negatives were used as 
negative controls.  All PCR products were loaded in agarose gels to visualise 
bands by the Gel Doc 2000 (BioRad, Hemel Hempstead, UK).  
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4.2.3.4 Quantitative Polymerase Chain Reaction (qPCR) 
 
qPCR was carried out to quantify level of expression of PCNA, CASP-3, OPN 
and BSP. It was set up by designing the layout for samples and genes to be 
tested. cDNA was prediluted to 1:5 in nuclease free water. A mastermix reaction 
for primer design SYBR green was made up from 10 μL of 2x Mastermix (Primer 
Design), 2 μL 3um Forward Primer, and 2 μL 3um Reverse Primer and 1 μL 
nuclease free water to adjust final volume to 15µl. In a bright white 96 well Q-
PCR plate (Primer Design Ltd), 5 μL of cDNA were added to each well followed 
by the addition of 15 μL of MasterMix to the corresponding wells. All samples 
were analysed in triplicate. 96 well plates was sealed with a clear adhesive 
qPCR seal sheet prior spun at 5000rpm for 5 min. Plate was loaded into the 
qPCR machine, ABI Prism 7000 Sequence Detection System and ABI Prism 
7000 SDS Software V1.0, (Life Technologies Ltd., UK). Reaction conditions 
were one cycle of an initial denaturing step of 95ºC for 10 min, followed by 40 
cycles of a denaturing step at 95ºC for 15 seconds, an annealing step at 55ºC 
for 30 seconds and an extension step at 72ºC for 30 seconds. Primer sequences 
were obtained from previous related studies that follow criteria of qPCR. Results 
of qPCR was analysed using the 2–ΔΔCt method (Livak and Schmittgen 2001). 
Expression of β-actin, a housekeeping gene, was used as a control reference. 
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4.2.3.5 Agarose Gel Preparation 
To visualise PCR products a 10 µL of sample was loaded on to 1-2 % agarose 
gels. To prepare a 2% agarose gels, 1.4g of agarose powder (Invitrogen, UK) 
was mixed with 70mL of 0.5xTBE buffer and heated by microwave for 20 
seconds. The mixture was swirled in between until the agarose solution was 
clear, prior to the addition of 1% Safeview DNA Stain (NBS Biological Ltd., UK). 
The gels were poured into a casting tray containing comb and allowed to set at 
4ºC, for 15 min. Gel was then placed in an electrophoresis tank containing 0.5x 
TBE buffer. The comb was carefully removed and then 10µl of PCR reaction 
added to wells, in addition to a 10 μL 100 and 50 base pair (bp) DNA step ladder 
(Promega). Loaded gels were subjected to electrophoresis, at 80mV for 
approximately 45 min, in 1x TBE running buffer.  The gel was visualised using 
UV light by GelDoc™ Scanner (Bio-Rad Laboratories Ltd., Hemel Hempstead, 
UK) and images were captured using Quantity One Image Analysis Software 
(Bio-Rad). 
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4.2.4 Cells proliferation, osteogenic and apoptotic staining 
4.2.4.1 Immunocytochemical staining  
Immunocytochemical staining was carried out on cells cultured in culture slides. 
Cells were washed with TBS for 5 minutes, then incubated with 4% 
paraformaldehyde for 30 minutes. Cells were suspended in PBS and stored at 
4oC until required. Before starting staining procedure TBS was removed from 
Table 4. 2: Forward and reverse primer sequences for gene markers used for PCR 
analysis. Β-actin was used as a housekeeping gene 
Gene 
Marker 
Primer sequence (5'->3') 
F, Forward; R,Reverse 
Annealing 
Temperatur
e  
Source 
β-actin F:TGAAGATCAAGATCATTGCTCCTCC 65 oC (Harrington 
et al. 2014) 
R:CTAGAAGCATTTGCGGTGGACGATG 65 oC 
PCNA F:TGA AGT TTT CTG CGA GTG GG 55 oC (Guo et al. 
2012) 
R:CAG TGG AGT GGC TTT TGT GAA 55 oC 
Casp-3 F:CAT GAC CCG TCC CTT GAA 55 oC (Cheng et 
al. 2008) 
R:CCG ACT TCC TGT ATG CTT ACT CTA 55 oC 
BSP F:CAGAAAGAGCAGCACGGTTG 55 oC (Li et al. 
2012) 
R:CCTCGTAGCCTTCATAGCCA 55 oC 
OPN F:TCC AAG GAG TAT AAG CAG AGG GCC 
A 
55 oC (Kawashim
a et al. 
1999) 
R:CTC TTA GGG TCT AGG ACT AGC TTG T 55 oC 
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wells and cells were washed three times in TBS. For detection of intracellular 
proteins, cells were incubated in 1% Triton-X 100 for 30 minutes followed by 
incubation at 1% BSA bovine serum albumin (BSA, Fisher Scientific, UK) for 1 
hour at room temperature. Serum was removed from the wells and cells 
incubated with appropriate primary antibody diluted in 1% BSA in TBS at 4oC for 
overnight. Proliferating cell nuclear antigen (PCNA), bone sialoprotein (BSP), 
cleaved caspase-3 (casp-3) and osteopontin (OPN)  primary antibodies, all were 
rabbit anti-rat except OPN was goat anti-rat (Santa Cruz Biotech, USA) diluted 
1:50 in 1% BSA/TBS. Isotype control antibodies, goat (Santa Cruz Biotech, 
USA) and rabbit (Cell Signaling Technology, UK), used in the same primary 
antibody concentrations, and primary antibody exclusion were used as a 
negative control antibody. Following primary antibody incubation cells were 
washed with 0.5% Tween-20 in TBS 3 times for 5 minutes each wash. Cells 
were then incubated for 1.5 hour under darkness with the appropriate 
fluorescent marker conjugated secondary antibody, goat anti-rabbit or rabbit 
anti-goat, (Santa Cruz Biotech, USA), diluted 1:250 with 1% BSA/TBS. Cells 
were washed with 0.5% Tween-20 in TBS 3 times for 5 minutes. The cells 
chamber was removed using ethanol and slide tool. Cells were stained with 
Vectashield® mounting medium with DAPI (Vector Laboratories Ltd, UK). Slides 
were covered by cover slips prior to sealing with nail polish. Cells were 
evaluated microscopically on an Olympus AX70 fluorescent microscope at 
373nm/456nm (FITC). Photographs were taken using a Nikon DXM digital 
camera and ACT-1 imaging software.   
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4.2.4.2 Alizarin red Staining 
Alizarin red Staining (Sigma-Aldrich, Inc) was used to determine the presence of 
calcific deposition by the cells. As before, fixed cells were washed twice with 
PBS prior alizarin red S staining. Cells were stained with 0.5 ml/well alizarin red 
S, prepared by dissolving 20g/L in double distilled water, pH 4.2, for 3 min at 
room temperature with gentle shaking. Wells were subsequently washed with 
distilled water until the wash solution was clear of red. Samples were left to dry 
at room temperature and viewed by light microscopy (Nikon Eclipse TS100). 
 
4.2.5 Statistical analysis 
Statistical analysis was carried out using the GraphPad InStat 3 software 
(GraphPad software, Inc, USA). Standard errors of the mean were calculated, 
and mean values were analysed using one-way ANOVA and Tukey’s post hoc 
test, to analyse differences between treatment types and controls. P values 
below 0.05 at 95% confidence intervals were held to be statistically significant. 
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4.3 Results 
4.3.1 Cellular morphology  
After 24 hours of initial culture, cells were further cultured for 14 days in culture 
medium (Figure 4.1)  or osteogenic medium (Figure 4.2) supplemented with 
either BMP2 or calcium hydroxide at pH 7 or 11 to investigate the effect of 
calcium hydroxide on BMSCs. During the culture period, cells for all groups were 
observed to increase in number and demonstrated a fibroblast like morphology 
with the characteristic long, spindle, bipolar shape. After day 7 there were 
marked variations in the proliferative capacity between the groups. Cells cultured 
in calcium hydroxide at pH 7 and BMP2 demonstrated high proliferative capacity 
similar to the control medium. In contrast, cells treated with calcium hydroxide at 
pH 11 began to change in their morphology at day 7 such that the cells became 
wider and larger in size, although still maintaining their spindle and bipolar 
shape. At day 14, cells treated with calcium hydroxide at pH 11 demonstrated 
significant decrease in cell number and tended to become round and started 
losing their shape. The cells became detached from culture walls and floated in 
the medium. 
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Figure 4- 1: Comparison of the morphological appearance of cells challenged with culture medium 
supplemented with either BMP2, Ca(OH)2 at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 days.  
Cells treated with calcium hydroxide at pH 11 were detached from the well and floated in the 
medium (arrow). Scale bar is 100um. 
D
a
y
 1
 
D
a
y
 3
 
D
a
y
 7
 
D
a
y
1
4
 
Culture medium +BMP2 +Ca(OH)
2 
pH7 +Ca(OH)
2 
pH11 
 
131 
 
 
 
 
 
 
 
 
 
 
Figure 4- 2: Comparison of the morphological appearance of cells challenged with osteogenic 
medium supplemented with either BMP2, Ca(OH)2   at pH7 or pH 11 and cultured  for 1, 3, 7 
and 14 days. Cells treated with calcium hydroxide at pH 11 were decreased in number looked 
more flattened than other cells (arrow). Scale bar is 100um 
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End-point PCR Gene Expression Level of PCNA, CASPASE-3 and 
BSP 
 
Expression of PCNA and CASPASE-3 were investigated at early and late culture 
time points to investigate the effects of Ca(OH)2  on cellular proliferation and 
apoptosis during culture while using β-actin as a housekeeping gene (Figure 4. 
3). PCNA was expressed in all cell groups at day 1, 3 and 7.  At day 14, PCNA 
was expressed in all cell group except cells treated with culture medium 
supplemented with Ca(OH)2 at pH11. Casp-3 was expressed in all cell groups at 
day 1, 3, 7 and 14 except at cells treated with culture medium supplemented 
with Ca(OH)2 at pH11 at day 14 where it demonstrated strong expression. 
Expression of BSPII gene was investigated in cells cultured for 14 days to 
investigate the effects of Ca(OH)2  on cellular differentiation (Figure 4.3). BSPII 
was expressed only in cells treated with osteogenic medium, osteogenic 
medium supplemented with Ca(OH)2  pH 7 and osteogenic medium 
supplemented with BMP2. The PCR-ve and RT-ve experimental controls 
demonstrated no expression of PCNA, CASPASE-3 and BSP genes. 
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Figure 4- 3: End-point PCR showing expression of PCNA, CASP-3 and BSPII gene markers 
from cells challenged with culture or osteogenic medium supplemented with either BMP2, 
Ca(OH)2   at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 days. β-actin was used as a 
housekeeping gene.   
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4.3.2 qPCR Gene Expression 
 
4.3.3 qPCR Gene Expression Levels of PCNA and CASPASE-3 
 
In culture medium supplemented group, PCNA and CASPASE-3 expression 
were analysed by qPCR to quantify expression of PCNA and CASPASE-3 
genes and compare proliferative and apoptotic effect of different treatment at 
different culture time. PCNA (Figure 4.4.A) was expressed similarly at all groups 
at day1. At day 3, cells treated with Ca(OH)2-pH7 demonstrated significant over 
expression of PCNA greater than BMP2 and control group (p<0.05). However, 
cells treated with BMP2 and Ca(OH)2-pH7 expressed significantly less PCNA 
than control group at day7 (p<0.05). No significant differences were observed 
between cells treated with BMP2 and Ca(OH)2-pH7 when compared with control 
group at day 14 (p>0.05). Among all groups, the highest expression of PCNA 
was observed in cells treated with Ca(OH)2-pH7 after 3 days of culture (p<0.05). 
However for expression of CASP-3 at culture medium supplemented group 
(Figure 4.5.A), there was significant decrease in expression of CASP-3 at all 
groups when compared with the control group at day 1, 3, 7 and 14 (P<0.05). 
Among all groups, the lowest expression of CASP-3 was observed in cells 
treated with Ca(OH)2-pH7 at all culture days (p<0.05). 
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When examining the osteogenic medium supplemented group, cells treated with 
Ca(OH)2-pH7 demonstrated less expression of PCNA than control and BMP2 
groups at day 1 (Figure 4.4.B) (p<0.05). When compared with the control group, 
cells treated with BMP2 and Ca(OH)2-pH7 demonstrated less expression of 
PCNA at day 3,  7 and 14 (p<0.05). In contrast (Figure 4.5.B), cells treated with 
BMP2 demonstrated higher expression of CASP-3 at day 1 greater than control 
and Ca(OH)2-pH7 groups (p<0.05). CASP-3 demonstrated similar expression at 
all groups at day 3, 7 and 14. Day 1 demonstrated the highest expression of 
CASP-3 among all groups (p<0.05).   
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Figure 4- 4: Gene expression of PCNA of cells challenged with (A) culture medium (CM) or  
(B) osteogenic medium (OM) supplemented with either BMP2 or Ca(OH)2 at pH7 and 
cultured  for 1, 3, 7 and 14 days. * p<0.05. Error bars indicate standard error of the mean.  
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Figure 4- 5: Gene Expressions of  CASPASE-3 of cells challenged with (A) culture medium (CM) 
or  (B) osteogenic medium (OM) supplemented with either BMP2 or Ca(OH)2  at pH7 and 
cultured  for 1, 3, 7 and 14 days. * p<0.05. Error bars indicate standard error of the mean 
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4.3.4 qPCR Gene Expressions of Osteopontin and Bone 
Sialoprotein  
 
qPCR was used to quantify level of expression of, bone related genes, 
osteopontin and Bone Sialoprotein after 14 days of cell culture (Figure 4.6). The 
culture medium supplemented group demonstrated no expression of osteopontin 
and bone sialoprotein at cell cultured with culture medium or culture medium 
supplemented with BMP2 and Ca(OH)2-pH7. Osteogenic medium supplemented 
group demonstrated expression of both osteopontin and bone sialoprotein. 
However there were no significant differences (P>0.01) for expression of bone 
sialoprotein between cells treated with osteogenic medium and osteogenic 
medium supplemented with BMP2 and Ca(OH)2-pH7. All osteogenic medium 
supplemented groups demonstrated a significant increase (P<0.01) in 
expression of osteopontin with significantly higher expression of osteopontin at 
cells treated with Ca(OH)2-pH7 when compared with cells treated with 
osteogenic medium or BMP2.  
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Figure 4- 6: qPCR Gene Expressions of osteopontin and Bone Sialoprotein from cells 
challenged with culture or osteogenic medium supplemented with either BMP2, Ca(OH)2   
at pH7 and cultured  for 14 days.CM :culture medium, OM: osteogenic medium, 
***P<0.01.  Error bars indicate standard error of the mean. 
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4.3.5  Immunocytochemical staining 
4.3.5.1 PCNA and Caspase-3 Immunolocalisation 
Within the culture medium supplemented group, PCNA (Figure 4.7) and 
Caspase-3 (Figure 4.9) were expressed in cells treated with culture medium and 
culture medium supplemented with BMP2, Ca(OH)2 at pH7 and pH11 at day 1, 3 
and 7. More cells were stained positive to PCNA were observed at day 3 in all 
treatment group. At day 14, PCNA and Caspase-3 were expressed in cells 
treated with culture medium and culture medium supplemented with BMP2 and 
Ca(OH)2 at pH7 but not with cells treated with culture medium supplemented 
with Ca(OH)2 at pH11 as no cells were available to stain. Negative controls 
where primary antibodies were omitted and control Isotype demonstrated only 
the dark blue nucleus with no non-specific staining (Figure 4.4 and 4.6).  
 
Within the osteogenic medium supplemented group, PCNA (Figure 4.8) and 
Caspase-3 (Figure 4.10) were expressed at day 1, 3 and 7 in all cell groups.  At 
day 14, PCNA and Caspase-3 were expressed in cells treated with osteogenic 
medium and osteogenic medium supplemented with BMP2 and Ca(OH)2 at pH7 
but not with cells treated with osteogenic medium supplemented with Ca(OH)2 at 
pH11 as no cells were available to stain. Negative controls where primary 
antibodies were omitted and control Isotype demonstrated only the dark blue 
nucleus with no non-specific staining (Figure 4.5 and 4.7). 
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Figure 4- 7: PCNA immunolocalisation for cells challenged with culture medium supplemented 
with either BMP2, Ca(OH)2   at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 days. PCNA was 
expressed at all cells groups. Isotype and exclusion antibody negative controls were only 
expressed the blue DAPI nuclear stain. Small boxes show cells with PCNA FITC stain without 
DAPI stain. 
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Figure 4- 8: PCNA immunolocalisation for cells challenged with osteogenic medium 
supplemented with either BMP2, Ca(OH)2   at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 
days. PCNA was expressed at all cells groups. Isotype and exclusion antibody negative controls 
were only expressed the blue DAPI nuclear stain. Small boxes show cells with PCNA FITC stain 
without DAPI stain. 
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Figure 4-9: CASP-3 immunolocalisation for cells challenged with culture medium supplemented 
with either BMP2, Ca(OH)2   at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 days. CASP-3 was 
expressed at all cells groups confirmed by green-FITC (arrow). Isotype and exclusion antibody 
negative controls were only expressed the blue DAPI nuclear stain. 
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Figure 4-10: CASP-3 immunolocalisation for cells challenged with osteogenic medium 
supplemented with either BMP2, Ca(OH)2   at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 
days. CASP-3 was expressed at all cells groups confirmed by green-FITC (arrow). Isotype and 
exclusion antibody negative controls were only expressed the blue DAPI nuclear stain. 
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4.3.5.2 Osteopontin and Bone Sialoprotein Immunolocalisation 
 
Within the culture medium supplemented group, BSP (Figure 4.11) and 
osteopontin (Figure 4.13) were not expressed at day 1, 3 and 7 in all cell groups.  
At day 14, BSP and osteopontin were expressed in cells treated with culture 
medium supplemented with BMP2 and Ca(OH)2 at pH7 but not with cells treated 
with culture medium. BSP and osteopontin expressions were not observed in 
cells treated with Ca(OH)2 at pH11 as no cells were available to stain. Negative 
controls where primary antibodies were omitted and control Isotype 
demonstrated only the dark blue nucleus with no non-specific staining (Figure 
4.11 and 4.13).  
 
Within the osteogenic medium supplemented group, BSP (Figure 4.12) and 
osteopontin (Figure 4.14) were not expressed at day 1, 3 and 7 in all cell groups.  
At day 14, BSP and osteopontin were expressed in cells treated with osteogenic 
medium and osteogenic medium supplemented with BMP2 and Ca(OH)2 at pH7. 
BSP and osteopontin expressions were not observed in cells treated with 
Ca(OH)2 at pH11 as no cells were available to stain. Negative controls where 
primary antibodies were omitted and control Isotype demonstrated only the dark 
blue nucleus with no non-specific staining (Figure 4.12 and 4.14). 
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Figure 4- 11:BSP immunolocalisation for cells challenged with culture medium supplemented with 
either BMP2, Ca(OH)2   at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 days. BSP was only 
expressed at day 14 at cells treated with culture medium supplemented with BMP2 and Ca(OH)2 at 
pH7 as confirmed by green-FITC (arrow). Isotype and exclusion antibody negative controls were 
only expressed the blue DAPI nuclear stain. 
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Figure 4- 12:BSP immunolocalisation for cells challenged with osteogenic medium supplemented 
with either BMP2, Ca(OH)2   at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 days. BSP was only 
expressed at day 14 at cells treated with osteogenic medium and osteogenic medium supplemented 
with BMP2 and Ca(OH)2 at pH7 as confirmed by green-FITC (arrow). Isotype and exclusion 
antibody negative controls were only expressed the blue DAPI nuclear stain. 
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Figure 4- 13: Osteopontin immunolocalisation for cells challenged with culture medium supplemented 
with either BMP2, Ca(OH)2 at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 days. OPN was only 
expressed at day 14 at cells treated with culture medium supplemented with BMP2 and Ca(OH)2 at 
pH7 as confirmed by green-FITC (arrow). Isotype and exclusion antibody negative controls were only 
expressed the blue DAPI nuclear stain. 
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Exclusion control  
 
 
 
Figure 4- 14: Osteopontin immunolocalisation for cells challenged with osteogenic medium 
supplemented with either BMP2, Ca(OH)2   at pH7 or pH 11 and cultured  for 1, 3, 7 and 14 days. OPN 
was only expressed at day 14 at cells treated with osteogenic medium and osteogenic medium 
supplemented with BMP2 and Ca(OH)2 at pH7 as confirmed by green-FITC (arrow). Isotype and 
exclusion antibody negative controls were only expressed the blue DAPI nuclear stain. 
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4.3.6  Alizarin Red Staining  
Alizarin red staining was performed to investigate effects of calcium hydroxide 
on osteogenic differentiation. Cells were examined for Alizarin red staining after 
14 days in culture (Figure 4.15). Within both culture medium and osteogenic 
medium supplemented group, cells cultured with Ca(OH)2 at pH 7 and BMP2 
were demonstrated multiple spherical nodules formation. Alizarin red staining 
was not detected in cells treated with culture medium or osteogenic medium 
supplemented with Ca(OH)2 at pH11 as no cells were available to stain. Alizarin 
red staining was negative in cells treated with culture medium but not with 
osteogenic medium. Alizarin red staining demonstrated that cells challenged 
with Ca(OH)2 at pH 7 demonstrated more nodule which was similar or higher 
than cells treated with osteogenic medium as well as BMP2.  
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Figure 4- 15: Alizarin red staining for cells challenged with culture medium or osteogenic medium 
supplemented with either BMP2, Ca(OH)2 at pH 7 or pH 11 at day 14. The red colour represents spherical 
nodules (arrow). 
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4.4 Discussion 
The previous chapter revealed that growth factors can be released from the ex 
vivo bone model following calcium hydroxide treatment; inducing cellular 
proliferation and differentiation. Calcium hydroxide demonstrated an ability to 
mediate dentinogenesis either through direct stimulation on the cells or by 
solubilisation of dentine extracellular matrix (Sangwan et al. 2013). By 
investigating the effect of calcium hydroxide on in vitro cell culture, this chapter 
interestingly demonstrated that continuous administration of calcium hydroxide 
at pH 11 is cytotoxic to the cells; however calcium hydroxide at pH 7 mediates 
proliferative and osteogenic capacity similar or higher than BMP2. 
 
Calcium hydroxide dissociates into calcium and hydroxyl ions. Calcium has been 
shown to play critical roles during cellular proliferation, migration, differentiation, 
and mineralization of the cells (Torneck et al. 1983; Kulesz‐Martin et al. 1984; 
Schröder 1985; Zayzafoon 2006). Alkaline conditioned medium, pH 7.8, has also 
been shown to enhance human dental pulp cells mineralization (Okabe et al. 
2006). It has been suggested that cells of oral mucosa have a protective 
response and demonstrated resistance to the effects of highly alkaline drinking 
water pH 11.2 and pH 12 (Merne et al. 2001). Extracellular calcium is also 
important during bone remodelling as it induced chemotaxis of osteoblasts and 
monocytes at site of resorption (Sugimoto et al. 1993). Although presence of 
calcium shows beneficial effect to the cells, increase calcium concentration can 
have a reverse effect on the cells. Influx of calcium can initiate toxic cell death 
(Schanne et al. 1979). It could be suggested that the highly alkaline environment 
triggered by the hydroxyl group caused disruption of the integrity of the cell 
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membrane followed by influx of high concentration of calcium ions across the 
damaged cell membrane leading to toxic death of the cells cultured with calcium 
hydroxide at pH 11. 
 
Cells appeared to be unable to tolerate the pH11 after 7 days which suggests 
that this pH was above the maximum that the cells can tolerate. Further culture 
of the cells in the alkaline medium was considered toxic environment for the 
cells that can not buffer or tolerate after 7 days. Calcium hydroxide at pH 12 is 
used in dentistry as an antimicrobial reagent providing a sterile environment at 
the superficial layer of dentine. However the results of this chapter demonstrated 
that alkaline pH is toxic and led to cell death as demonstrated by reduction in 
cell viability and cytological examination. It may be possible that calcium 
hydroxide at pH 11 can exert either apoptotic effect or necrotic effect. Caspase 
three is a protein that is activated in the apoptotic cell (Salvesen 2002; Ghavami 
et al. 2009) after apoptotic signalling events have occurred (Walters et al. 2009). 
Immunocytochemistry and PCR for casp-3 were performed to investigate the 
effect of calcium hydroxide on the cells. However, The alkaline environment 
appeared to reduce cell attachment, possibly due to cell death, and thus cells 
were difficult to find.  
 
Addition of calcium hydroxide at pH 7 is similar to suplememting the cells with 
calcium only, since the effect of the hydroxyl group is eleminated during pH 
optimization. It has been reported that calcium has the ability to influence 
proliferation and differentiation of cells (Walker et al. 2006) and extracellular 
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calcium has also been shown to induce cellulaur differentiation without reducing 
cellular proliferation (Micallef et al. 2009). Result of this chapter demonstrated 
that cells cultured with calcium hydroxide at pH 7 demonstrated a similar effect 
to cells cultured with BMP2. BMP2 is also known to stimulate celluar proliferation 
and differentiation (Liu et al. 2009; Hakki et al. 2014). It is likely that both calcium 
and BMP2 were stimulting the proliferation and differentiation of the cells as 
demonstrated by the positive expression of PCNA, OPN and BSP and alizarin 
red staining. 
 
Calcium hydroxide at pH 11 was applied continuously to the cells leading to a 
gradual decrease in cell number during the culture period. Calcium hydroxide at 
alkaline pH however was shown at previous chapter to facilitate cellular 
proliferation, migration and differentiation in ex vivo experiments through the 
release of growth factors. It could be that the concentraion used in this 
expirement was higher than cell’s ability or the continuous addition of alkaline 
calcium hydroxide resulted in cell death found during cell culture with calcium 
hydroxide at pH 11. It has been reported that calcium hydroxide may be 
mitogenic at certain concentrations (Torneck et al. 1983) and the pH used in this 
experiment could be too high for cell survival. 
 
PCNA, a proliferation marker, and capase-3, apoptotic marker, were expressed 
in all groups at gene as well as protein level. Peak of cellular proliferation has 
been demonstrated in several studies to be at day 3 (Einhorn 1998; Ai-Aql et al. 
2008; Dimitriou et al. 2011). However PCNA gene expression was upregulated 
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at day 1, 3, 7 and 14 and this was also confirmed by immunolocalization. This 
could be because the cells cultured at same seeding density; rate of proliferation 
were similar among all groups except at alkaline calcium hydroxide where cells 
were decreased in number. Although culturing the cells at alkaline calcium 
hydroxide demonstrated a cytotoxic lethal effect, capase-3 was not only 
upregulated at cells cultured with alkaline calcium hydroxide but also expressed 
at the other group. This is likely a programmed cell death due to the nature of 
bone marrow stem cells were they constantly replaced due to continual bone 
turnover and remodelling during life-span (Parfitt 1984). 
 
Immuolocalization demonstrated expression of osteopontin and bone 
sialoprotein at cells treated with calcium hydroxide at pH 7 and BMP2 at both 
culture and osteogenic medium groups. Expression of osteopontin and bone 
sialoprotein were also confirmed by qPCR analysis at osteogenic medium 
supplemented group but not at culture medium supplemented group. It could be 
that osteogenic medium was the cause of osteogenesis at gene and protein 
level not BMP2 or calcium hydroxide but osteogenesis was induced by culture 
medium supplemented by BMP2 and calcium hydroxide. These were confirmed 
by alizarin red staining as well as Immuolocalisation.  Osteopontin and bone 
sialoprotein were analysed for gene levels at day 14 and it could be that their 
synthesis and gene expression were missed at day 14 at culture medium 
supplemented groups but osteogenic medium supplemented group have an 
additional factor for osteogenesis- induced by osteogenic medium.  Alizarin red 
staining demonstrated multiple spherical nodules formed at cells treated with 
cells treated with osteogenic medium, BMP2 and calcium hydroxide at day 14 
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which represent the beginning of calcified deposition of the extracellular matrix. 
Results demonstrated that number of nodules was higher at cells treated with 
calcium hydroxide. Also osteopontin was upregulated at cells treated with 
calcium hydroxide. It has been reported that osteopontin have a high affinity to 
binds to multiple calcium ions (Chen et al. 1992; Kläning et al. 2014) inducing 
hydroxyapatite formation (Ito et al. 2004). Culturing of the cells for longer period 
will further investigate effect of calcium hydroxide on matrix calcification and 
mineralization.   
 
Although both osteopontin and bone sialoprotein are bone related genes and 
they upregulated at cells treated with BMP2 and calcium hydroxide, osteopontin 
was highly expressed when compared with expression of bone sialoprotein. 
Osteopontin is a phosphorylated glycoprotein expressed by osteoblasts and 
involved in cell adhesion, migration, and survival (Sodek et al. 2000). It has been 
reported that osteopontin is first to be expressed during differentiation of 
osteoblast progenitors (Yamate et al. 1997) and prior to the expression of BSP 
(Liu et al. 1994; Lekic et al. 1996). The cells cultured at day 14 are still at stage 
of osteoblastic differentiation and are not fully mature osteoblast. This suggest 
that osteopontin was expressed more than bone sialoprotein. Furthermore, 
osteopontin was significantly upregulated in cells treated with calcium hydroxide 
more than cells treated with BMP2. This is likely indicate that calcium hydroxide 
is able to induce osteoblastic differentiation more than BMP2. It has been 
demonstrated that calcium ion induced mRNA expression of osteopontin 
(Rashid et al. 2003; Chang et al. 2008) 
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Calcium hydroxide is incorporated in multiple clinical materials and is used at 
different pH ranging from physiological to alkaline pH. Although calcium 
hydroxide is a gold standard treatment in endodontic therapies, it has been 
associated with some side effects related to its alkalinity, viscosity, and 
application time. The results of this chapter demonstrated that calcium hydroxide 
effect on the cell is different at different pH. While continuous supplementation of 
calcium hydroxide at pH 7 mediates proliferative and osteogenic capacity of the 
cells, calcium hydroxide at pH 11 is cytotoxic to the cells. Testing calcium 
hydroxide at different pH, concentration and application time will give better 
understanding of its effect on the cells and maximise its beneficial effect of 
mediating not only dentine regeneration but also bone regeneration. 
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Chapter 5.  
Expression of bone morphogenic fusion protein in HEK cell 
lines and assessment of their biological activity 
5.1 Introduction 
Bone morphogenetic proteins (BMP) are important growth factors that have a 
wide range of developmental and post-natal functions. They have been shown to 
be important in skeletal system, for instance BMP2 is known to be 
osteoinductive agent; inducing commitment and differentiation of progenitor cells 
into osteoblasts (Wang et al. 1993; Ogasawara et al. 2004). It also plays a 
critical role as a chemoattractant agent, stimulating migration of progenitor cells 
and mature osteoblasts to the site of injury (Fiedler et al. 2002). BMP7, another 
bone morphogenetic protein, has been shown to stimulate proliferation, 
osteogenic differentiation and mineralization in vitro in human osteoporotic 
tissues inducing alkaline phosphatase activity and calcium production in growing 
osteoblasts (Pountos et al. 2010a). BMP7 has also been shown to stimulate 
osteogenesis, cementum regeneration,  and new attachment formation at 
mandibular osseous defects (Giannobile et al. 1998) and in maxillary sinus floor 
augmentation procedures before placing implant (Bergh et al. 2000).  
 
BMPs have been used in in vitro, animal models and human clinical trials to 
investigate and maximise their potential benefits in improving osteogenesis. 
BMPs, particularly BMP2 and BMP7, have been used clinically and 
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demonstrated a therapeutic effect for the treatment of bone diseases such as 
treating open tibia, non-union fractures and spine injuries (Friedlaender et al. 
2001; Carragee et al. 2011). When compared with conventional fracture 
therapies such as bone grafts, BMP2 and BMP7 have been demonstrated to 
have effective and superior outcomes especially in healing of open tibial 
fractures and spinal fusion injuries (Garrison et al. 2007). In 2002, a large 
prospective study with 450 participants from France, Germany and the UK, 
patients received 1.5 mg/ml BMP2 for treating open tibia fractures. Results 
demonstrated enhanced bone repair and significant reduction of the risk of 
secondary intervention and infection (Govender et al. 2002b). 
 
Although BMP2 and BMP7 have been approved for clinical use showing 
remarkable outcomes, there are still some concerns associated with their clinical 
treatments. A major obstacle for the therapeutic uses of BMP2 and BMP7 are 
the biological short half-life of the growth factor; about 30 min in case of BMP7 
(Vukicevic et al. 1998) and ranging from 4-6 hours in case of BMP2 (Gruendler 
et al. 2001). Clinical use of BMP2 and BMP7 have been shown to be successful 
in some cases (McKay et al. 2007; White et al. 2007) and unsuccessful in other 
cases (Carragee et al. 2011), which could be that the concentration of BMP 
required by each tissue is different and tissues/ cells may respond differently to 
different BMPs. This could be due to the issue of the perfect time to add external 
BMP to the tissue and the present of local proteins that may interact with 
external BMP in an agonist or antagonist effect (Brazil et al. 2015). Noggin is 
one of the soluble BMP antagonist which binds to BMPs inhibiting BMPs from 
binding to their cell surface receptors and disabling the initiation of BMP signal 
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transduction in target cells (Groppe et al. 2002; Winkler et al. 2004). It has been 
demonstrated that BMP heterodimers are more resistant to inhibition by 
antagonists such as noggin (Zhu et al. 2006). Furthermore the high effective 
dose required which can reach into milligram and a series of potential side 
effects lead to the concerns in using BMP in the clinic. Some of the common 
side effects associated with BMP include inflammatory reactions, radiculitis, 
ectopic bone formation, osteolysis, malignancy (Carragee et al. 2011) and life-
threatening events such as compression of the airway and/or neurological 
structures (Food and Drug Administration 2008). All of these limitations of BMP 
administration arose from the high dose of the protein required for bone 
formation, the poor stability and transient biological activity of the protein, insist 
the need of better way to enhance protein stability and reduce the concentration.  
 
Gene therapy provides an alternative treatment strategy to deliver BMPs to the 
tissues. It has been shown that delivering BMP7 gene to periodontal bone 
defects in rats demonstrating bridging of the periodontal bone defects and 
periodontal tissue engineering through rapid osteogenesis and cementogenesis 
(Jin et al. 2003). Different studies have aimed to compare the effects of BMP2-7 
heterodimer and BMP homodimers on bone regeneration. An in vitro studies 
demonstrated that a rhBMP2-7 heterodimer induced cell migration and cell 
differentiation with a significantly lower concentration and greater effect than the 
rhBMP2 and rhBMP7 homodimers (Zheng et al. 2010). In a bone defect model, 
a BMP2-7 heterodimer was also shown to induce new bone formation in a 
significantly higher quality and quantity of bone volume and bone implant contact 
greater than that of BMP2 and BMP7 homodimers in peri-implant bone defects 
 
160 
in minipig calvaria (Wang et al. 2012) and on minipig frontal skull (Sun et al. 
2012). Both studies used collagen sponges with low-dose (30 ng/mL) BMP2-7 
heterodimer, BMP2 or BMP7 homodimers and concluded that BMP could be 
applied at a low dose to reduce the cost and side effects of BMP (Sun et al. 
2012; Wang et al. 2012). Growth factor therapy is required to be applied at an 
appropriate dose with a suitable carrier at the correct application time and with 
reduced costs and side effects of the therapy. Gene therapies are now being 
used as a promising technique that may provide a better way to enhance protein 
stability and reduce the cost and concentration of current clinical growth factor 
application. This chapter aims to transfect BMP2-2, BMP7-7 homodimers and 
BMP2-7 heterodimer into HEK cell lines followed by assessment of the efficacy 
of low dose of BMP protein on hBMSCs. 
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5.2 Materials and Methods 
5.2.1 Preparation of Transformation and Transfection reagents 
A 15.5 g of 2xYT microbial growth medium powder (Sigma Aldrich, UK) was 
dissolved in 500 ml of dH2O and sterilized by autoclaving. After autoclaving, a 
480 μL of ampicillin (100 mg/ml) was added to 480 ml medium at room 
temperature as ampicillin contained medium (2xYT-ampicillin) and 20 ml of the 
medium without ampicillin was used as ampicillin free medium. A LB-amp 
Broth/Agar was prepared by dissolving 17.5 g of LB-broth powder (Sigma Aldrich, 
UK) in 500 ml of dH2O and sterilized by autoclaving. A 500 μL ampicillin (100 
mg/ml) was added to the LB-broth solution at room temperature after 
autoclaving. The liquid agar was poured into bacterial plates, and left to set for 
10 min prior storing at -4ºC. Full medium for cell culture was consisted of 
Dulbecco's modiﬁed Eagle's medium (DMEM), 10% foetal calf serum (FCS, 
Invitrogen, UK), and 1% antibiotics (100 units/ml penicillin G sodium, 0.1µg/ml 
streptomycin sulphate and 0.25µg/ml amphotericin; Invitrogen, Paisley, UK). 
Selective medium was made from the full medium in addition to 400ug/ml 
Zeocin™. 
 
5.2.2 Transformation of competent cells 
 
Three fusion proteins, BMP2 homodimer, BMP7 homodimer and BMP2-7 
heterodimer, were previously constructed from a pS-L-Fc vector by Dr Xiao-Qing 
Wei, School of Dentistry, Cardiff University. Briefly, pS-L-Fc, a mammalian 
expression vector which was constructed to fuse two proteins, BMP2-2, BMP7-7 
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and BMP2-7, linked with a linker peptide (3xGGGGS), in-frame with the human 
IgG1 Fc region (Figure 5.1). A 50 μL aliquot of DH5 α competent cells 
(Invitrogen, Scotland) was mixed gently with 5ng plasmid. Cells were incubated 
on ice for 30 minutes then immediately transferred in a previously warmed water 
bath (42°C) for 20 seconds then replaced again on ice for 2 minutes. A 950 μL 
aliquot of room temperature ampicillin free medium was added to each tube. 
Cells were incubated on a shaking incubator (Innova 4300, New Brunswick 
scientific Co., Inc., USA) at 37°C at 225 rpm for 1 hour. After incubation, cells 
were centrifuged at 13.000 rpm for 15 seconds. Cell supernatants were 
discarded and the pellet was resuspended and plated out using a cell spreader 
into LB- agar plates containing (100 mg/ml) ampicillin. Plates were incubated 
overnight at 37°C to allow colony formation, and plates stored at -4ºC.   
 
After colony formation, two single colonies were picked from each plate using a 
pipette tip and placed in a universal tube previously filled with 2ml of 2xYT-
ampicillin. Cells were incubated on a shaking incubator at 37°C and 225 rpm for 
overnight. After incubation, 1 ml of the culture medium was used to extract DNA 
using a QIAprep miniprep kit for plasmid purification and digestion to select the 
best colony and the remaining medium was stored at -4ºC. 
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Figure 5- 1: A map of pSecTag2 vector (A) modified to construct BMP2-2, BMP2-7 and 
BMP7-7 fusion protein (B). Three fusion proteins BMP2-2, BMP7-7 and BMP2-7 were 
constructed from pSec-L-Fc vector. The vector carries s ampicillin and Zeocin™ resistance 
genes for antibiotic selection. It contains a human hinge Fc domain for intracellular 
stability, quantitative assay and purification. 
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5.2.2.1 Miniprep Plasmid Purification 
A QIAprep spin miniprep kit (Qiagen, UK) was used for plasmid isolation and 
purification of bacterial cultures grown in 2xYT medium. 1ml of bacterial cell 
culture was centrifuged at 13.000 rpm for 3 min at room temperature. Pellets 
were resuspend in 250 μL Buffer P1 and transferred to a microcentrifuge tube 
prior to addition of 250 μL of Buffer P2. The solution was mixed thoroughly by 
inverting the tube 4–6 times until the solution became clear. 350 μL of Buffer N3 
was added and the solution mixed immediately and thoroughly by inverting the 
tube 4–6 times. The solution was centrifuged for 10 min at 13,000 rpm. The 
supernatant was transferred to the QIAprep spin column prior centrifuging for 1 
min and the flow-through was discarded. The QIAprep spin column was washed 
by adding 0.75 ml buffer PE and centrifuged for 1 min. The flow-through was 
discarded and the column was recentrifuged for 1 min to remove residual wash 
buffer. The QIAprep column was placed in a clean 1.5 ml microcentrifuge tube 
and 50 μL buffer EB was added to the center of the QIAprep spin column to 
elute DNA, left to stand for 1 min, and centrifuged for 1 min.  
 
5.2.2.2 Plasmid Digestion 
The purified DNA isolated by the miniprep was digested using three digestion 
enzymes. Single digests were performed using 2 μL miniprep DNA sample, 1 μL 
BamH1, 2 μL buffer E, 0.2 μL BSA and made up to a total volume of 20 μL with 
15 μL dH2O. Double digests were performed using 2 μL miniprep DNA sample, 1 
μL EcoR1, 1 μL Pst1, 2 μL buffer H, 0.2 μL BSA and made up to a total volume 
of 20 μL with 14 μL dH2O. Double digests were also performed using 2 μL 
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miniprep DNA sample, 1 μL BamH1, 1 μL EcoR1, 2 μL buffer E, 0.2 μL BSA and 
made up to a total volume of 20 μL with 14 μL dH2O. All digestion enzymes and 
buffers were supplied from Promega (Promega, UK). All DNA/digests solutions 
were incubated in a previously warmed water bath (37 ºC) for 1 hour. After 
incubation, DNA/digests solutions were analysed using agarose gel 
electrophoresis (as in section 4.2.3.5). Accordingly, single and double inserts 
were identified. 
 
5.2.2.3  Midiprep Plasmid Purification 
After colony formation, 500 μL from a previously stored culture colony was 
incubated with 100 ml of 2xYT-ampicillin. Cells were incubated on shaking 
incubator at 37°C and 225 rpm overnight. After incubation, culture medium was 
centrifuged at 3800 rpm for 15 min at 4 ºC.   DNA was extracted using a QIA 
plasmid plus midi kit (Qiagen, UK) for plasmid purification. Bacterial Pellets were 
resuspended in 4 ml Buffer P1 prior to adding 4 ml of Buffer P2. The solution 
was mixed thoroughly by inverting the tube 4–6 times until the solution became 
viscous then incubated at room temperature for 3 min. 4 ml of Buffer N3 was 
added and the solution mixed thoroughly by inverting the tube 4–6 times until the 
solution became clear. The lysate mix was transferred immediately into QIAfilter 
Cartridge, which was previously placed into a universal tube and incubated at 
room temperature for 10 min. During incubation, QIAGEN Plasmid Plus spin 
columns and tube extenders were placed into Vac-Man® laboratory vacuum 
manifold (Promega, UK).  After incubation, the plunger was gently inserted into 
the QIAfilter Cartridge and the cell lysate was filtered into the tube. The QIAfilter 
Cartridge was removed and 2 ml Buffer BB was added to the cleared lysate in 
 
166 
the universal tube, and mixed by inverting 4–6 times. The lysate was then 
transferred into the tube extenders/QIAGEN Plasmid Plus spin column on the 
vacuum manifold. Vacuum was switched on until the liquid was drawn through 
all columns. The QIAprep spin column was washed by adding 700 μL buffer 
ETR and centrifuged for 1 min. The flow-through was discarded and the column 
was rewashed by adding 700 μL buffer PE and centrifuged for 1 min. The 
column was recentrifuged for 1 min to completely remove residual wash buffer. 
The QIAprep column was placed in a clean 1.5 ml microcentrifuge tube and 200 
μL buffer EB was added to the center of the QIAprep spin column to elute DNA, 
let stand for 1 min, and centrifuged for 1 min. DNA samples were stored at -
20ºC. To quantify the amount of DNA in each sample, a NanoVue (GE 
Healthcare, UK) was used. The NanoVue was standardised with 2 μL of Buffer 
EP as a blank before using 2 μL of DNA sample to quantify.  
 
5.2.3 Determining Zeocin™ Sensitivity 
Zeocin™, a selective antibiotic, was used to identify transfected cells. HEK- 293 
cells (American Type Culture Collection, USA) were cultured in a 6-well plate in 
a seeding density of 5x104 cells/cm2. Cells were cultured for 24 hours in a full 
medium prior changing to medium containing varying concentrations of Zeocin™ 
(0, 100, 200, 400, 600, and 800μg/mL) to each well. Selective medium was 
replaced every 3–4 days and the percentage of surviving cells observed for 1 
week. 400μg/mL was selected as the concentration leading to death of the 
majority of the cells. 
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5.2.4 HEK cells Culture and Transfection 
HEK cells were cultured in full medium in a T75 flask until 80% confluent. Cells 
were then passaged using trypsin and counted before being transferred into 24-
well plate. Cell density was adjusted to 1x105 cells/cm2 prior to seeding 1ml into 
each well of 24 well plate and cultured overnight. After 24hrs, 500 μL of medium 
was removed just before transfection. Transfection reagents were prepared 
according to the manufacture instruction, which included Lipofectamine 3000 
and p300 reagent. Lipofectamine® 3000 Reagent 0.75 and 1.5 μL were diluted in 
two tubes of 25 μL serum free medium and mixed well. Master mix of DNA was 
prepared by diluting 2.5μg/μL DNA in a 50 μL serum free medium and 2 μL 
P3000™ Reagent and mixed well. Diluted DNA was added to each tube of 
Diluted Lipofectamine® 3000 Reagent in (1:1 ratio). DNA-lipid complex was 
incubated for 5 minutes at room temperature prior adding 50 μL of them to each 
well of HEK cell culture in 24-well plate. Transfected cells were incubated for 48 
hours before passaging the cells into 100mm petridish for Zeocin selection 
(400ug/ml). Supernatant medium was collected from transfected cells and a 
control non transfected cell for hFc detection by ELISA. 
 
5.2.5 hIgFc capture ELISA 
A 96-well ELISA plate (Thermo Fisher Scientific , USA) was coated with 50µl of 
0.5ug/ml Anti-Human IgG (Fc gamma-specific) biotin, diluted in 0.1M Na2 
HCO3/dH2O and the plate incubated in 4°C for overnight. The plate was washed 
with ELISA wash buffer (0.05% tween 20, PBS) 3 times, prior adding 100µl of 
blocking buffer (10% FBS/PBS) and incubated at 37°C for 2 hours. The plate 
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was washed with ELISA wash buffer 3 times, prior adding 50µl of the sample or 
a series of double diluted standard (Human IgG) into each well followed by 
incubating the plate in 4°C for overnight. The starting point of the standard 
began from 20ng/ml and a double dilution was made to 0ng/ml. The plate was 
washed with ELISA wash buffer 5 times before adding 50 µl of 1/1000 diluted 
Biotin conjugated anti-human Fc specific antibody and incubated at 37°C for 1-2 
hours. The plate was washed with ELISA wash buffer for 5-6 times prior adding 
50 µl of 1/1000 diluted HRP Avidine in blocking buffer and incubated at 37°C for 
1 hour. The plate was washed with ELISA wash buffer for 7 times before adding 
50 μL of TMB and incubated at 37°C for colour development for 15 minutes. The 
reaction was stopped by adding 50 μL of stop buffer prior to reading in a plate 
reader at 450nm using SPECTRO star Omega plate reader v3 and MARS data 
analysis software v2.41 (BMG LABTECH). The colour intensity is proportional to 
the amount of Fc and hence BMP. The concentration of BMP-Fc captured in the 
samples was calculated by using standard curve and polynomial (order 4) 
equation to compare the absorbencies to standards of known concentrations. 
 
5.2.6 Single Cell Colony Isolation and Culture Expansion               
The plate was washed with 10 ml PBS twice after discarding medium, then 5 ml 
of PBS was added to cover the cells. The plate was tilted to expose the colony, 
and 10 μL PBS was added onto the colony and scraped it out with 200 μL tip. 12 
single colonies were selected from each 100 petri dish plate. Selected colonies 
were visible as a white spot with clear edge and separated from other colonies. 
Each colony was mixed in 96-well plate with 40µl trypsin and incubated for 1-2 
min to separate cells into single cell suspension. Cells were then transferred into 
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a 24-well plate and cultured overnight in 1ml of full medium. The medium was 
changed into selection medium (400µg/ml Zeocin) and cells cultured until 
confluent. Medium was collected and hIgFc level detected by ELISA. Cells with 
positive ELISA results were transferred into a 6-well plate for further expansion. 
After cells reached confluent, ELISA was made again for supernatants medium 
to identify colonies with positive hIgFc expression. Cells with a high positive 
hIgFc expression were sub cultured into a T75 flask for further expansion. Cells 
cultured in T75 flasks for 11 days without medium changes and 200 μL of 
supernatant medium were collected every other day. Collected supernatant 
medium were concentrated using a centrifugal concentrator Vivaspin 20 MWCO 
(Fisher Scientific, UK) and hIgFc concentrations detected by ELISA. 
 
5.2.7 Assessment of functionality of BMP using human bone 
marrow stromal cells 
Human bone marrow stem cells (hBMSCs), a kind gift from W Nishio Ayre 
(School of Dentistry, Cardiff University, UK), were seeded at 4000 cells/cm2 and 
cultured with α-MEM supplemented with 10% Fetal Bovine Serum (FBS) 
(Invitrogen), 1% antibioticantimycotic and 1% L-ascorbic acid 2-phosphate 
(Sigma). Cells were incubated at 37oC in 5% CO2. Medium was changed every 
two days and mycoplasma testing was routinely conducted every passage.  
When cells reached approximately 80% confluence, they were passaged with 
accutase (Sigma), counted with a haemacytometer using Trypan Blue and 
reseeded at 4000 cells/cm2. Cells were continually propagated and underwent 
multiple passages until sufficient cells were gained. Cells were seeded in 24-well 
plates and 48-well plates in triplicate at 4000cells/cm2 and cultured with culture 
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medium or culture medium supplemented with 50ng/ml of either rhBMP2 
(Invitrogen, UK) or BMP2-2 homodimer. Cells in 24-well plates were used for 
RT-PCR and 48-well plates for ALP and ARS assays.  Cells were incubated at 
37oC in a 5% CO2 atmosphere for 14 days during which medium was changed 
with fresh supplemented medium every third day and images were taken. Cells 
were washed with PBS and fixed with 4% paraformaldehyde at day 3, 7 and 14. 
 
5.2.7.1 Alkaline phosphatase staining  
Fixed cells were washed with washing buffer made from 0.05% Tween 20 in 
PBS. Cells were incubated with substrate solution made by dissolving one 
BCIP/NBT tablet (SigmaFastTM BCIP-NBT; Sigma Aldrich) in 10 ml distilled 
water. Plates were placed at room temperature in the dark for 5-10 min. Cells 
were washed with washing buffer then replaced with PBS. Cells were evaluated 
under light microscope and images captured using Canon P1234 camera 
(Canon UK Ltd., UK). 
 
5.2.7.2 Alizarin red staining 
Fixed cells were washed with distilled water then incubated with Alizarin Red S 
staining solution. Alizarin Red S staining solution was prepared by dissolving 1g 
Alizarin Red S (sigma, UK) in 50ml distilled water and pH adjusted to 4.1 - 4.3 
with 0.1% NH4OH. Plates were placed in the dark at room temperature for 45 
min. Cells were washed four times with distilled water and then replaced with 
PBS. Cells were evaluated under a light microscope and images captured using 
Canon P1234 camera (Canon UK Ltd., UK). 
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5.3 Results 
5.3.1 DH5 Transformation  
DH5 competent cells were used for cells transformation with BMP2-2, BMP2-7 
and BMP7-7. After transformation, cells were plated out onto LB- agar plates 
containing (100 mg/ml) ampicillin which allowed selection of only transformed 
cells. Examination of the plates demonstrated that plates number 1 (BMP2-2), 2 
(BMP2-7) and 3 (BMP7-7) demonstrated colonies formation, when compared 
with the control plate number 4. Colonies formation at transformed plates 
demonstrated that successful transformation was achieved (Figure 5.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5- 2: DH5 competent cells transformed with BMP2-2, BMP2-7, BMP7-7 and control. 
Plates number 1 (BMP2-2), 2 (BMP2-7) and 3 (BMP7-7) demonstrated colonies formation 
(arrow).  No colony formation was seen at the control plate.  
BMP2-2 
BMP7-7 
BMP2-7 
Control 
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5.3.2 Plasmid Digestion 
Agarose gel electrophoresis was used for further transformation analysis. Two 
colonies were used from each transformed sample and digested with three 
restriction enzymes. The number of bands appeared in each lane was 
corresponded to the restriction enzyme used. Lane number 1, 4, 7, 10, 13 and 
16 demonstrated single inserts because one digestion was made by BamH1. All 
other lanes demonstrated double inserts because a double digestion was made 
by either ECOR1/Pst1 or BamH1/ECOR1. As predicted, all lanes demonstrated 
a ~5Kb band corresponding to the pSec vector. Other bands were related to 
BMP2= 350bp and BMP7= 400bp (Figure 5.3). 
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A 
B 
Figure 5- 3: single and double insert after cell transformation were detected by agarose gel 
electrophoresis (A). Numbers represent sample and restriction enzymes as seen in details 
in the table (B). Bands are shown corresponding to approximately BMP2= 350bp and 
BMP7= 400bp. All lanes contain a ~5Kb band corresponding to the pSec vector. Ladder= 
1000 Kg.  Restriction enzymes: BamH1, ECOR1 and Pst1, BamH1 and ECOR1. 
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5.3.3 Determining Zeocin™ Sensitivity  
Cells were cultured with different Zeocin concentrations and monitored for 7 
days to identify the concentration that can be used during culture for antibiotic 
selection. Cells were cultured with medium supplemented with Zeocin at 
concentrations of (0, 100, 200, 400, 600, and 800μg/mL). At day 7, most of the 
cells were viable at cells cultured with 100 and 200μg/mL Zeocin when 
compared with the control (0μg/mL). However, all cells died when cultured with 
600μg/mL, and 800μg/mL. The majority of the cells died at cells cultured with 
400μg/mL. Thus the 400μg/mL concentration was used for antibiotic selection 
(Figure 5.4). 
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Figure 5- 4: Determining Zeocin™ Sensitivity. Cell 
cultured with different Zeocin concentration and 
cultured for 3 days (A) and 7 days (B). Plate (C) 
demonstrated colour change of the medium with live 
cells (yellow) and dead cells (pink). Scale bar, 100μm 
C 
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5.3.4  hIgFc capture ELISA 
ELISA was used to determine the efficacy of cell transfection by detecting the 
concentration of hFc and hence BMP from the supernatant medium after 
lipofectamine transfection. hFc was detected in supernatant medium collected 
from cells transfected with BMP2-2, BMP2-7 and BMP7-7 at both 0.75ug  and 
1.5ug DNA concentration. No hFc was detected in control transfections as well 
as HEK cells demonstrating that successful transfection was achieved (Figure 
5.5). 
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Figure 5- 5: ELISA for hFc to identify efficacy of HEK cells transfection. 
Comparison of hFc detected at supernatant medium collected from cells transfected 
with BMP2-2, BMP2-7 and BMP7-7 at 0.75 and 1.5ug DNA concentration. Error 
bars indicate standard error of the mean 
 
 
177 
5.3.5 Colony formation  
After cell transfection, cells were passaged and cultured with medium 
supplemented with zeocin for antibiotic selection. Zeocin is lethal to un-
transfected cells (Figure 5.6). Light microscope images demonstrated colonies 
formation after transfection and antibiotic selection. Plates with transfected cells 
demonstrated survival and proliferation with multiple colonies formed throughout 
the plate. However, no cells were available at control plates during the entire 
culture period (Figure 5.6).   
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Figure 5- 6: Example of colony formed after transfection and antibiotic selection.  Colonies 
formed at all transfected plates but not at the control plate. Scale bar, 100μm 
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5.3.6 Assessment of functionality of BMP2-2 on hBMCs 
5.3.6.1 Cellular morphology 
hBMCs cells were cultured for 14 days in culture medium or medium 
supplemented with either BMP2-2 or rhBMP2 to investigate the effect of BMP2-2 
on hBMCs. During the culture period, cells of all groups were observed to 
increase in number and demonstrated a fibroblast like morphology with the 
characteristic long, spindle, bipolar shape. Greater numbers of cells were 
observed at day 7, when compared with day 3. After 14 days in culture, there 
were marked variations in the proliferative capacity between the groups. Cells 
cultured in BMP2-2 demonstrated high proliferative capacity greater than cells 
cultured with BMP2 or control culture medium (Figure 5.7).   
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Figure 5- 7: hBMCs cells cultured in culture medium or medium supplemented 
with either BMP2-2 or rhBMP2 for 14 days. Scale bar, 100μm 
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5.3.6.2 Alkaline phosphatase staining  
Alkaline phosphatase staining was used to investigate the effects of BMP2-2 on 
the cells. After 3 days in culture, cells of all groups were demonstrated negative 
staining to alkaline phosphatase. When compared with cell cultured at control 
culture medium or BMP2, cells exhibiting positive staining for the alkaline 
phosphatase could be observed at day 7 in cells cultured with BMP2-2. Cells 
appeared with the characteristic alkaline phosphatase blue –violet colour. When 
compared with cells at day 7, cells cultured with BMP2-2 demonstrated high 
staining to alkaline phosphatase demonstrating multiple cells stained dark blue-
violet at day 14. Control culture and cells cultured with rhBMP2 demonstrated no 
staining to alkaline phosphatase at day 14 (Figure 5.8). 
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Figure 5- 8: Alkaline phosphatase staining for hBMCs cells cultured in culture 
medium or medium supplemented with either BMP2-2 or rhBMP2 for 14 days. 
Cells cultured with BMP2-2 demonstrated positive staining to alkaline phosphatase 
at day 7 and 14 (arrow). Scale bar, 100μm 
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5.3.6.3 Alizarin red staining 
Alizarin red staining was used to investigate effects of BMP2-2 on osteogenic 
differentiation. Cells at all groups demonstrated similar negative staining to 
alizarin red staining at day 3 and 7. However, at day 14 cells cultured with 
BMP2-2 stained positively with alizarin red staining demonstrating multiple cells 
with red colour. Control culture and cells cultured with rhBMP2 demonstrated no 
alizarin red staining at day 14 (Figure 5.9). 
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Figure 5- 9: Alizarin red staining for hBMCs cells cultured in culture medium or medium 
supplemented with either BMP2-2 or rhBMP2 for 14 days. Cells cultured with BMP2-2 
demonstrated positive staining to alizarin red staining at day 14 (arrow). Scale bar, 100μm 
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5.4 Discussion 
 
The results presented in this chapter demonstrate that BMP2-2 and BMP7-7 
homodimers and BMP2-7 hetrodimer were successfully transformed into DH5α 
competent cells and successfully transfected into HEK cells. BMB2-2 homodimer 
expressed by  HEK cells was successfully demonstrated osteogenic potential. 
The osteogenic ability of BMB2-2 homodimer was greater than commercial 
recombinant human bone morphogenetic protein-2 and at a nanogram dose. 
 
Although E.coli is commonly used for protein expression due to its rapid, ease of 
use and relatively low cost (Portolano et al. 2014), production of high yield of 
recombinant protein is challenging due to low expression and poor protein 
stability (Baneyx 1999). Mammalian cells such as Chinese hamster ovary (CHO) 
and HEK cells demonstrate superior advantages in production of recombinant 
protein more than E.coli, particularly HEK cells have better advantages over 
other expression vehicles due to their ease of culture and high transfection 
efficiency (Huh et al. 2007; Nettleship et al. 2015). Transfections were made 
using Lipofectamine® 3000 reagent protocol. In summary the cells were 
transfected by DNA-lipid complex and cultured for 48h. Results from ELISA 
demonstrated that BMP2-7 heterodimer, BMP2-2 and BMP7-7 homodimer were 
detected at supernatant in all test groups but not at the control cells which 
confirm transfection. Transfections were also confirmed by culturing transfected 
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cells with Zeocin™ antibiotic. Colonies were formed in all test groups but not at 
the control plate. The pSecTag2 vectors carry Zeocin™ resistance gene which 
acts as a selective antibiotic. Cells that have this gene were able to survive at 
the medium but cells that do not have Zeocin™ resistance gene were destroyed 
at Zeocin™ containing medium thus no cells were available at the control plate. 
Furthermore it was mandatory to determine the appropriate concentration when 
using Zeocin™ as using it at a high dose (e.g. 700ug/ml) were lethal to the cells. 
Thus using Zeocin™ at 400ug/ml was capable to do the selection for transfected 
cells that carry Zeocin™ resistance gene.  
 
Cells cultured for 11 days, during which supernatant medium were collected and 
BMP concentrations were quantified by ELISA and concentrated using 
centrifugal concentrator Vivaspin. However there were no high expression of 
BMP7-7 homodimers and BMP2-7 heterodimers enough to conduct the 
experiment of testing their biological functions on the cells. Low protein 
expression is a common issue across protein expressions from mammalian 
cells. There are several techniques which can be used in the future to increase 
expression of the protein from mammalian cells. It has been reported that 
lowering culture temperature to 30–33°C resulted in higher expression of a 
variety of recombinant proteins using CHO cells (Kaufmann et al. 1999; Yoon et 
al. 2003) and HEK cells (Lin et al. 2015). These studies suggest that the 
enhancement of protein expression after culturing the cells at low temperature is 
mainly because hypothermia increases cellular productivity of recombinant 
proteins while reducing the growth rate of the cells, through inducing cell growth 
suppression due to cold-induced cell cycle arrest (Kaufmann et al. 1999; Yoon et 
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al. 2003; Lin et al. 2015). Recent studies demonstated a novel and accessible 
protocols to express and purify milligram quantities of protein through performing 
transient transfections of suspension grown HEK cells at shaking incubator 
(Portolano et al. 2014) or using 10-layer cell factories at standard incubator 
(Aydin et al. 2012). Furthermore it has been suggested to culture transfected 
cells under the antibiotic selection pressure to maximize the chances of higher 
percentage of pure population of cells containing the gene of interest (Novo et 
al. 2012). A possible way to increase expression of the protein also is by 
selecting hundred colonies after colonies formation and select the highly positive 
colonies as the best expression cells after protein screening (Strukov and 
Belmont 2008). 
 
Cells cultured in medium supplemented with BMP2-2 demonstrated ALP 
staining more than cells cultured in control medium or medium supplemented 
with rhBMP2. ALP is expressed by osteoblasts and osteoblasts precursor and it 
has been reported that ALP is up-regulated during differentiation (Walsh et al. 
2000). rhBMP2 has been shown to regulate and induce ALP gene expression in 
cultured osteoplastic cells (Takuwa et al. 1991). Cells cultured in medium 
supplemented with BMP2-2 homodimer expressed ALP at day 14 more than at 
day 7. ALP expression has been found to be continuously increased over the 
time course (Rawadi et al. 2003) demonstrating peak  expression at two weeks 
(Sun et al. 2012). Although both proteins were used in the same concentration, 
results demonstrated that BMP2-2 demonstrated superior effect over rhBMP2. 
rhBMP2 has been used clinically but in a very high dose, a minimum of 
1.5mg/ml, and associated with serious post-operative complications (Carragee 
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et al. 2011). The concentration used in this experiment was 50ng/ml which was 
below the ED50 of the rhBMP2. This suggests that BMP2-2 has a better 
mineralization effect at a low concentration and can reduce the clinical 
complication demonstrated form rhBMP2 treatment. BMP2-2 was produced by 
HEK cells; however rhBMP2 was produced by E-coli. Since BMP2-2 produced 
by mammalian cells this could reduce the complications created by using protein 
produced from bacterial or viral origin. In this study, CHO cells were failed to 
express BMP fusion proteins when compared with HEK cells. HEK cells are 
originated from human cells and they could be better than CHO cells which are 
originated from hamster. These promising results can allow the use of BMP2-2 
clinically in a safe, effective and low concentration. 
 
BMP2-7 heterodimer, BMP2-2 and BMP7-7 homodimer were purified and 
expressed in the supernatant mammalian HEK cells. The vector used in this 
investigation was constructed by inserting a (3XGGGGS) linker to link the two 
dimers together. When compared with conventional disulphide linked dimers 
available commercially (Zheng et al. 2010; Sun et al. 2012; Wang et al. 2012), 
this linker has been shown to give greater protein solubility, flexibility, stability 
and function because it improves fusion protein expression and folding as well 
as protein half-life (Chen et al. 2013). Alizarin red and alkaline phosphatase 
staining results demonstrated an enhanced activity of (3XGGGGS) linked 
BMP2-2 homodimers and revealed regeneration potential greater than 
disulphide linked rhBMP2. These promising results are encouraging to further 
investigate and compare the biological activity of BMP2-7 heterodimer, BMP2-2 
and BMP7-7 homodimer. It has been reported that using BMP 2-7 heterodimers 
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in relatively low dosage induced new bone formation in a significantly higher 
efficacy more than BMP2-2 and BMP7-7 homodimers (Zhao et al. 2005; Wang 
et al. 2012). Thus further investigation is required to assess the osteoinductive 
potentials of each protein and their effect on migration, proliferation and 
differentiation of osteoblasts cells. 
 
BMP2-7 heterodimer, BMP2-2 and BMP7-7 homodimer have been used in peri-
implant bone defects in minipig calvaria (Wang et al. 2012) and on minipig 
frontal skull (Sun et al. 2012). BMP fusion proteins could be used in the future at 
ex vivo fractured rat mandible model described in this thesis to gain better 
understanding of the roles of BMP2-7 heterodimer, BMP2-2 and BMP7-7 
homodimer in bone repair. Agarose beads could be soaked in BMP fusion 
proteins then applied to the fracture site. Another application to investigate the 
biological activity of these fusion proteins would be asses its effects on dental 
implants osseointegration, dental and periodontal tissue regeneration. It has 
been demonstrated that BMP heterodimers are more resistant to inhibition by 
antagonists such as noggin (Zhu et al. 2006). Another avenue of investigation 
could be treating fractured rat mandible model topically with BMP2-7 
heterodimer, BMP2-2 or BMP7-7 homodimer followed by trowel type culture in 
the presence of various BMP antagonists. This would allow a greater 
understanding of the osteoinductive abilities of theses fusion protein and hence 
its resistance to antagonists. 
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Chapter 6.  
General discussion and Future Direction 
 
Bone has been reported to contain numerous growth factors which are proposed 
to be released from the matrix during injury and play an essential role during 
bone repair. The thesis set out mainly to investigate the hypothesis that calcium 
hydroxide can release endogenous growth factors from mandibular bone. 
Moreover, the use of combinations of growth factors, such as the combinations 
found in the bone matrix, may be more effective in promoting bone healing 
compared with single growth factor therapy such as BMP2, which has found 
clinical application, but requires high doses to be effective. The thesis 
successfully identifies and compares the effect of bone matrix derived growth 
factor combinations and recombinant BMP2 on cellular behaviour in mediating 
bone repair processes using ex vivo fractured mandible slices model. The model 
was demonstrated an effective way to investigate cellular effect of growth factor 
during early bone repair process.  
 
By comparing the effect of calcium hydroxide and BMP2 on ex vivo fractured 
mandible slices, both treatments demonstrated maintenance of tissue 
architecture throughout the section. Fractured mandible slices treated with 
calcium hydroxide however exhibited a significant increase in cell numbers and 
immunopositivity to bone markers when compared with BMP2 treated slices. 
Calcium hydroxide treated slices were demonstrated a significant increase in 
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release of VEGF, TGF-β1 and BMP2 from treated surfaces. The release of 
these cocktail of growth factors from bone surfaces by calcium hydroxide can 
effectively stimulates cellular reparative processes during bone regeneration and 
consequently will definitely avoid issues regard single growth factor therapy. 
 
Calcium hydroxide at pH 11 was applied continuously to the cells while applied 
topically for 5 min on the fractured mandible slices followed by washing with 
PBS. Thus the alkaline medium caused a decrease in cell number at in vitro but 
increased in cell number at ex vivo model. The alkaline pH of calcium hydroxide 
was lethal to the cells at in vitro but was beneficial to the cells at ex vivo. 
Calcium hydroxide at pH 11 facilitates growth factors released from bone matrix 
stimulating migration and proliferation of the cells. This suggests that calcium 
hydroxide at pH 11 could be not lethal to the cells if applied to the cells for less 
time. Studies support that calcium hydroxide at pH 11 plays dual effects on cells 
as well as on the bone matrix. It could be that single cell culture at in vitro can 
not withstand the alkaline pH like cells surrounded by bone matrix at ex vivo 
fractured mandible slices which provide support to the cells to tolerate the 
alkaline pH.  
 
Growth factors are essential during wound healing and tissue regeneration (Raja 
et al. 2009). During repair process, every growth factor has precise role, at 
specific concentration and at definite exposure time. Application of different 
growth factors at same time may work in agonist or antagonist way. 
Supplementation or overexpression of VEGF has been shown to inhibit BMP2 
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expression and osteogenesis in rat mesenchymal stem cells and ectopic bone 
formation in in vivo (Schonmeyr et al. 2010). BMP2 and TGF-β1 have been 
shown to have opposite effects on osteoblast differentiation and mauration in 
which TGF-β1 inhibited the ability of BMP2 to induce cell mineralisation 
(Spinella-Jaegle et al. 2001). However, scaffolds with dual release growth factor 
(VEGF & BMP2) have shown to enhance bone regenerative capability in a 
critical sized femur defect in which VEGF was released more after 7-days in 
culture up to 28 days then an increased in BMP2 compared to VEGF was 
observed (Kanczler et al. 2010). Thus delivering combination of different growth 
factors should be applied in an optimal ratios and precise delivery system. 
Results of this thesis have been demonstrated that using calcium hydroxide can 
provide an effective way to utilise endogenous growth factors. Avenue for future 
study is to investigate if calcium hydroxide can stimulate bone regeneration 
greater than scaffolds with dual release growth factor. Clinical application of 
calcium hydroxide on bone will be easier and avoid the obstacles of constructing 
a scaffold with multiple growth factor release which will need a long time to be 
approved for clinical use. 
 
Several experimental and clinical trials have supported the safety and efficacy of 
using exogenous growth factors and some growth factors have been licensed for 
clinical use particularly BMP2 and BMP7 (Axelrad and Einhorn 2009). Current 
clinical BMPs therapies use a single BMPs treatment to treat bone injuries. 
However, multiple BMPs are expressed during bone development and fracture 
healing. The high dosages of BMP2 and BMP7 at current clinical therapies are 
due to the short half-life of the protein. Using Fc domain and (3XGGGGS) linked 
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protein were successfully stimulated bone osteogenesis greater than 
commercially available recombinant BMP2. It has been demonstrated that Fc 
domain and (3XGGGGS) linker provide greater protein solubility, flexibility, 
stability and function as it improves fusion protein expression and folding as well 
as protein half-life (Chen et al. 2013). Clinical use of BMP2 has been associated 
with several complications such as hematoma, swallowing and breathing 
difficulties (Shields et al. 2006; Smucker et al. 2006) and epidural heterotopic 
ossification (Joseph and Rampersaud 2007). These significant side effects are 
either caused by the high dose which can reach to milligram, the delivery 
mechanism or off-label use of the growth factors. However using calcium 
hydroxide to release endogenous matrix-bound growth factors can provide 
alternative safe and effective way for bone repair and regeneration. Calcium 
hydroxide has been used for ages to facilitate formation of reparative dentine 
and demonstrates ability to release TGF-β1 from the dentine (Tomson et al. 
2007) and from bone slabs (Smith et al. 2011). Further Investigation of applying 
calcium hydroxide at pH 11 on in vitro cells culture for 5 min and topical 
application of calcium hydroxide at pH 7 on ex vivo fractured mandible slices is 
advisable. Looking at that will give better understanding on the effect of calcium 
hydroxide at different pH on the cells. 
 
Bone repair is mainly carried out by synthesis and deposition of bone that 
carried out by bone cells, particularly osteoblast cells, which are post mitotic 
cells and have a short half-life (Almeida and O'Brien 2013). For bone formation 
to continue uninterrupted throughout the healing process, osteoblast cells need 
to be constantly replaced to supply injury site with new cells originating from 
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osteoprogenitor cells (Park et al. 2012).  Results demonstrated that periodontal 
ligament stem cells can provide a good source for multipotent stem cells that 
have osteogenic potential and able to differentiate into osteoblast cells during 
fracture repair. Another venue of future investigation would be looking to marker 
of PDLSCs such as periostin and α-smooth muscle actin (αSMA) that proved to 
be a useful marker for identification of stem cells in the periodontium (Horiuchi et 
al. 1999; Fujii et al. 2008; Fujii et al. 2010). PDLSCs can be harvested easily 
from impacted or extracted teeth and used for investigating effect of calcium 
hydroxide and BMP2 and BMP7 homodimers and BMP2-7 heterodimer. 
PDLSCs can also be isolated and transplanted with a scaffold into fractured 
bone to investigate chemically derived growth factors on enhancing bone repair.  
 
The novel findings gathered from the studies of this thesis indicate that ex vivo 
mandible model can be fractured and cultured with trowel type culture for long 
time without gross damage to the adjacent tissue. Ex vivo mandible model and 
Trowel type cultures can be considered a suitable and reproducible way to 
investigate effect of novel material. Ex vivo fractured mandible model can be 
stimulated by exogenous growth factors (BMP2) and chemically induced 
endogenous growth factors. Interestingly, calcium hydroxide is found to induce 
release of TGF-β1, BMP2 and VEGF from the bone matrix which influences 
cellular reparative processes. Although the studies were carried out on 
mandibular bone, the clinical end point of these results can be extended beyond 
fractured mandibular bone. For instance calcium hydroxide can be used to 
facilitate osteointegration through inducing endogenous growth factor release 
from the bone before implant, plates and screw placement. It can be used after 
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tumour resection to improve healing after bone reconstruction. Furthermore, 
calcium hydroxide can be apply on bone surface before placing scaffold and 
bone graft to accelerate bone regeneration through the release of endogenous 
growth factors. All of these suggestions will accelerate bone reparative 
processes and improve bone repair clinical outcomes. 
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